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Synopsis 
The importance of vascular risk factors in various age-related pathologies has been 
extensively researched. Nevertheless, the haemodynamic disturbance occurring in 
various ocular and systemic vascular beds to impact upon ocular function remained 
largely unknown. The purpose of the following studies was to explore the presence and 
impact of both ocular and systemic vascular dysregulation as well as biochemical vascular 
risk factors in healthy elderly individuals and patients with age-related macular 
degeneration. Furthermore, the possible role was played by circulatory oxidative stress 
and its relationship with endothelial dysfunction at both ocular and systemic levels has 
also been investigated. There were four principal sections to the present work: 
 
1. To assess the relationship between ocular and systemic anti-oxidative defence 
in healthy individuals  
The principal findings of this work were: 
 It has been shown that MPOD significantly and positively related with circulatory GSH 
levels. 
 
2. To investigate macro- and microcirculation and oxidative stress in early AMD 
patients without overt systemic disease 
The principal findings of this work were: 
 AMD patients exhibit abnormal macrocirculation compared to the controls. 
 Blood GSSG level was significantly higher in early AMD patients than controls. 
 AMD patients showed abnormal microcirculation at retinal level compared. 
 In early AMD patients, retinal venous RT positively correlated with blood GSSG 
levels. 
 
3. To assess the relationship between ocular vascular function and circulatory 
markers of endothelial dysfunction and CVD risk  
The principal findings of this work were: 
 Age had a positive effect on ET-1, vWF and slope of retinal arterial constriction in 
otherwise healthy individuals. 
 Even in otherwise healthy individuals, retinal arterial vascular function showed a 
significant correlation with circulatory markers of endothelial dysfunction and CVD 
risk. 
 
4. To assess age-related changes in ANS and vascular function, and their 
relationship to retinal vascular function parameters  
The principal findings of this work were: 
 Elderly individuals demonstrated abnormal circadian changes of PSNS activity 
compared to middle-aged group. 
 Elderly groups showed higher ET-1 and vWF level as well as C-IMT and AIx, and also 
impaired retinal vascular function compared to the middle-aged group. 
 In the elderly group, impaired retinal vascular function significantly correlated with the 
dysregulation of PSNS activity. 
 
Keywords: Retinal vascular function, oxidative stress, endothelial function, age-related 
macular degeneration.  
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1.1 Background 
The number of aged people has increased during the past 50 years in the developed 
countries (Wood et al., 2005), as the life also improved reaching today in England 82 
years for women and 77 years for men (Hayes et al., 2011); compared with 49 years for 
women and 45 years for men in 1901 (Hicks J, 1999). However, despite an improvement 
in the living condition elderly individuals still face higher risk of chronic diseases that can 
dramatically affect their quality of life. 
 
Ageing is a primary risk factor for dysfunctions in all systems and organs of the human 
body including the eye and the blood vessels, thus resulting in high rates of disability and 
mortality. In addition, it also results in biochemical imbalances with high levels of oxidative 
stress (Cai et al., 2000;Khandhadia and Lotery, 2010), chronic inflammation (Nagineni et 
al., 2012) and endothelial dysfunction (Lip et al., 2001) that all contribute further to various 
ocular and systemic morbidities. Indeed, ocular diseases such as cataract (Haveman et 
al., 2011), glaucoma (Leske et al., 2008) and age-related macular degeneration (AMD) 
(Jonasson et al., 2011) occur with an increased frequency in elderly individuals. 
Systemically, ageing results in dilation, stiffening and thickening of the arteries as well as 
a reduction in cardiac function (Lee and Oh, 2010;Sawabe, 2010). Moreover, ageing is 
accompanied by a reduction in parasympathetic tone even in the absence of disease, 
resulting in a high risk for hypertension (Charkoudian and Rabbitts, 2009). The 
endothelium power to counteract the sympathetic-induced vasoconstriction is also 
diminished in the elderly, therefore contributing to the increased cardiovascular risk and 
mortality in these individuals. Moreover, a high blood pressure (BP) variability associated 
with an impaired ability of the body to counteract it, could also contribute to the higher risk 
for acute circulatory events in elderly population. This haemodynamic imbalance could 
affect multiple organs, including the eye. 
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The role of systemic circulatory disturbances in the aetiology of age-related ocular 
diseases resulting in blindness, such as AMD and glaucoma have been extensively 
studied (Caprioli et al., 2010;Choudhury et al., 2011;Gherghel et al., 2010;Sato et al., 
2006a); however, changes in retinal microcirculation that occur with ageing in the absence 
of systemic disease have been addressed by far fewer investigating (Klein et al., 
2007;Zaliuniene et al., 2008). Moreover, the effect of ageing on the vascular function in 
retinal circulation and its relationship to systemic circulatory abnormalities and 
biochemical imbalances has not been properly studied.  
 
Therefore, gaining more knowledge in this area could be important for better prevention 
and early diagnosis of blinding diseases and their systemic vascular associations; in 
addition, a comprehensive study of the link between vascular microcirculatory changes 
with other systemic and biochemical markers for ageing-related disturbances would be 
necessary for patient-tailored preventive and/or therapeutic intervention to decrease the 
risk for morbidity and mortality in patients at risk. The purpose of the present work was to 
study these complex relationships in both healthy elderly individuals and in patients 
suffering from AMD. 
 
For the purpose of interpretation of this thesis, understanding the anatomy and physiology 
of the systemic and ocular circulation and their regulatory mechanisms are required. A 
summary of these is also presented in the first part of this report. 
 
1.2 Ageing and cardiovascular system’s health 
1.2.1 Anatomy of cardiovascular system 
The present research concentrates on both systemic and ocular circulation in healthy 
elderly and in patients with AMD. Cardiovascular activity and BP in general are great 
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important for ocular circulation. Therefore, an understanding of the cardiovascular 
anatomy and physiology is necessary in this study. 
 
The cardiovascular system is a part of the circulation system, which distributes bloods to 
the whole body. The main components of the cardiovascular system are the heart and 
blood vessels (arteries, capillaries and veins). The cardiovascular system includes two 
circulations:  
 Pulmonary circulation: the heart (right side) receives deoxygenated blood from the body at 
low pressure and pumps it to the lungs. 
 Systemic circulation: the heart (left side) receives oxygenated blood away from the lungs 
and pumps it at high pressure to the body. 
 
The human heart as a pump is responsible for maintaining the blood circulation around 
the vascular network of the body. It consists of four chambers: the left and right atrium, 
and left and right ventricle (Figure 1.1). The right atrium receives deoxygenate blood from 
the body through the superior vena cava, and the deoxygenate blood is then ejected to 
the right ventricle, and then into the pulmonary artery and into the pulmonary circulation 
(Gray, 1985). After the pulmonary circulation, oxygenated blood returns to the left atrium 
through the pulmonary vein, and then is pumped to the left ventricle, aorta, and into the 
systemic circulation to supply oxygen and nutrient to all tissues and organs (Gray, 1985).  
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Figure 1.1: Systemic circulation shows red colour is oxygenated blood, and blue 
colour is deoxygenated blood. Adapted it according to Gray (Gray, 1985). SVC: 
superior vena cava; RA: right atrium; RV: right ventricle; PA: pulmonary artery; PV: 
pulmonary vein; LA: left atrium; LV: left ventricle; AO: aorta.  
 
1.2.1.1 Vascular structure  
Systemic circulation is the part of the circulatory system which carries oxygenated blood 
away from the heart to the body, and returns deoxygenated blood back to the heart. The 
blood vessels acts as a key part of the vascular circulation, and play a vital role in the 
movement of blood throughout the body. The human vessels are divided to three 
varieties: arteries, capillaries and veins. In general, most human blood vessels usually 
consist of three histological tunics (membranes) from the outermost layer of the blood 
vessel inward. Anatomically, they are the tunica adventitia, the tunica media and the 
tunica intima (Figure1.2).  
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Figure 1.2: Diagram showing the layers of vessels. Adapted it according to Pugsley 
and Tabrizchi (Pugsley and Tabrizchi, 2000). 
 
Tunica adventitia  The outermost layer of the blood vessel. It is almost entirely made 
of fibro-elastic connective tissue, which provides stability for blood vessels. It also contains 
nerves that supply the vessel (Pugsley and Tabrizchi, 2000). 
 
Tunica media  The thickest layer as mainly contains smooth muscle cells and elastin 
fibers. These cell layers tend to be more highly organized in larger arteries and play an 
important role in the movement of blood. Another layer that is common to this membrane 
of the blood vessel is an external elastic lamina, which provides structural support 
(Pugsley and Tabrizchi, 2000).  
 
Tunica intima  The innermost and thinnest constituent layer, and is made up of a 
single layer of endothelial cells and surrounded by an internal elastic lamina, which 
organized by a thin layer of sub-endothelial fibro-elastic connective tissue that provides 
flexibility and stability for endothelial cells (Pugsley and Tabrizchi, 2000). 
 
The layer of endothelial cells forms the endothelium, and performs an important role in 
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maintaining vascular homeostasis (Kedzierski and Yanagisawa, 2001;Rubanyi and 
Botelho, 1991;Rubanyi, 1993;van Hinsbergh et al., 1983) through a number of important 
primary regulatory functions: 
 
 Synthesis of collagen I, fibronectin, laminin and growth factors that contribute to 
tissue synthesis and catabolism. 
 Production of intracellular adhesion molecules, vascular cell adhesion 
molecules, and E-selectin promoting leukocyte recruitment and activation. 
 Hydrolysis of low-density lipoprotein in order to aid lipoprotein metabolism. 
 Production and release of coagulant and anticoagulant factors as well as 
vasodilator and vasoconstrictor factors to aid haemostasis. 
  
1.2.1.2 Coronary arteries 
The coronary arteries are the first blood vessels which branch off from the aorta. The 
coronary arteries extend from the aorta to the heart walls supplying blood to the atriums, 
ventricles and septum of the heart. There are two main coronary arteries: right coronary 
artery and left coronary artery (Figure 1.3). The right coronary with one major branch 
(posterior descending artery) mainly supply oxygenated blood to right atrium and ventricle 
as well as the interventricular septum, in some cases they may also supply parts of the left 
atrium and left ventricle (Gray, 1985). The left coronary artery directs oxygenated blood to 
the two major branches: left anterior descending artery and left circumflex artery (Figure 
1.3). The left anterior descending artery mainly nourishes the ventricles and left atrium as 
well as to the anterior portion of the interventricular septum; whereas the left circumflex 
artery mainly nourishes the ventricles and left atrium (Gray, 1985). The venous blood is 
drained via the coronary veins, which follow a distribution similar to the main coronary 
arteries. 
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Figure 1.3: Vascular supply of heart via coronary arteries.  
 
1.2.1.3 Common carotid arteries  
Oxygenated blood originating from the pulmonary circulation, is pumped to the body via 
the aortic arch (a part of AO). The major arteries supplying the upper body are from the 
upper border of aortic arch, including the brachiocephalic artery, left common carotid 
artery and left subclavian artery (Gray, 1985). Indeed, the principal arteries of supply to 
the head and neck are the two common carotid arteries, one for each side. The left and 
right common carotid arteries follow the same course excepting their origin. The left 
common carotid artery originates from the aortic arch, and the right arises from the 
brachiocephalic artery (Gray, 1985). They ascend in the neck and each divides in two 
branches: the external carotid artery which supplies the exterior of the head, the face and 
the greater part of the neck; in addition, the internal carotid artery, supplying to a great 
extent the parts within the cranial and orbital cavities including the ocular circulation such 
as ophthalmic artery and its branches that supply all the structures in the orbit as well as 
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some structures in the nose and face (Gray, 1985). More details of ocular vessels supply 
will be described in Section 1.3. 
 
The blood in ocular or cerebro-circulation through the local capillaries and microcirculation 
to drain into the internal jugular veins (left and right internal jugular veins) (Gray, 1985), 
which collect the deoxygenated blood from the head and neck as well as ocular venous 
drainage. Ultimately, those blood drain into the right atrium (RA) through the superior vena 
cava (SVC) (Gray, 1985).  
 
1.2.2 Vascular physiology 
Blood vessels play an important role to transport blood throughout the body due to their 
both elastic and conduit properties. The blood vessels, particularly arteries have a degree 
of ability to regulate their inner diameter by vasodilation and vasoconstriction of the 
smooth muscular layer, which is mediated by endothelial-dependent factors [55]. This 
changes the blood flow to downstream tissues and organs, and is controlled by the 
autonomic nervous system (ANS). Oxygen and other nutrients carried by the blood from 
the heart to arteries, and to the capillaries which enable the actual exchange of nutrients 
between the blood and the tissues, and then the veins carry the deoxygenated blood from 
the capillaries back toward the heart (Levick, 2000). This circulating blood exerts a force 
to the vascular walls that is also named BP, which is one of the principal vital signs.  
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1.2.3 Cardiac physiology 
1.2.3.1 Cardiac cycle 
The cardiac cycle consists in electrical and mechanical events that result in rhythmic atrial 
and ventricular contractions that pump blood into the systemic and pulmonary circulations 
(Lilly, 2003).  
 
Electrical events The cardiac muscle, also called the myocardium, undergoes 
automaticity and rhythmic contractions coordinated by the sinoatrial node (SAN, also 
known as the cardiac pacemaker), which is located in the upper wall of the right atrium 
(Gray, 1985). In the normal human adult heart, the SAN generates oscillations of 
approximately 70 beats per minute. From SAN, the electrical excitation spreads over the 
atria and when it reaches the junction between the atria and the ventricles, it excites 
another electrical centre named the atrioventricular node (AVN). The ventricular 
contraction is the result of transmission of the excitatory signal along a bundle of modified 
cardiac fibres known as the Purkinje bundle (Levick, 2000). 
 
Mechanical events The ventricular contraction (systole) is the beginning of the cardiac 
cycle. As the ventricles start contraction, the inside pressure of ventricles increased 
rapidly and soon exceed the inside the aorta and pulmonary artery, leading to the blood is 
ejected into the pulmonary and systemic circulations (Levick, 2000). After the ejection, the 
pressure decrease and ventricles relax and refilled with blood, the process referred to as 
diastole; then the cycle repeats itself. 
 
1.2.3.2 Autonomic control of cardiac rhythm 
The heart is innervated by both the sympathetic and parasympathetic divisions of the 
ANS; heart rate (HR) monitoring is thus a reflection of their modulating effect on the 
Chapter 1 
_______________________________________________________________________ 
 
34 
 
cardiac pacemaker cells (Goldberger, 1999). During the day, there is an augmentation of 
sympathetic tone, while vagal (parasympathetic) tone is highest during resting conditions 
(Goldberger, 1999). Sympathetic activation results in an increase in HR, conduction 
system velocity and contractility (Freeman, 2006;Stiell et al., 1992), while parasympathetic 
innervation slows the HR via the direct activation of acetylcholine (Pumprla et al., 2002).  
 
1.2.4 The electrocardiogram (ECG) 
The electrocardiogram (ECG) is a non-invasive technique to measure cardiac activity. It 
provides the information about both on cardiac structure and function.  
 
1.2.4.1 Sequence of normal cardiac activation 
Each cardiac cycle (heart beat) is shown by an ECG, consists of three major parts 
(Levick, 1995) (Figure 1.4): 
 
 P wave is the first positive wave of the cardiac cycle. It represents atrial 
contraction (depolarization).  
 QRS complex represents the rapid contraction of the ventricles/ventricular muscle 
cells. A typical QRS complex includes three continues waves: Q-wave is the first 
downward wave of the QRS complex; followed by an upward R-wave which is a 
narrower and taller wave; and S-wave is defined as a downward wave following 
the R-wave (Lilly, 2003). 
 T wave represents the recovery (repolarization) of the ventricles.  
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Figure 1.4: The cardiac cycle is expressed by the ECG graph. ECG: electrocardiogram. 
PR interval: the time measured from the beginning of the P wave to the beginning of the 
QRS complex; RR interval: the time measured between an R wave and the next R wave; 
QT interval: the time from the beginning of the QRS complex to the end of the T wave. 
 
1.2.4.2 Technical considerations 
ECG is recorded on either a paper or computer monitor. The ECG graph represents with 
time on horizontal (X) axis and voltage on vertical (Y) axis. The graph paper has a 
background pattern of 1mm squares. As at a paper speed of 25mm/s, therefore each 
1mm horizontal line separation represents 0.04 seconds. The voltage is expressed in 
millivolts (mV), and each 1mm vertical line separation represents 0.1 mV (Figure 1.5). 
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Figure 1.5: An electrocardiogram strip. Each 1 mm on the vertical axis represents 0.1 
mV and each 1mm on the horizontal axis represents 0.04 seconds. 
 
1.2.4.3 ECG analysis 
ECG is altered whenever there is a cardiac abnormality or disease. Therefore, a careful 
analysis is crucial for detection of pre-clinical and/or clinical conditions. The below 
parameters can be accessed through the ECG (Lilly, 2003): 
 
 HR is the number of heartbeat in one minute. It is calculated according to one of 
the formulas (Equation 1.1) through the ECG: 
 Heart rhythm: the normal heart rhythm is represented at HR between 60-100 
beats/minute which is referred as a normal sinus rhythm.  
 Major waves and their abnormalities.    
 Intervals (PR, QRS complex, QT) (Figure 1.4). Normal PR interval is between 0.12 
and 0.2 sec; QRS complex is less than 0.1 sec; QT interval is between 0.3 and 
0.43 sec, or < ½ RR interval (Lilly, 2003). 
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 ST-segment and T wave abnormalities. These occur whenever there is a 
difference between myocardial oxygen demand and supply (myocardial ischaemia) 
and are represented by:  
- ST depressions, in subendocardial ischaemia and metabolic abnormalities; 
- ST elevations, in cardiac infarct and pericarditis (inflammation of the 
pericardium). 
 
                
Equation 1.1: The calculation of heart rate through an electrocardiogram strip. 
 
1.2.5 Systemic blood pressure 
During the contraction (systole) and expulsion of the blood from the left ventricle, the 
aortic pressure rises from its resting value of about 80 mm Hg (DBP-diastolic BP) to about 
120 mm Hg (SBP-systolic BP). It is this pressure that is measured with a 
sphygmomanometer. However, these values can vary due to various factors such as 
(Sunthareswaran, 2002): 
 
 Ageing; this causes an increase in BP due to a concomitant decrease in arterial 
compliance. As a rule, SBP is equal to 100 mmHg plus age in years; 
 Sleep; 
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 Exercise can increase BP due to either increase in cardiac output or as a result of 
the pressor response; 
 Stress increases BP due to a higher sympathetic tone during periods of stress. 
 
In 1978, Millar-Craig et al. first described a circadian pattern of BP variation (Millar-Craig 
et al., 1978). The classic description states that in healthy young subjects after waking, 
SBP rises rapidly by 20 to 25 mmHg and DBP by 10 to 15 mmHg, throughout the rest of 
the day levels are then highest in the late afternoon, beginning to decline in the evening 
and attaining lowest levels during sleep (Baumgart, 1991;Hermida et al., 2007;Smolensky 
and Haus, 2001). In addition, recent data also shows that BP exhibits two peaks in day-
time: one around 9am and one around 7pm; and also men exhibit higher BP and lower 
HR than women (Hermida et al., 2007). This variation in systemic BP is due to mainly to 
external factors, such as physical activity, temperature, emotional state, diet, consumption 
of alcohol and caffeine as well as sleep-night routine (Baumgart, 1991;Hermida et al., 
2007). Several attempts have been made to eliminate these external influences and 
determine the “true” circadian variation in BP. Previous studies reported that subjects 
during 24-h of bed rest and found that the circadian rhythm of BP had a smaller amplitude 
compared to those reported under normal, ambulatory conditions (Mann et al., 1979;van 
den Meiracker et al., 1988). And later reports found that subjects confined to 24-h bed rest 
without sleep and with meals distributed evenly across a 24 hour period, there was no 
circadian rhythm in BP (Kerkhof et al., 1998;Van Dongen et al., 2001). Nevertheless, the 
effect of endogenous variables such as variations in the ANS activity, and in the levels of 
biological active substances should not be neglected. It has been shown that plasma 
levels of catecholamines (Akerstedt and Froberg, 1979)  and muscular sympathetic nerve 
activity (Somers et al., 1993) decrease at night. Moreover, there is a decrease in plasma 
cortisol, resulting in reduced vascular sensitivity to catecholamines (Reis, 1960). The 
nocturnal reduction in BP could further exacerbated by a lower venous return due to 
translocation of blood to the peripheral circulation (Cranston, 1964) and the effects of the 
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recumbent posture typically adopted during sleep which suppresses renal sympathetic 
activity and the renin-angiotensin system, and facilitates sodium and water excretion 
(Takakuwa et al., 2001). 
               
1.2.6 Vascular function 
Vascular tone/function is mediated by vascular smooth muscle cells, and mostly is 
influenced by a range of endothelium-derived factors through vasodilation and 
vasoconstriction. It has been shown that endothelium not only regulates vascular tone, but 
also plays a role in the coagulation processes, maintaining vascular structure, and 
mediating inflammatory and immunological responses (Davies and Hagen, 1993;Rubanyi 
and Botelho, 1991). Vasoactive, endothelium-derived factors include prostanoids, nitric 
oxide (NO) and NO-containing compounds, smooth muscle cell hyperpolarization factors, 
and endothelin. Furthermore, the local renin-angiotensin system in the vessel wall is also 
involved in vasomotor regulation (Blazquez-Medela et al., 2010). These endothelium 
released factors can be divided into endothelium-derived relaxing factor and endothelium-
derived constricting factors (Dorner et al., 2003).  
 
1.2.6.1 Endothelium-derived relaxing/dilating factor 
Production of the so-called endothelium-derived relaxing factor (EDRF) was first 
described by Furchgott and Zawadzki in 1980 (Furchgott and Zawadzki, 1980). They 
observed that the vasodilation induced by acetylcholine is dependent on the presence or 
absence of vascular endothelium. They concluded that the endothelium produces an 
EDRF, and plays a key role in the effects of acetylcholine on vascular tone. Recently, it 
has been proved that EDRF-mediated vasodilation response is present also in the rat 
retinal arterioles (Mori et al., 2011). 
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Initially believed to be the same as EDRF, NO was also recognized for its vasodilation 
properties (Palmer et al., 1987) and its roles in systemic and ocular vascular physiology 
have been investigated in depth (Dorner et al., 2003;Haefliger et al., 1994a;Haefliger et 
al., 1994b;Kiss et al., 1999;Koss, 1999;Schmetterer and Polak, 2001). 
 
The NO has a very short half-life, and is synthesized from oxygen and L-arginine by NO 
synthases (NOS). Three different isoforms of NOS have been identified including 
endothelial isoform (endothelial NO synthase, eNOS), neuronal isoform (nNOS) and 
inducible isoform (iNOS) (Arnal et al., 1999). NO release could be regulated by shear 
stress (Arnal et al., 1999) which described as a frictional force acting in the direction of 
blood flow on the surface of endothelium, and pressure-stretch which acts perpendicularly 
to the vascular wall and affects endothelial cells and smooth muscle cells (Michiels, 2003). 
The increase in blood flow that can induce the shear stress and leads to an increased NO 
release from endothelial cells (Xiao et al., 1997). Shear stress causes a rapid eNOS 
activation and upregulates eNOS gene expression by transcription activation of the eNOS 
promoter (Xiao et al., 1997).  
 
NO also can diffuse to the vascular smooth muscle cells where it stimulates soluble 
guanylate cyclase (GC) resulting in an accumulation of cyclic guanosine monophosphate 
(cGMP) and subsequent vasodilaton (Denninger and Marletta, 1999). NO also play a key 
role to control the blood pressure, as verified that infusion of a NOS inhibitor such L-
NMMA, can increases the blood pressure through the regulation of vasodilation and 
vasoconstriction (Fleming et al., 1996).   
 
Other roles of NO include:  
 Anti-oxidative and neuroprotective effects by interaction with reactive free radicals 
(Mastrodimou et al., 2008;Tsuda, 2009). 
 Mediating toxicity after excess glutamate release (Osborne et al., 1999). 
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 Inhibition of the rolling and adhesion of leukocytes in micro-vessels (Hickey, 2001). 
 Regulation of intestinal motility (Huang et al., 1993). 
 Role in penile erection (Chuang et al., 1998). 
 
Since NO has such complex and varied roles, any disturbances in its homeostasis could 
have important consequences. Indeed, it has been shown that systemic NO deficiency 
can result in (Avogaro et al., 2011;Bhutto et al., 2010;De Caterina et al., 1995;Kaur and 
Halliwell, 1994;Pigozzi et al., 2011): 
 Excessive vasoconstriction 
 Increased oxidative stress 
 Inflammation 
 Platelet aggregation and thrombosis 
 Leukocyte activation and infiltration  
 
There has been extensive research into the role of NO on ocular circulation (Dorner et al., 
2003;Kiss et al., 1999;Koss, 1999;Mastrodimou et al., 2008;Schmetterer and Polak, 
2001;Totan et al., 2001). In animal studies, NO has been able to modulate the contractile 
tone of retinal pericytes (Haefliger et al., 1994b) and Müller cells (Kawasaki et al., 1999). 
The human ocular angioarchitecture is, however, different from that of other species. 
Human experiments indicate that the arterioles and capillaries are in a constant state of 
vasodilatation, which is maintained by continuous release of NO (Dorner et al., 2003;Kiss 
et al., 1999;Schmetterer and Polak, 2001). 
 
1.2.6.2 Endothelium-derived constricting factors 
Aside their roles in vascular relaxation, endothelial cells also produce potent 
vasoconsticting substances. The most potent endothelial vasoconstictive factors are 
endothelins (ETs), a group of 21-amino acid peptides. The endothelins family consists of 
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three isoforms, which are ET-1, ET-2 and ET-3. Endothelins are not only produced by 
endothelial cells (Pernow and Wang, 1997), but can be also generated from vascular 
smooth muscle cells (Resink et al., 1990) and cardiomyocytes (Suzuki et al., 1993).   ET-1 
generated by vascular endothelial cells has vasoactive properties that affect both systemic 
and peripheral circulation (Angerio and Kot, 1997).  
 
There are two major classes of endothelin receptors in the blood vessels: endothelinA 
(ETA) and the endothelinB (ETB) receptors. The ETB has been further subdivided into ETB1 
and ETB2 based on their pharmacological responses (Leite-Moreira and Bras-Silva, 2004). 
In vascular smooth muscle cells, the activation of ETA receptors evokes marked and 
sustained vasoconstriction, while ETB could mediate NO production. ET-1 and ET-2 have 
a similar affinity for the ETA subtype, whereas ET-3 has much lower affinity for the ETA 
receptor than for ETB. Binding ET-1 causes vasoconstriction through activation of ETA 
which expressed in smooth muscle cells (Kedzierski and Yanagisawa, 2001;Michiels, 
2003). Binding to ETB receptor can mediate ET-1-induced NO release from endothelial 
cells and an accompanying vasodilation response, which opposes the vasoconstricting 
action of ET. This explains the transient vasodilation that usually occurs prior to the 
vasoconstriction (Lanzl et al., 2011).  
 
In the choroid, both ETA and ETB receptors have been found, and could be involved in the 
modulation of choroidal blood flow (MacCumber and D'Anna, 1994;Wollensak et al., 
1998). In choroid, the interaction between ETB receptor-mediated NO vasodilation and ETA 
receptor-mediated ET vasoconstriction could occur, although choroidal blood vessels 
appear to be more sensitive to NO than ET in overcoming resistance (Kiel, 1999).  
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1.2.7 Pathophysiology of vascular disease - endothelial 
dysfunction 
Endothelial dysfunction refers to an impairment of endothelium-dependent vasodilation 
caused by a loss of NO bioavailability in vessels wall (Virdis et al., 2010). This 
endothelium-dependent vasodilation represents a protective mechanism against time-
dependent changes in the body‟s haemodynamics; any disturbances in this mechanism 
could, therefore, represent an important risk factor for circulatory ischaemic events 
(Giraldez et al., 1997;Shaw et al., 2001;Zeiher et al., 1995). Indeed, endothelial 
dysfunction indicates a generalised alteration in cells function resulting in an imbalance of 
vasodilation and vasoconstriction, impaired endothelial control of inflammation and 
fibrinolysis and abnormal expression of vascular adhesion molecules (Michiels, 
2003;Virdis et al., 2010).  
 
There are a number of factors that can contribute towards endothelial dysfunction. 
These include an insufficient NO release or bioavailability, overproduction of reactive 
oxygen species (ROS) or ROS are insufficiently degraded that leads to an 
accelerated inactivation of NO (Cai and Harrison, 2000). In addition, high levels of 
vasoconstrictors (Donato et al., 2009;Loot et al., 2009;Rubanyi and Botelho, 1991;Szabo 
et al., 2004) (ET-1, angiotension II) can also play a role. The resultant endothelial 
dysfunction has major consequences on the vascular health that in turn further down-
regulates the endothelial function (Schram and Stehouwer, 2005). Ultimately, endothelial 
dysfunction triggers a set of chain reaction causing biochemical changes that finally lead 
to vascular structural changes and overt systemic vascular diseases (Bartolomucci et al., 
2011;Bartolomucci et al., 2011;Pigozzi et al., 2011;Rubanyi, 1993). 
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1.2.8 Endothelial dysfunction and arterial stiffness  
Arterial stiffness is often used to describe the loss of intrinsic elastic properties of the 
arteries. Endothelial dysfunction is considered an initiating event in adhesion molecule 
expression, leading to leukocyte recruitment into the subendothelial space. In the intimal 
area, macrophage lipid accumulation and secretion of pro-inflammatory mediators, and 
together with vascular smooth muscle cells proliferation and their intimal infiltration that 
accelerate the process of atherosclerosis and arterial stiffness (Nedeljkovic et al., 2003).  
 
The term „arterial compliance‟ refers to the ability of large arteries to distend in response 
to a given pressure. The aorta and its major branches act as an elastic reservoir, buffering 
pulsatile flow from left ventricular ejection, and ensure a smoother, less-pulsatile flow to 
reach the peripheral vasculature (Oliver and Webb, 2003). Most of the arterial tree has 
both elastic and conduit properties, although one or other tends to predominate in any 
given arterial segment. For example, the ascending aorta is predominantly elastic and the 
peripheral, more muscular, arteries are predominantly conduit vessels. Any abnormality in 
arterial compliance could represent a marker of arterial stiffness and, therefore, 
repositions the site of pulse wave reflections. As the blood from the heart travels towards 
to a peripheral artery of decreasing diameter, a reflected force (wave) is created and 
towards to the heart (Oliver and Webb, 2003). When the arteries are compliant (e.g. a 
normal healthy young subject), the reflected arterial waves arrive at the central aorta 
during late systole to diastole (Figure 1.6), thus augmenting DBP and coronary artery 
filling (Oliver and Webb, 2003). As the large arteries stiffen (e.g. advanced age and 
cardiovascular risk factors), wave reflection occurs earlier so that SBP is augmented and 
DBP reduced (Figure 1.6). Therefore, this reflected pulse pressure augmentation could 
represent an indicator of arterial stiffness, and can be measured using the SphygmoCor 
device and pulse wave analysis (PWA). More details about PWA are offered in Section 
2.3.4. 
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Figure 1.6: Representation of reflected pulse pressure augmentation in subjects 
with and without arterial stiffness. When the large arteries are compliant the initial 
systolic pressure wave, P1, traveling from the heart to the periphery, is responsible for 
peak SBP. P2, is reflected pressure waves, arrive at the central aorta in diastole, 
augmenting DBP and coronary artery filling. Whereas large arteries stiffen, wave reflection 
occurs earlier and therefore SBP is augmented and DBP falls. PP: pulse pressure; P: the 
difference between P2 and P1, represents for the pulse pressure augmentation. In 
general, P is negative in healthy young subjects, but is positive in subjects with 
advanced age or increasing cardiovascular risk and arterial stiffness. 
 
1.2.9 Autonomic nervous system (ANS) 
The ANS, along with the endocrine system with which it is closely allied, controls the 
body‟s internal environment. Its name, „autonomic‟ indicates that it is almost entirely 
independent of conscious control. The ANS is divided into two primary systems, the 
sympathetic nervous system (SNS) and parasympathetic nervous system (PSNS), which 
differ in anatomy, pharmacology, and behavioural outcome.  The SNS, first studied by 
Bernard in 1849 (Alquier and Kahn, 2004) readies the organism for emergency and 
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conflict, whilst PSNS is primarily concerned with the conservation of energy and the 
maintenance of the body during periods of rest.  The ANS is also under the influence of 
other important substances and mediators, such as peptides, cytokines and NO that 
together with the hormonal connections controls most of the organs of the human body, 
including the eye (Trachtman, 2010). 
 
The ANS function can be measured using a number of methods (Table 1.1). For the 
purpose of this thesis, the heart rate variability (HRV) was employed for measurement of 
ANS function and is described in Section 2.3.2. 
 
 
Technique Description 
heart rate variability 
(HRV) 
 Frequency-domain analysis of HRV (HF and LF 
parameters) (Iellamo et al., 2006); 
 Time-domain analysis of HRV-analysis or RR intervals 
(Yildiz et al., 2011).  
Provocation tests 
 Valsalva maneuver (Hetzel et al., 1999); 
 Pressor drug infusion (Goldberger, 1999) (Goldberger, 
1999) 
Other techniques 
 Plasma levels of norepinephrine for the overall level of 
sympathetic activity (Cryer, 1977); 
 Microneurography (Hagbarth, 1979); 
 Cardiac norepinephrine spillover for the sympathetic 
firing rate in the heart (Esler, 1993); 
Blood pressure variability (Lanfranchi and Somers, 
2002). 
 
Table 1.1: Autonomic assessment tests. HF: high frequency; LF: low frequency. 
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1.2.9.1 Interaction between ANS and endothelial function: the    vascular 
tone 
In healthy individuals, the ANS works closely with the vascular endothelium to insure a 
stable vascular tone. In response to local factors, the vascular endothelium continuously 
releases vasodilating factors (e.g., NO, endothelium-derived hyperpolarizing factor, 
prostacyclin, substance P, acetylcholine) which counteract the vasoconstrictor effect of 
the sympathetic activation (Harris and Matthews, 2004). The balance between these 
opposing forces acts on the vascular smooth muscle cells to maintain the appropriate 
vascular tone (Burnstock, 1990). Although the vascular endothelial cells do not receive 
direct ANS innervation, it still can be influenced through the activation of its own alpha2- 
and beta- adrenoreceptors that results in NO release and vasodilation (Guimaraes and 
Moura, 2001). In addition, the PSNS can contribute to acetylcholine release and 
vasodilation (van Zwieten and Doods, 1995), while the SNS can stimulate the release of 
endothelium-derived vasoconstrictors such as endothelin-1 (ET-1) (Bacic et al., 
1992;Harris and Matthews, 2004) (Figure 1.7). More recently study has demonstrated that 
nNOS also contributes directly to the regulation of human vascular tone (Seddon et al., 
2008). Maintaining a balance between all these factors is crucial for an appropriate 
perfusion with blood and, any disturbance that occurs in either ANS or endothelial function 
is ultimately reflected in impairments that occur in both systems (Harris and Matthews, 
2004). Indeed, some diseases such as glaucoma, cardiovascular disease, hypertension 
and congestive heart failure, have been associated with both abnormalities of ANS 
regulation (Edwards et al., 2011;Gherghel et al., 2007;Lensch and Jost, 2011) and 
abnormalities of endothelial function (Hornig et al., 1996;Li et al., 1997;Resch et al., 
2009;Su et al., 2008). It is difficult to determine however whether a dysfunction in one 
system may have driven a dysfunction in the other and if so which occurred first, or 
whether both systems have developed a dysfunction independently as part of the disease 
process. In young patients with essential hypertension, both ET-1 levels and sympathetic 
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activation were higher (Kuklinska et al., 2010). Moreover, in patients with congestive heart 
failure, studies have found that ET-1 levels correlate negatively with some measures of 
HRV (Aronson et al., 2001). Nevertheless, other external influences, such as the level of 
oxidative stress and the ageing effect on the vascular function, should also be considered 
when studying the complex interaction between ANS and endothelial function in health 
and disease. Indeed, an altered vascular tone may result in higher vulnerability of various 
organs including the eye to damage from free radicals or inflammatory stress (Hollyfield et 
al., 2008).  
 
                     
 
Figure 1.7: The interactions between the ANS and endothelium to regulate vascular 
tone. ANS: autonomic nervous system; SNS: sympathetic nervous system; PSNS: 
parasympathetic nervous system. 
 
1.2.10 Ageing effect on cardiovascular system 
Ageing associates with a redox imbalance manifested as high levels of oxidative stress 
(Jones, 2006a;Junqueira et al., 2004), inflammation and endothelial dysfunction (Ogita 
and Liao, 2004) and, therefore, confers a background for functional and structural 
disturbances in both macro- and microcirculation in subjects at risk (Nedeljkovic et al., 
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2003). Indeed, dilatation, stiffening, and thickening of the arteries as well as a reduction in 
cardiac functions are widely reported as ageing-associated changes of the vasculature 
(Lee and Oh, 2010;Sawabe, 2010). Although few previous reports suggested that 
sympathetic vasoconstrictor outflow increases with age (Charkoudian and Rabbitts, 
2009;Fagius and Wallin, 1993), more studies demonstrated a decrease in both PSNS and 
SNS controlled function including cardiovascular function are one of the major 
characteristic of senescence (Amano et al., 2001;Antelmi et al., 2004;Bigger et al., 
1996;Choi et al., 2006;Corino et al., 2007;Hrushesky et al., 1984;Oida et al., 1999;Yu et 
al., 2010). The endothelium power to counteract the sympathetic-induced vasoconstriction 
is also diminished in elderly, therefore contributing to the increased cardiovascular risk 
and mortality in these individuals. All this changes are reflected by depressed HRV and an 
increased BP variability in older individuals (Monahan, 2007). HRV depression reflects 
into a lower capacity physical activity; however, as physical activity is important in 
maintaining a good HRV during ageing (De Meersman and Stein, 2007;Tsuji et al., 1994), 
the entire process enters a vicious circle. Moreover, a high BP variability associated with 
an impaired ability of the body to counteract it, could also contribute to the higher risk for 
acute circulatory events in elderly population. This haemodynamic imbalance could affect 
multiple organs, including the eye. This hypothesis will be discussed later in the present 
thesis.  
 
Previous studies demonstrated that a decreased NO production due to ageing was 
associated with various risk for vascular pathologies (Donato et al., 2009;Jin and 
Loscalzo, 2010;Vallance and Chan, 2001). Indeed, in physiological quantities, NO has 
important protective roles; however, in large quantities it can also be toxic, being included 
(together with peroxynitrite -ONOO-) in the so-called reactive nitrogen species (RNS), 
which represent very strong oxidant and can accelerate damage associated with ageing. 
The role of oxidative stress in vascular pathologies will be discussed in Section1.2.11. 
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1.2.11 Oxidative stress and vascular function 
In 1956, Denham Harman suggested that free radical-induced oxidative stress is 
produced during aerobic respiration that causes cumulative oxidative damage to cells and 
tissues (Harman, 1956), resulting in ageing and mortality (Beckman and Ames, 1998). 
Generally, free radicals are defined as unpaired electrons of some molecules and atoms. 
Free radicals are unstable and highly reactive because the unpaired electrons tend to 
form pairs with other electrons. The free radical theory is only concerned with free radicals 
such as superoxide anion (O2
-) strictly (Harman, 1956). Indeed, one and two electrons 
reduction of O2 generates O2
- and hydrogen peroxide (H2O2); further, O2
- and H2O2 
together can generate the hydroxyl radical (OH-) (Beckman and Ames, 1998). Therefore 
free radical has been enlarged to include oxidative damage from H2O2 and OH
- refers to 
ROS.  
 
As ROS are always generated during the organism respires in an aerobic environment 
and highly reactive, it could damage various molecules in the human body. The target 
elements include cellular proteins and lipids, as well as DNA (deoxyribonucleic acid) 
causing biological error that could induce to apoptosis and therefore, accelerate ageing 
process (Kelly, 2011). 
 
In fact, an antioxidant defence could against the harmful action of ROS. Cells can 
synthesize some enzymes to circumvent ROS such as superoxide dismutase (SOD) and 
glutathione peroxidase, small molecule antioxidants such as glutathione, as well as other 
antioxidants are obtained from nature through nutrition such as vitamin C and E, and 
carotenoids (Junqueira et al., 2004). These act as antioxidants can prevent or repair 
oxidative damage on cells and tissues of body. 
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However, if ROS are produced excessively or antioxidants are defective, the balance 
between formation and removal is broken, resulting in oxidative stress (Junqueira et al., 
2004). Consequently, excessive ROS can attack cells and tissues (Stadtman, 2006), thus 
causing various age-related diseases at both ocular (Beatty et al., 2000;Winkler et al., 
1999) and systemic levels (Higashi et al., 2009). For example, AMD, which is the due to 
oxidative stress-induced angiogenesis (the growth of blood vessels from pre-existing 
vasculature), and leading to blood and protein leakage from the neovascular (new growth 
of small blood vessels) below the macular. Therefore, oxidative stress could refer as a 
„harmful state of the body‟, which arises when oxidative reactions exceed antioxidant 
reactions due to the imbalance between them. 
 
Oxidative stress is defined by the presence of pathological levels of ROS relative to the 
antioxidant defence. Excessive production of ROS can lead to DNA mutation, lipid 
peroxidation, protein damage and ultimately cell death via necrosis or apoptosis (Carmody 
and Cotter, 2001;Ueda et al., 2002). This Oxidative stress can induce endothelial 
dysfunction, leads to a series of reaction causing adhesion molecule expression and 
secretion of pro-inflammatory mediators, consequently influence vascular tone and 
function (Nedeljkovic et al., 2003).  
 
In the late 1980s, in the course of defining the mechanisms of endothelial control of blood 
flow (Castro and Freeman, 2001), another free radical species, NO, was described 
(Mulsch et al., 1992). It has also been shown that excessive production of NO can be 
cytotoxic. The rapid reaction between NO and O2
- yields peroxynitrite (ONOO-) an 
extremely potent oxidizing species (Koppenol et al., 1992). Peroxynitrite, referred to as 
RNS, is assumed to react preferentially with CO2 in vivo to produce nitrogen dioxide (NO2) 
and trioxocarbonate radicals. It also nitrates tyrosine residues of the proteins, stimulating 
the production of 3-nitrotyrosine (3-NT), which disrupts the normal function of the proteins. 
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Nitric oxide and secondary species derived from it are known as RNS (Castro and 
Freeman, 2001). 
 
1.2.11.1 Reactive species in human pathology 
In certain situations free radicals can be generated in an exaggerated manner and can 
injure tissues and organs by interacting with their anatomy, physiology or genetic activity 
(Valencia et al., 2002). Oxidative stress has been implicated in a large number of human 
diseases including different autoimmune diseases (Ahsan et al., 2003;Buhl et al., 1989), 
alcoholic liver disease (Videla and Guerri, 1990), cancer (Beutler and Gelbart, 1985), as 
well as in ischaemia-reperfusion injury (Ferdinandy and Schulz, 2003;Nanetti et al., 2011). 
Oxidative stress also results in vascular endothelial dysfunction (Ashfaq et al., 
2008;Nedeljkovic et al., 2003;Ogita and Liao, 2004;Zalba et al., 2007). It has been 
demonstrated that patients with poor endothelial function are at increased risk for 
developing cardiovascular and cerebral ischaemic events (Cai and Harrison, 2000;Pigozzi 
et al., 2011;Zalba et al., 2007).  
 
1.2.11.2 Oxidative stress and ageing 
Ageing is a process of degeneration of tissues with a decrease in cell population, which 
could lead to a decline in organ function over time and an increase in the risk of 
development of disease, even death (Harman, 2001). These senescent changes can 
contribute to the development of genetic defects, disease and the innate ageing process; 
those are the risk factors for disease and death especially in the developed countries 
(Harman, 2006). There are many theories have been considered for the ageing process, 
such as, telomere shortening (Kruk et al., 1995), senescence genes in the DNA (Harman, 
2006) and degeneration of proliferation capability of cells, as well as oxidative stress 
causing harmful accumulation as a toxic factor to reduce the life span of the cells and 
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organism and further accelerate ageing process (Harman, 1993;Harman, 2006). However, 
not a single theory can explain all the mechanisms of ageing, some studies reported that 
free radial-induced oxidative stress plays a vital role for ageing process and ageing-
related pathologies (Beckman and Ames, 1998;Harman, 2006;Junqueira et al., 2004). 
 
This oxidative stress-induced endothelial dysfunction may further result in vasoconstriction 
(loss of vasodilation), platelet aggregation, inflammation, vascular collagen and protein 
synthesis due to insufficiency of NO bioavailability effecting on vascular tone and function 
(Nedeljkovic et al., 2003) and therefore, influences arterial stiffness (Zieman et al., 2005) 
(Figure1.8). Therefore, oxidative stress also plays an important role to vascular tone 
function.  
                  
 
Figure 1.8: Representation of a relationship between oxidative stress and NO, and 
their mediated actions on vascular function. ROS: reactive oxygen species; NO: nitric 
oxide; eNOS: endothelial NO synthase.  
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1.3 Anatomy of ocular vessels  
1.3.1 Retrobulbar vascular supply  
The retrobulbar ocular vessels (Figure 1.9) are comprised of ophthalmic artery (OA), 
central retinal artery (CRA) and ciliary arteries. The OA, which represents the first branch 
of the internal carotid artery (ICA), provides most of the blood supply to the orbit and to 
some of the surrounding scalp (Wang et al., 1998). It enters the orbit through the optic 
foramen, below and lateral to the optic nerve and then passes over the nerve to reach the 
medial wall of the orbit. From this point the OA is situated horizontally, beneath the 
superior oblique muscle.  
 
The CRA represents a direct branch of the OA. It enters the medial aspect of the optic 
nerve approximately 5-15 mm behind the globe; then it travels inside the optic nerve 
before appearing at the surface of the optic disc. The CRA provides four retinal arterioles 
(one for each quadrant of the retina), and several small branches within the anterior optic 
nerve.  
 
The ciliary arteries are divided in three groups: short posterior, long posterior and anterior 
ciliary arteries. In normal population there are 1 to 5 posterior ciliary arteries (PCAs); they 
branch from the OA and are then grouped into medial and lateral trunks situated either 
side of the optic nerve. Each main PCA divides into approximately 10 to 20 short PCAs 
just before or after entering the posterior sclera (Harris et al., 1998). They supply the 
choroid, and ciliary processes. The anterior ciliary arteries leave the OA and run a short 
course within the rectus muscles bellies; then travel forward and reach the anastomotic 
circle in the ciliary muscle and the major arterial circle of the iris, supplying mainly the 
anterior uvea (Buchi, 1996). 
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Figure 1.9: The anatomy of ocular blood arteries. Adapted it according to Snell and 
Lemp (Snell and Lemp, 1998).  
 
1.3.2 Retinal circulation 
Retinal vessels are supplied by the CRA, which branches to form four retinal arterioles, 
one for each quadrant of the retina (Gray, 1985). These arterioles are situated within the 
nerve fibre layer (NFL) and give rise to an extensive capillary network that supplies the 
inner two thirds of the retina. 
 
There are strong resemblances between the retinal and the brain circulations; the 
principle difference is that the retinal circulation has no autonomic innervation (Bill and 
Sperber, 1990). The retina is protected from toxic molecules by a blood-retinal barrier 
similar to the blood-brain barrier; this is due to the presence of tight junctions between 
retinal capillary endothelial cells, which prevent leakage of proteins, lipid molecules and 
small water-soluble metabolic substrates (Sagaties et al., 1987;Simo et al., 2010;Strauss, 
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2005). The retinal endothelial cells are surrounded by a single layer of muscular pericytes, 
which help in altering local vascular resistance (Ciulla et al., 2002;Sims, 1986). 
 
Due  to  their  functional  structure,  the  retinal  endothelial  cells  are  considered  to  be  
a  major component of the inner blood-retinal barrier (BRB). The endothelium maintains 
retinal blood flow and vessel tone by releasing vasoactive factors (NO, ET-1) have 
been already described in Section 1.2.6.1 and 1.2.6.2. 
 
1.4 Regulation of ocular blood flow 
An adequate blood supply is a basic requirement for all tissue beds to remain healthy. In 
order to maintain a constant perfusion, the cardiovascular system has the ability to adjust 
the vascular resistance. In 1902, Bayliss suggested that despite variation in systemic BP, 
arteries could preserve constant blood flow through the tissues due to the existence of 
vascular tone provided by vascular smooth muscle or other contractile elements in the 
vessels‟ wall (Bayliss, 1902). This mechanism is called autoregulation and represents the 
mechanism that allows tissues and organs to get a proper blood supply despite varying 
haemodynamic conditions (Orgul et al., 1999;Qrgul et al., 1995). 
 
The vascular tone is adjusted by vasoactive nerves and circulating hormones, as well as 
endothelial factors, myogenic and metabolic factors. These adjustments are described 
below. 
 
1.4.1 Metabolic autoregulation 
The metabolic hypothesis of blood flow autoregulation suggests that perfusion and tissue 
metabolism are tightly coupled. Therefore, any reduction in arterial blood flow results in an 
increase of vasodilator metabolites in the affected tissue; this could be the result of either 
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insufficient washout or increase in the production of metabolites, or both (Kontos et al., 
1978;Orgul et al., 1999;Sullivan and Johnson, 1981). The metabolic products that may 
influence the vascular tone include adenosine, potassium (K+), carbon dioxide (CO2), pH 
and osmolality changes (Ishizaka and Kuo, 1997). Moreover, changes in tissue oxygen 
(O2) levels can also influence vascular tone (Johnson, 1986). 
 
1.4.1.1 The role of CO2 
In the cerebral circulation, decreased arterial blood oxygen saturation is compensated by 
increased cerebral blood flow (CBF) and consequently the oxygen supply to the brain 
normally remains unchanged (Hayakawa et al., 1996). Hypercapnia results in cerebral 
arterial dilation (Bari et al., 1998;Wei et al., 1980), decreased cerebral resistance, and 
increased CBF (Hoffman et al., 1996;Narayanan et al., 2008). Changes in blood gas 
levels influence the retinal and optic nerve blood flow in a manner similar to that in the 
cerebral circulation. In the eye, hypercapnia results in increased choroidal, retinal and 
retrobulbar blood flow (Deutsch et al., 1983;Roff et al., 1999), just as acute hypoxic stress 
might result in increased ocular haemodynamic parameters (Mullner-Eidenbock et al., 
2000). 
 
1.4.1.2 The role of O2 
The retina receives O2 from two anatomically separated sources, the choroidal and retinal 
circulations. The retinal microcirculation oxygenates only the inner retina down to the inner 
nuclear layer, while the choroidal circulation oxygenates the rest of the retina and the 
pigment epithelium.  
 
Autoregulatory mechanisms in the inner retina maintain O2 at constant values during 
systemic hyperoxia or hypoxia (Wangsa-Wirawan and Linsenmeier, 2003). This process is 
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of extreme importance since the intraocular vessels are very sensitive to changes in O2. 
Hyperoxia results in a strong vasoconstriction of the inner retinal arterioles, in a manner 
similar to cerebral circulation (Harris et al., 1996;Wangsa-Wirawan and Linsenmeier, 
2003), while hypoxia induces vasodilation of the retinal arterioles similar to that observed 
in cerebral blood flow studies (Eperon et al., 1975;Kogure et al., 1970;Wangsa-Wirawan 
and Linsenmeier, 2003). The haemodynamic response to hyperoxia in the retinal 
circulation is believed to be mediated via endothelin (Takagi et al., 1996). 
 
1.4.2 Myogenic autoregulation 
By means of myogenic autoregulation, blood flow through different tissues is maintained 
despite changes in BP (Johnson, 1986). The myogenic mechanism is triggered by 
variation in the transmural pressure during moderate variations in BP, and is achieved by 
changes in the vascular resistance (Alm and Bill, 1973). The exact mechanism involved in 
myogenic regulation is still unknown. It seems, however, that extracellular calcium plays 
an important role; moreover, different endothelial factors could partially mediate the 
myogenic control of the blood flow (Davies and Hagen, 1993;Davies and Tripathi, 1993). 
 
1.4.3 Neurogenic control of vascular tone 
The ANS supplies a large network of vasomotor nerve fibres; these fibres are directed 
towards the uvea, the PCAs, and the extra-ocular portion of the CRA (Ehinger, 
1966;Laties, 1967). Vessels in the retina and prelaminar portion of the optic nerve, 
however, have no neural innervation (Laties, 1967;Ye et al., 1990). Consequently, 
stimulation of the cervical sympathetic chain results in vasoconstriction in the uvea but 
has no effect on retinal or anterior optic nerve blood flow (Alm, 1977;Bill et al., 
1977;Weiter et al., 1973).  
 
Chapter 1 
_______________________________________________________________________ 
 
59 
 
Neurogenic regulated ocular circulation seems be mediated by a multitude of substances 
such as acetylcholine (Riva et al., 1994), noradrenaline (Riva et al., 1994), NO, substance 
P, calcitonin gene-related peptide, neuropeptide Y, and adenosine triphosphate (ATP), 
vasoactive intestinal polypeptide (VIP) (Nilsson and Bill, 1984;Wiencke et al., 1994). The 
role played by each of these compounds in the physiology of ocular circulation is, 
however, still poor understood. 
 
Although adrenergic receptors of the α-1, α-2, β-1, and β-2- types have been found in 
retinal vessels (Ferrari-Dileo, 1988;Forster et al., 1987), stimulation of sympathetic 
nervous system does not influence retinal and optic nerve blood flow (Beausang-Linder 
and Hultcrantz, 1980). However, stimulation of the sympathetic nervous system plays an 
important role in regulation of blood flow towards the eye. It has been suggested that the 
probable role of the sympathetic innervation is in preventing overperfusion during an 
increase in systemic BP, thereby assisting myogenic autoregulatory mechanisms (Bill et 
al., 1977). 
 
1.4.4 Endothelial regulation of the vascular tone 
This mechanism has already been described in Section 1.2.6.1 and Section 1.2.6.2. 
 
1.4.5 Neurovascular coupling 
Neurovascular coupling refers to the relationship between local neural activity and 
subsequent changes in local blood flow. The amount and spatial location of blood flow 
changes are strongly associated with changes in neural activity through complex 
mechanisms of communication between neurons, astrocytes and vascular cells, 
especially endothelial cells (Lecrux and Hamel, 2011).  
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Astrocytes are characteristic star-shaped neuroglia cells in the brain and spinal cord. They 
are anatomically positioned close to both the vascular smooth muscle cells and 
microvessels putting them in the ideal location to mediate neuronal activity and many of 
the endothelial pathways, such as ET-1 and NO and have also been demonstrated in 
astrocytes (Filosa, 2010). Additionally astrocytes have also been linked to the re-
establishment of vasomotor tone following neuronal stimulation (Filosa, 2010). Those 
studies suggest that astrocytes act as a mediator and play an important role in 
neurovascular coupling. Several studies have found that neurovascular coupling is also 
present in the retina through a complex mechanisms of communication between neurons, 
astrocytes and retinal vessels (Falsini et al., 2002;Lanzl et al., 2011;Riva et al., 2005). A 
study by Metea and Newman also suggested that flicker-evoked retinal hemodynamical 
changes through promoting astrocytes express eNOS leading to NO mediate endothelial-
dependent vasomotor response in retina (Metea and Newman, 2006). Although NO is 
generally considered to be a vasodilating agent, NO levels may regulate whether neuronal 
activity results in vasodilation and/or vasoconstriction in the retina through a complex 
process (Metea and Newman, 2006). Initially, arteries are dilated in response to light (or 
flicker) in nominally zero NO conditions, and constricted as NO levels increased (Metea 
and Newman, 2006). Thereby, NO also plays an important role in the neurovascular 
coupling through modulating astrocytes regulation of these vasomotor responses in the 
retina. 
 
1.5 Retinal pigment epithelium (RPE) 
RPE represents a pigmented monolayer of hexagonally shaped cells of neural origin firmly 
attached to the underlying choroid and overlying the photoreceptor layer of the inner retina 
(Figure 1.10). Through the release of various diffusible agents, it protects the outer retina 
from excessive light-generated ROS and maintains retinal homeostasis, in addition to 
regenerate the outer segment; moreover, it regulates the transport of nutrients and waste 
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products to and from the retina through the expression and activity of specific protein 
(Alfaro et al., 2005;O'Shea, 1998;Simo et al., 2010).  
 
           
Figure 1.10: Diagram showing the layers of the retina. RPE: Retinal pigment 
epithelium. Adapted it according to Purves et al. (Purves et al., 2001).  
 
Physiologically, the RPE is part of the outer of the BRB, the inner BRB being formed by 
the retinal vascular endothelium (Simo et al., 2010). The adjoining RPE cells and the 
retinal endothelial cells are joined tightly together to control fluids and to prevent toxic 
molecules and plasma components enter to the retina, and consequently to prevent those 
substances to impact the ocular metabolism (Sagaties et al., 1987;Strauss, 2005). Indeed, 
the RPE maintains the outer third of retinal metabolism through transporting nutrients and 
removing the waste products of photoreceptor metabolism to be cleared by the choroidal 
circulation (Mannermaa et al., 2006). Thereby, RPE as both a selective barrier and a 
regulator of the photoreceptor layer, plays a key role in its maintenance of a stable retinal 
environment (Figure 1.11). 
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Figure 1.11: Representation of the cross section of the retina. RPE: retinal pigment 
epithelium.    
 
1.6 Macula         
Macula represents a 5.5 mm diameter area located roughly in the center of the retina, 
temporal to the optic disc (Figure 1.12). Near its center is the fovea, approximately 1.5 
mm in diameter (Leung, 2008) that contains the densest concentration of cone and rod 
photoreceptor cells and is responsible for central and high resolution vision. In the 0.2 mm 
diameter of the central fovea (foveola) only contains cone cells and is responsible for 
sharp central vision (Gray, 1985). The rod cells which assist the dark vision are relatively 
sparse in foveola and then gradually increase towards to the periphery within macular 
region whereas the cone cells progressively decreases (Leung, 2008). In the absence of 
its own retinal blood vessels, the fovea has to receive oxygen from the vessels in the 
choroid. However, this blood supply alone is not sufficient for the high foveal metabolic 
demand during bright light exposure and oxidative stress; thus, the fovea exists in a state 
of hypoxia when under bright illumination, as a result, it may suffer the consequence of 
enzymatic failure over time with the accumulation of metabolic debris and lipofuscin 
(O'Shea, 1998), terms drusen. 
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Figure 1.12: A colour photograph of a normal fundus. The area within the black circle 
is the macula. The center of macular is the fovea. 
 
1.6.1 The macular pigment (MP)  
In 1945, Wald was first to identify the MP as belonging to the Xanthophyll family (Wald, 
1945); later, Bone separated the carotenoids from the macula and consistently showed 
the presence of three components: Lutein (L) [(3R,3‟R,6‟R)-β,ε-Carotene-3,3‟-diol], 
zeaxanthin (Z) [(3R,3‟R)-β,β-Carotene-3,3‟-diol] and zeaxanthin‟s stereoisomer, mera-
zeaxanthin (MZ) [(3R,3‟R)-β,β-Carotene-3,3‟-diol] (Bone et al., 1985;Bone et al., 1993). L, 
Z and MZ are not able to be produced within the human body, and therefore, they have to 
be provided by dietary intake. Indeed, some reports also confirmed an increased optical 
density of MP with oral anti-oxidant supplementation (Connolly et al., 2010;Johnson et al., 
2008;Thurnham, 2007). This increase is steady and slow, and needs more than 140 days 
to reach a peak level (Landrum et al., 1997). In addition, the supplements‟ levels decrease 
at a slow rate after cessation being shown to remain present for a period of at least 6 
months (Hammond et al., 1997). 
 
Human MP peaks at the centre of the fovea, and gradually decreases with increasing 
eccentricity (Leung, 2008). The absorption spectrum of MP peaks at 460nm (blue light) 
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(Algvere et al., 2006;Wu et al., 2006), so that plays a role as a broadband filter to protect 
the macula against the photo-oxidative effects of damaging blue light (short wavelength 
light) in the 440 to 460 nm range (Pease et al., 1987;Young, 1988). 
 
1.7 Effects of ageing on ocular circulation 
Ageing clearly causes biological effects that could reduce functional capacities and 
enhance the risk of developing diseases. These declines necessarily include many 
variations within the eye; for example, decreased ocular blood flow (Ravalico et al., 1996), 
increased lipids and fat accumulate in the macular and Bruch‟s membrane (Booij et al., 
2010), increased calcification of elastic fibres and collagen fibres in Bruch‟s membrane 
(Booij et al., 2010), and vulnerable vascular beds (Ehrlich et al., 2009). The results of 
these multiple alterations with ageing on the eye contribute to some diseases such as 
AMD and glaucoma. 
 
1.7.1 Ageing effect on ocular blood flow  
Within addition to systemic vascular changes, ageing is also strongly related with changes 
in the ocular structure and function and with development of ocular diseases such as AMD 
(Bhutto et al., 2010). In addition, it also results in reduction of retrobulbar (Groh et al., 
1996;Harris et al., 2000;Williamson et al., 1995), choroidal (Grunwald et al., 
1998;Ramrattan et al., 1994) and optic nerve (Greenfield et al., 1995;Groh et al., 1996) 
circulation with various consequences on the ocular health. Indeed, it has been 
demonstrated that ageing results in an increase in the resistance of ocular vessels which 
results from the increase of systolic blood pressure and systolic flow velocity in the 
ophthalmic arteries (Ehrlich et al., 2009), and leading to a higher velocity and decreased 
blood flow in the retinal microcirculation (Boehm et al., 2005). In retrobulbar and optic 
nerve circulation, some reports shown that reduced blood flow velocities were also 
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correlated with advancing age (Greenfield et al., 1995;Groh et al., 1996;Rizzo et al., 
1991). Moreover, Kida et al. study found that a significant diurnal to nocturnal decrease in 
optic nerve head blood flow with ageing due to the elderly population having a less 
sensitive autoregulatory system at night (Kida et al., 2008). Additionally, some reports 
suggested that an increase of ocular perfusion pressure (OPP) (Ramrattan et al., 1994) 
and decreased fundus pulsation amplitude to be associated with advancing age in the 
choroidal circulation (Ramrattan et al., 1994;Ravalico et al., 1996).  
 
1.7.2 Ageing effect on retina: age-related macular degeneration 
(AMD) 
With ageing, the reduction in the number of photoreceptor cells causes a widespread 
reduction in visual function (Gao and Hollyfield, 1992;Sun et al., 2007). In addition, there 
is a decrease in melanin (Feeney-Burns et al., 1984;Weiter et al., 1986), and increased 
lipofuscin accumulation, both factors contributing to a higher risk of developing AMD 
(Feeney-Burns et al., 1984;Weiter et al., 1986), which is an ocular degenerative disease of 
the central retina (macula) and is the most common cause of vision loss in people aged 
over 50 in developed countries (Jager et al., 2008).  
 
1.7.2.1 Pathophysiology of AMD 
The pathology of AMD is dominated by age-associated degeneration changes involving in 
the RPE, Bruch‟s membrane and choriocapillaris (Young, 1987). The primary lesion in 
AMD appears to the RPE, possibly due to a high rate of molecular degradation and basal 
deposits in Bruch‟s membrane that represent the early pathological changes in this 
disease (Coleman et al., 2008). The combination of these deposits with further changes 
within the RPE, leads to the formation of drusen (Sarks et al., 2007). Hard drusen (less 
than 63 µm in diameter with discrete borders) deposits composed of a hyaline-like 
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material are located between the RPE and Bruch‟s membrane (Bird et al., 1995;Klein et 
al., 2004). In general, soft drusen (more than 63 µm in diameter with indistinct borders) 
are larger and related with detachment of the RPE and diffusely abnormal Bruch‟s 
membrane alterations (Bressler et al., 1994;Sarks et al., 1999). The soft drusen could 
contribute to further damage to the retina, RPE and choroid, and therefore leading to 
choroidal neovascularisation or cell death in the RPE. 
   
1.7.2.2  Risk factors of AMD 
1. Age 
The incidence of AMD dramatically increases with age. Geographic atrophy and 
neovascular AMD are unlikely to occur under the age of 55, but more frequently occurs 
after 75 years old (Klein et al., 2004).  
 
2. Smoking 
Smoking was discovered to be a major risk factor for development and progression of 
AMD (Clemons et al., 2005;Klein et al., 2006). Specially, increased chance of 
development of exudative AMD was found in smokers (Complications of Age-related 
Macular Degeneration Prevention Trial (CAPT) Research Group., 2008;Tamakoshi et al., 
1997).  
 
3. Diet 
Dietary fat intake and alcohol consumption can effect on risk of developing AMD 
(Knudtson et al., 2007;Seddon et al., 2003b). Greater body mass index (BMI) was 
established to increase the risk of progression of AMD (Seddon et al., 2003a). Antioxidant 
micronutrient intake has been shown to reduce the risk of AMD (van Leeuwen et al., 
2005).  
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4. Genetics 
Genetic factors have been investigated, as family history is an established risk factor for 
AMD (Klein et al., 1994). Ethnicity has been suggested as an effect, such that white 
population were significantly more likely than Afro-Caribbeans to develop large drusen 
and focal pigmentation and to progress from medium- to large-sized drusen or pigment 
abnormalities within macular area (Chang et al., 2008). And also neovascular AMD is less 
widespread in darkly pigmented races compared to white race (Klein et al., 2006).  
 
5. Oxidative stress and vascular factors 
High levels of oxidative stress (Cai et al., 2000;Khandhadia and Lotery, 2010), chronic 
inflammation (Nagineni et al., 2012), and endothelial dysfunction (Lip et al., 2001) have 
also been involved in the pathogenesis of this disease. The retina is an organ of high 
consumption of oxygen and its exposure to visible light; therefore, the retina is particularly 
susceptible to oxidative stress (Beatty et al., 2000;Organisciak et al., 1998). Moreover, 
some studies reported that a reduction in risk for AMD in people who consumed food rich 
in the antioxidant vitamins A, C and E (Chow, 1991;Seddon et al., 1994;Smith et al., 
1999), and also the Eye Disease Case Control study found that low plasma level of 
vitamin C were associated with increased risk of AMD (Eye Disease Case-Control Study 
Group, 1993). In addition, AMD is associated with significantly reduced levels of plasma 
glutathione reductase which is required for regeneration of glutathione (Cohen et al., 
1994). 
 
Data from the Rotterdam Eye (Vingerling et al., 1995), Beaver Dam Eye (Klein et al., 
1993) and Cardiovascular Health Studies (Klein et al., 2003) showed that AMD is 
associated with subclinical signs of cardiovascular disease (CVD). In addition, the 
Atherosclerosis Risk in Communities (ARIC) Study found that patients suffering from AMD 
are at higher risk than age-matched healthy controls for developing overt pathologies, 
such as coronary heart disease (CHD) and stroke (Wong et al., 2006;Wong et al., 2007), 
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all leading to a decreased survival rate (Tan et al., 2008). By screening more than 1.5 
million subjects over 65 years of age, Liao et al (Liao et al., 2008) also found that 
independent of demographic factors and comorbidity, the risk of incident stroke was 
higher in AMD patients compared to controls.  
 
Table 1.2: The summarized risk factors for age-related macular degeneration (AMD). 
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1.7.2.3 Clinical Manifestations 
The clinical hallmark and usually the first clinical finding of AMD is the presence of drusen 
(Figure 1.13), small yellow-white deposits of acellular, polymorphous debris between the 
RPE and Bruch‟s membrane. The drusen may be found in both macula and peripheral 
retina (Klein et al., 2004). Drusen are categorised as small (<63 m in diameter), medium 
(63 to 124 m) and large (>125 m) (Jager et al., 2008). Drusen are also categorised as 
hard or soft on the basis of the appearance of their borders. Hard drusen presents 
discrete borders and is no more than 63 m in diameter; conversely, soft drusen generally 
have indistinct borders and a diameter larger than 63 m (Bird et al., 1995;Klein et al., 
2004).  
 
In most cases of AMD, drusen occurs in both eyes (Klein et al., 1992). However, the 
presence of only few small, hard drusen is not considered to be diagnostic for AMD and 
they are often seen in people aged over 50 years as part of normal ageing process (Jager 
et al., 2008). However, the presence of drusen over 63 m in diameter represents a high 
risk for AMD (Fine et al., 2000). Excess drusen can lead to damage to the RPE. Some 
studies found that the damage of the RPE and a chronic aberrant inflammatory response 
could result in large areas of RPE atrophy with clearly visible choroidal vessels (called 
geographic atrophy), and the neovasculogenesis (new formation of blood vessels) and 
angiogenesis (the growth of new blood vessels from pre-existing vasculature) due to 
expression of vascular endothelial growth factor (VEGF) (de Jong, 2006;Donoso et al., 
2006;Hageman et al., 2001). Choroidal neovascularisation may extend through breaks in 
Bruch‟s membrane causing haemorrhage, fluid exudation, lipid deposition, detachment of 
the RPE from the choroid, fibrotic scars, or a combination of all these signs (Grossniklaus 
and Green, 2004).  
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Figure 1.13: Colour fundus images of age-related macular degeneration. (A) Dry 
AMD. (B) wet AMD. Arrow, drusen. †, bleeding, leaking and scarring caused by 
neovascularization.  
 
1.7.2.4 Classification of AMD  
AMD have been categorised as two stages: early, whereby visual symptoms are 
inconspicuous (Hogg and Chakravarthy, 2006), and late stage, in which severe visual loss 
is present. Furthermore, late AMD is subdivided in two main types: dry (or geographic 
atrophy or non-exudative); and wet (or neovascular or exudative), characterised by 
choroidal neovascularisation (Kanski, 2003). 
 
There are multiple systems that have been developed to grade AMD. The two main 
systems are the International Classification and Grading System (Bird et al., 1995), and 
the Wisconsin Age-Related Maculopathy grading system (Klein et al., 1991). The grading 
systems have used standard sizes of concentric circles to define the location of AMD 
lesion (Bird et al., 1995;Klein et al., 1991) (Figure 1.14), and standard measuring 
templates to assess size of drusen (Bird et al., 1995;Klein et al., 2004) (Figure 1.15).    
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Figure 1.14: The standard grading grid is used for estimation of lesion area. (A) A 
standard grid used to define subfields in the macula. These circles represent respectively 
the central, middle and outer subfield. The circles should be adjusted by a diameter of a 
normal optic disk which depends on the fundus camera used, as clinical convention of 
considering the diameter of the average optic disk to be 1500 m. Therefore, the diameter 
of the innermost circle of this grid corresponds to 1000 m (2/3 optic disk), and the middle 
and outer circle is respectively 3000 m (2 times optic disk) and 6000 m (4 times optic 
disk) in diameter (Klein et al., 2004). The spokes may used to help in centring the grid on 
the macula and in estimating the length of a lesion. (B) The standard grid is placed on 
stereoscopic fundus photographs, centred on the fovea. The sizes of the circles should be 
adjusted that depends on the fundus camera used.                                                          
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Figure 1.15: The standard measuring templates to assess size and area of drusen.  
 
Figure 1.15 shows the standard measuring templates composed of circles of varying size 
diameter is used to estimate size of drusen, area involved by drusen, and area involved 
by other AMD lesion and other abnormalities in fundus. The circles A, B, C, D and E are 
used for all subfields. The circles should be adjusted on a transparent sheet depends on 
the fundus camera used, so that they are 1/24, 1/12, 1/8.6, 1/6 and 1/3 diameter of optic 
disk, corresponding to diameters in average fundus of 63 m, 125 m, 175 m, 250 m 
and 500 m (Bird et al., 1995). All circles could be used for assess the size of drusen. 
Circle A distinguishes between small and large drusen. Circle B and C could be used for 
estimating area occupied by increased retinal pigment associated with AMD (the presence 
of granules or clumps of grey or black pigment in or beneath the retina) or RPE 
depigmentation. Circle D and E could be used for estimating area of geographic atrophy 
or neovascular AMD.  
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Wisconsin Age-Related Macular Degeneration grading system is widely used to grading 
AMD (Cheung et al., 2007a;Cheung et al., 2007b;Tan et al., 2008;Wong et al., 2006), and 
this category of AMD include early and late stages (Klein et al., 2006) (Table 1.3). 
 
Stage Definition 
Early 
AMD 
The presence of either soft drusen alone, retinal pigment epithelium 
depigmentation alone, or a combination of soft drusen with pigmentary 
abnormalities in the absence of late AMD. 
Late 
AMD 
The presence of exudative AMD or pure geographic atrophy. 
 
Table 1.3: Overview of early and late stages of AMD. The soft drusen are defined as 
lesions with a diameter larger than 63m. The pigmentary abnormalities (either increased 
retinal pigment or RPE depigmentation) are defined as present or absent.  
 
1.7.2.5 Endothelial dysfunction in AMD 
Endothelial dysfunction refers to an impairment of endothelium-dependent vasodilation 
caused by a loss of NO bioavailability in the vessel wall. It also plays an important role for 
the development of AMD, as endothelial abnormalities leading to defects on Bruch‟s 
membrane or the choroidal vasculature (Archer and Gardiner, 1981) and further resulting 
in the AMD process (Grossniklaus and Green, 2004;Zarbin, 2004). In Lip et al. study 
showed that in AMD subjects, there is a significantly increased level of plasma von 
Willebrand factor (vWF) which released when endothelial cells damaged and therefore, it 
is a marker of endothelial dysfunction (Lip et al., 2001). This may suggest that impaired 
endothelial function is related to the pathogenesis of AMD. This may hypothesis that the 
higher level of vWF in AMD caused by oxidative stress-induced endothelial dysfunction, 
and will be discussed in later present thesis.  
Chapter 1 
_______________________________________________________________________ 
 
74 
 
1.8 Summary  
Ageing is a primary factor to influence function and structure of both ocular and systemic 
vascular network thus contributing to the occurrence of age-related diseases, such as 
AMD and cardiovascular disease. Nevertheless, to date only few studies have 
investigated the influence of ageing on vascular function in both macro- and micro-
circulation in health and disease. Moreover, the effect on the ocular health of systemic 
factors, such as oxidative stress that are enhanced by ageing has scarcely been studied. 
The purpose of the below work is to fill in all the gaps in knowledge and offer a better 
overview of the effect of ageing on the vascular ocular health.  
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2.1 Recruitment of participants 
Healthy subjects and AMD patients were recruited by advertising at Aston University, 
Birmingham, UK. Ethical approval was sought from the local ethics committee, and written 
informed consent was received from all participants prior to enrolling into the study. The 
study was designed and conducted according to the principles of the Declaration of 
Helsinki.  
 
2.1.1 Exclusion criteria  
Systemic and ocular exclusion criteria are listed below: 
 Smoking 
 Any history of chronic systemic disease including autoimmune diseases (Ahsan et 
al., 2003), alcoholic liver disease (Videla and Guerri, 1990), cancer (Beutler and 
Gelbart, 1985), and diabetes mellitus (Beard et al., 2003).  
 Subjects suffered from cardio- or cerebro-vascular disease, such as coronary 
artery disease, heart failure, arrhythmia, stroke and transient ischemic attacks. 
 The presence of inflammatory conditions (i.e. rheumatoid arthritis and systemic 
lupus erythematosus)  
 Subjects receiving hormone replacement therapy.  
 Patients diagnosed with ocular diseases such as cataract and glaucoma.   
 
2.2 Subjects preparation and experimental protocol 
The participants were asked to fast for 12 hours prior to the date of the study, and could 
only drink water in the morning of the date of the test. They were also asked to avoid any 
cooked breakfast, meat, cereal, fresh fruits and fruit juice, and any nutritional supplements 
(Jones et al., 1992). In addition, subjects were asked to abstain from caffeinated 
Chapter 2 
_______________________________________________________________________ 
 
77 
 
beverages and chocolate and from alcohol for at least two hours before the visit. All 
investigations were performed in the same day and approximately 2 – 2.30 hours for each 
participant. All the participants underwent standardized anthropometric measurements for 
height and weight, and then used to calculate BMI (weight/height²). In addition, the 
participants were required to complete a questionnaire on their general health, daily diet, 
physical activity, smoking and alcohol consumption. The experimental schedule is 
exhibited in Figure 2.1.   
 
                  
Figure 2.1: A flowchart of the measurements performed. 
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2.3 Assessments of systemic parameters  
2.3.1 Blood pressure (BP) measurement 
BP was measured in each subject in the morning of the study, with a BP monitor (UA-779, 
A7D Instruments Ltd., Oxford, UK). In preparation for this measurement, each subject 
rested in a sitting position for approximately 10 minutes in a quiet room to achieve 
sufficient mental and physical calm. The SBP and DBP were measured three times (1 
minute apart). The average readings for SBP and DBP were then used to calculate the 
mean BP (MBP) (Equation 2.1).           
   
                             
 
Equation 2.1: The calculation of mean blood pressure. 
 
2.3.2 24-hour BP and HRV assessment 
Ambulatory BP monitoring provides a better prediction of major cardiovascular events 
than occasional measurements performed in the physician‟s consulting room (Ernst and 
Bergus, 2003;O'Brien, 2003;Verdecchia et al., 2004). This method not only provides a 
better estimate of the true BP profile of the participants, but also helps avoid the so-called 
“white-coat” effect encountered so often in the clinical practice, especially in elderly 
individuals (Pickering et al., 2002). 
 
 
MBP = 1/3 SBP + 2/3 DBP 
•  MBP: mean blood pressure 
•  SBP: systolic blood pressure 
•  DBP: diastolic blood pressure 
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2.3.2.1 CardioTens: an ambulatory BP and ECG monitor 
The device used for the purpose of this thesis was a computer-operated ambulatory BP 
and ECG monitor (Cardiotens-01, Meditech Ltd, Hungary; and representative by PMS 
Instruments, Maidenhead, UK). This device measures BP automatically using an 
oscillometric method. The device can be connected to the serial port of a computer with 
an optoelectronic interface. CardioTens can store 1000 BP measurements and a total of 4 
to 5 hours of ECG recordings. In the event of a faulty reading, the device is programmed 
to reinflate a second time, which helps to avoid missing data points. The monitor is also 
able to analyze ECG signals from beat to beat in real time and stores full HR, as well as 
HRV data.  Moreover, it is the only ambulatory BP and ECG monitor capable of triggering 
BP recordings during episodes of abnormal cardiac activity (Uen et al., 2003). 
 
The final data reading consists on graphical (Figure 2.2) or worksheet-like displays, 
printouts and statistical analysis for evaluation. 
 
2.3.2.2 The principle of ANS function assessment through HRV 
During normal resting conditions, the sinusal rhythm is highly irregular and this behaviour 
is apparent when HR is examined on a beat-to-beat basis. This HRV is the result of 
complex changes that occur in physiological parameters such as respiration, BP, body 
temperature, metabolic rate, hormonal levels, and sleep cycles, reflected by ANS 
controlled function. As a result, the analysis of HRV has been extensively applied both in 
the investigation of normal physiology and in pathological conditions.  
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Figure 2.2: Representation of 24-hour blood pressure and electrocardiogram 
recordings using CardioTens-01 (graphic display). (A) A sample of 24-h blood 
pressure readings (vertical lines) and heart rate curve (interrupted line). (B) A sample of 
electrocardiogram. 
The principal domains in which HRV analysis has provided useful results are:  
 
 Clarifying the role of the ANS in regulating the cardiovascular response to changes 
in posture, stress and exercise (Malliani et al., 1991).  
 Exploring the physiology of normal ageing and identifying those at risk of 
premature cardiac diseases (Whitsel et al., 2001). 
 Assessing the autonomic function in a variety of non-cardiac diseases such as 
diabetes mellitus (Ewing et al., 1980;Ewing et al., 1991;O'Brien et al., 1991), renal 
diseases (Vita et al., 1988), chronic liver disease, respiratory disorders (Watson et 
al., 1999) and neurological diseases (Rapenne et al., 2000).  
Chapter 2 
_______________________________________________________________________ 
 
81 
 
 Evaluating cardiovascular diseases such as myocardial infarction (Flapan et al., 
1993), chronic cardiac failure (Nolan et al., 1992) and hypertension (Singh et al., 
1998).  
 In occupational health to explore the potential elevated cardiovascular risk in shift 
workers.  
 
HRV can be assessed either by using a frequency-domain or a time-domain analysis of 
ECG recordings. For the purpose of the present work, the first method was applied that is 
fundamentally categorized into high-frequency (HF: 0.15-0.40 Hz) and low-frequency (LF: 
0.04-0.15 Hz), which assesses ANS function by estimating the predominance of the 
sympathetic and parasympathetic divisions of the ANS (Kitney and Rompleman, 1980). In 
normal individuals cyclic changes in HR occur in association with respiration and this HF 
cyclical HRV is mediated by the PSNS (Pagani et al., 1986). However, cyclic variations 
due to changes in BP result from changes in baroreceptor activity and are typically LF in 
nature, being mediated via the both SNS and PSNS (Akselrod et al., 1981;Amano et al., 
2001;Berger et al., 1989;Fukuba et al., 2009;Porges, 2007)  (Figure 2.3). The ratio of LF 
to HF (LF/HF) represents the dynamic of the HRV signal and is considered to measure 
the sympathovagal balance of ANS function (Choi et al., 2006;Diedrich et al., 2003;Pagani 
and Malliani, 2000).  
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Figure 2.3: Representation of analyzing heart rate variability (HRV) in the frequency 
domain. (A) The compressed spectral array (CSA), which represents a set of 72 power 
spectral density (PSD) charts calculated with 20-minute intervals for 24 hours, based on 
the first 4 minutes of each 20-minute interval. The vertical axis represents PSD and the 
horizontal axis represents the frequency in hertz (Hz). (B) PSD is automatically calculated 
using fast fourier transform algorithm. The vertical axis represents PSD and the horizontal 
axis represents the frequency. LF: low frequency component; HF: high frequency 
component. 
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2.3.2.3 CardioTens measurement 
Measurements were performed in ambulatory conditions. For each subject the BP was 
measured every 15 minutes over the day time (the time is defined as the true wake time) 
and 30 minutes over the night time (the time is defined as true sleep time). The 24 hour 
BP and the ECG data were downloaded and analysed using the Cardiovision 1.7.2 
software (PMS Instruments Ltd., Maidenhead, UK). Average day time (active period), 
average night time (passive period) and overall (average 24 hours) SBP and DBP were 
assessed. Active and passive periods were determined for each participant based on the 
true wake and sleep times recorded by individual self-report.  
                                       
Heart rate variability HRV values were calculated from the ECG recordings using the 
Cardiovision 1.7.2 software (PMS Instruments Ltd., Maidenhead, UK) after the recordings 
were uploaded into a computer. For the purpose of this thesis, the frequency domain 
parameters (LF, HF and LF/HF ratio) were collected. These parameters were 
automatically calculated for both the active and passive periods of the recording via the 
Cardiovision 1.7.2 software. Circadian changes in LF, HF and LF/HF parameters were 
also calculated as active period minus passive period values. A sample of such recording 
is presented in Appendix 1. 
 
2.3.3 Carotid intima-media thickness (C-IMT) measurement  
C-IMT is the thickness between tunica intima and tunica media of a carotid artery. C-IMT 
(Figure 2.4) is a well established surrogate marker of atherosclerosis and associate with 
cardio-/ cerebro-vascular diseases (Greenland et al., 2000;Poredos, 2004). For the 
purpose of the present thesis, C-IMT was applied to assess the cardio-/ cerebro-vascular 
risk and the extent of the atherosclerosis. The thickness greater than 1 mm was 
considered as increased C-IMT, and it will accelerate atherosclerosis (Gasparyan, 2009), 
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leading to increase the risk of developing cardio-/cerebro-vascular events (Greenland et 
al., 2000). 
 
           
 
Figure 2.4: An image of left common carotid artery. The red bar is showing where 
the C-IMT was measured.  
 
C-IMT was measured using the high-resolution B-model ultrasound system, with an 8MHz 
linear probe (Siemens; Acuson Sequoia, UK) applied on the left common carotid artery 
(CCA). For steps, the participant was required face-up lying on the test bed with head 
supported, and using the 8MHz linear probe performed on the left CCA where a region 
free of plaque and the double-line pattern was observed (Figure 2.4), a scanned image 
obtained and then was analysed subsequently to determine the C-IMT according to 
Mannheim Carotid Intima-Media Thickness Consensus (Touboul et al., 2007).  
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2.3.4 Assessment of arterial stiffness- Pulse wave analysis (PWA) 
The measurement of arterial stiffness was assessed by using the SphygmoCor device 
and PWA. It is a non-invasive assessment of arterial stiffness lends itself to a wide range 
of applying in the research area and clinical setting (Matsui et al., 2004;Oliver and Webb, 
2003). 
 
Augmentation index (AIx) was used as a measure of arterial stiffness by PWA. It indicates 
the amount by which the aortic pressure is increased by the peripheral reflection of the 
blood flow. In the peripheral arteries, the outgoing systolic pulse wave is reflected back 
towards the heart and adds to („augments‟) the central aortic pressure in late systole 
(O'Rourke et al., 2001;Oliver and Webb, 2003). The amount by which the aortic pressure 
is increased by this phenomenon is the augmentation pressure (∆P). The AIx represents 
the aortic ∆P as a percentage of the aortic „pulse pressure‟ (PP) (Equation 2.2) (Oliver and 
Webb, 2003). Therefore, AIx (∆P/PP) indicates the combined influence of large artery 
pulse wave velocity, peripheral pulse wave reflection and endothelial function (O'Rourke 
et al., 2001;Oliver and Webb, 2003;Wilkinson et al., 2002). As AIx varies with heart rate it 
is commonly adjusted to a „standard heart rate‟ of 75 beats per minute (Wilkinson et al., 
2000). The AIx increased with arterial stiffness (Oliver and Webb, 2003). 
  
                        
 
Equation 2.2: The calculation of the augmentation index. 
 
AIx= P/PP x 100% 
•  AIx: augmentation index 
•  P: augmentation pressure 
•  PP: pulse pressure 
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2.3.4.1 The procedure of PWA measurement 
The measurement used a high-fidelity tonometer to place on the radial artery. The shapes 
of the pulse waves were captured electronically using the SphygmoCor pulse wave 
analysis system and a laptop computer. Pulse waves captured over a 12-s period were 
used to produce an average pulse wave contour. The SphygmoCor system converts the 
peripheral waveform to an aortic waveform (Figure 2.5) using a proprietary algorithm 
which called “general transfer function” (O'Rourke et al., 2001), and AIx was generated 
automatically.                 
 
The quality of the pulse waves captured both visually on screen and also numerically with 
the device‟s in-built quality index score (QI %, based on average pulse height, pulse 
height variation and diastolic variation). In order to ensure reliability of measurements, 
only those readings obtained with high quality (QI % is not less than 80 %) were 
considered acceptable.  
 
         
Figure 2.5: Cardiovascular indices derived from Pulse Wave Analysis. ∆P: 
augmentation pressure; PP: pulse pressure. 
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2.4 Assessment of ocular circulation - Dynamic retinal 
vessel analysis (DVA)  
The retinal vascular functionality was reflected through the retinal vascular reactivity to 
flicker provocation which was measured using the dynamic vessel analysis (DVA) 
(IMEDOS Systems UG, Germany) (Figure 2.6). This is a computer controlled instrument 
consists of a high resolution fundus camera (FF450 plus, Zeiss GmbH, Jena, Germany), 
which can continuously measure retinal vessels diameter along a selected vascular 
segment over a defined time. An essential part of the DVA is the fundus camera, which 
includes illumination and the observation optical pathway. For the purpose of real-time 
analysis in retinal vascular diameter, the fundus was recorded onto the charge-coupled-
device (CCD, a detected light signal is converted to digital imaging) chip of the video 
camera; moreover, the fundus image can be inspected on the real-time monitor. An 
optoelectronic shutter is inserted in the camera, interrupts the observation light (530–600 
nm), and produces a bright-to-dark contrast ratio of at least 25:1; therefore the flicker 
frequency is generated at 25Hz. The optoelectronic shutter was controlled by a special 
program running on the DVA computer, and participants were visually aware of the 
flickering light.  
 
Therefore, DVA used to assess the retinal vascular auto-regulation mechanisms by 
measuring retinal vascular dilation responded to flickering stimulus, as an indirect 
provocation to the retinal vessels due to ocular metabolic increase. For the purpose of this 
present thesis, the reactivity capability of selected vessel (arteries and veins) segments in 
a flickering light provocation was assessed using DVA, to reflect the retinal vascular/ 
endothelial function.  
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Figure 2.6: Dynamic Vessel Analysis (DVA) system and main components.  
 
 
Reaction mechanism    Flickering stimulus can increase the retinal blood flow and 
metabolic demand (Garhofer et al., 2003), and therefore indirectly affect the retinal 
endothelial function and vascular tone (Dorner et al., 2003). An increase of the retinal 
metabolic demand cause NOS to be released by endothelial cells of retinal and choroidal 
blood vessels (Dorner et al., 2003); as consequence there is an increase of NO in the 
retina circulation that cause the observed retinal vascular dilation. After stimulus removal, 
the retinal vascular diameter recovers to baseline values. In a normal subject, maximum 
dilation is reached after approximately 20 seconds of flickering stimulus. After the flicker 
stimulus is stopped the arteriolar diameters decrease below the baseline, reaching a 
minimum diameter after approximately 10-40 seconds (Polak et al., 2002). This over 
reactive constriction after the flicker stimulation is thought to be triggered by an 
overshooting regulatory mechanism of the retinal vascular endothelium. Some previous 
studies reported that an average of 80 seconds of recording is needed for the diameter to 
recover to baseline values after the flickering light stopped (Heitmar et al., 2008;Heitmar 
et al., 2010;Polak et al., 2002).  
 
Chapter 2 
_______________________________________________________________________ 
 
89 
 
Therefore, DVA not only measure retinal vessels diameter and also could evaluate ocular 
endothelial function through measuring retinal vessel diameter responses to a flicker light 
because NO as a vascular dilating factor released from ocular endothelium caused by 
flickering stimulation. Therefore, measuring the retinal vessel responses (vasodiation and 
vasoconstriction) to the flicker light could indicate the ocular vascular/endothelial function 
indirectly. More details about the mechanisms involved in the retinal vascular reactivity 
response post-flickering light were offered in the Section 4.6.1. 
 
2.4.1 The DVA measurements protocol  
For the present research, measurements were performed in one randomly selected eye of 
each participant. Retinal vascular reactivity of both arteries and veins were assessed by 
the DVA system. In order to obtain a good quality measurement, pupils were dilated using 
tropicamide 1.0%. The camera needs to be set at 30 degrees image field angle to obtain a 
clear fundus image with good contrast and illumination (without reflections).  
 
The examination was conducted in a dark and temperature controlled room. After full pupil 
dilation was reached, the participant was asked to focus on the tip of a fixation bar within 
the camera while the fundus was examined under green light. An artery and vein segment 
of approximately 1-1.5 mm in length were selected, where were location within a circular 
area of between half and two disc diameters without crossing or bifurcation for the 
measured segments (Kotliar et al., 2004;Nagel and Vilser, 2004;Nagel et al., 
2004;Nguyen et al., 2009) (Figure 2.7). Once the selected segments were identified, the 
reactivity of selected segments in diameter was automatically tracked by the DVA. 
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Figure 2.7: An example of the measurement locations for arteriolar (A) and venular 
(V) segments. 
 
This vascular reactivity was assessed continuously over 350 seconds according to an 
established protocol in previous studies (Heitmar et al., 2008;Heitmar et al., 2010). In 
brief, the steps of the measurement were: 50 seconds still illumination (baseline 
recording) followed by three cycles of 20 seconds flicker provocation and 80 seconds 
(recovery time) still illumination (Figure 2.8). When the eye blinked, the vessel segments 
were not measured and measurement restarted once again, then the vessel segments 
were automatically re-identified.  
 
 
Figure 2.8: The measurement protocol of dynamic retinal vessel assessment. F1: 
the first flickering stimulus; F2: the second flickering stimulus; F3: the third flickering 
stimulus. 
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The diameter of the vessel segments was calculated automatically, and then created a 
dynamic curve (Figure 2.9). The calculated diameter was saved as a Microsoft Excel file, 
and these raw data sets were used for further analysis which described detailed in next.  
 
 
 
Figure 2.9: An illustration of dynamic analysis (next to the fundus image, red curve 
is the retinal arterial dynamic). The time course related the point of diameter on the top 
of the screen (arterial diameters shown in red, and venous diameter shown in blue). 
 
2.4.2 Analysis of DVA 
Retinal vessel dynamics were determined using elements of the newly defined method of 
„Sequential and Diameter Response Analysis‟ (SDRA) (Heitmar et al., 2010). This method 
overcomes the limitations of the inbuilt DVA software analysis which has been 
demonstrated to make inaccurate assumptions about the nature of the vascular response, 
by using the raw data set and allowing an enhanced analysis of vascular reaction 
patterns. 
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However, the SDRA method mainly described the retinal vessel diameter change and the 
time course to reach the point of maximum dilation in response flicker stimulation, but not 
describes the response pattern (Garhofer et al., 2010). It is possible that similar to 
research performed on human brain arterioles (Bauser-Heaton and Bohlen, 2007;Chan et 
al., 2008), retinal blood vessels have a fixed maximum dilation that is similar to a rubber 
band, a vessel with a certain diameter has elastic properties that permit various diameter 
fluctuations (dilatation and constriction) up to a certain amount. As retinal vessels have 
similarities to those in the brain, it could be expected that a similar type of vascular 
reactivity as the one described above occurs in retinal arterioles and veins. However, the 
diameter fluctuations could be fast or slow to reached the maximum dilation and 
constriction that regulated by the vascular/ endothelial function, and therefore, the 
analysis of “slope” could directly represent how fast the retinal vessel reaching the 
maximum dilation and constriction, and indirectly could reflect the retinal vascular / 
endothelial function. For this reason, a novel approach was developed for the first time in 
the present thesis and is described detailed below.  
 
2.4.2.1 Novel approach: slope analysis 
In order to fully explore the nature of the entire dynamic response profile of both the 
dilation and constriction responses of the retinal microvasculature to flicker light 
stimulation, rather than just focusing on the dilation response of the vasculature, the 
SDRA methodology was expanded by using the raw response data and applying a 
statistical polynomial regression algorithm, which was implemented using  the polyfit 
and polyval functions in the Matlab high-level programming language (MATLAB 
R2010a; MathWorks Inc., Natick, MA). Given the measurements iy at times Titi ,...,1,  , 
we approximated )(tfy  by a polynomial of degree nas 
1
1
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in a least squares sense. The polyfit function locates the coefficients 121 ,,...,, nn pppp
such that the error    
T
i ii
tpy
1
2
)( is minimized. This involves solving the system of 
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The polyval function was used to calculate the values of the fitted polynomials which 
ultimately provided us with curves representative of the dynamic vascular response profile 
which could then be used for analysis. The polynomial regression algorithms were 
performed on each of the 3 flicker cycles individually as well as on the averaged data for 
each individual participant, as illustrated in Figure 2.10. To ensure reliability, averaged 
data were used in all analysis in this study as complete recording of each individual flicker 
cycle was not always obtained in all cases. The degree of the polynomial, n, is an 
adjustable parameter. In the present work,      was applied, as this value provided the 
closest fit polynomials on the data points. 
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Figure 2.10: Representation of the polynomial fitted curves generated for each 
individual participant through Matlab from the raw data of each of the three flicker 
cycles and their averages.  
 
 
The parameters were calculated from the generated averaged profiles depicted in Figure 
2.11, and used for further analysis. In addition, baseline corrected flicker response (BFR), 
a parameter which indicates the overall dilation response of the vessels to flicker after 
correcting for the fluctuations in baseline diameter which occur with arterial pulse (Nagel 
et al., 2004), was also calculated by subtracting the baseline diameter fluctuation (BDF) 
from the difference between the maximum diameter and minimum diameter during the 
baseline recording. In addition, the original SDRA parameters maximum dilation (MD), 
maximum constriction (MC), reaction time (RT) to reach the MD to flicker, dilation 
amplitude (DA), BDF (Figure 2.11), BFR, the polynomial fitted curves allowed the nature 
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of the dynamic response profile and the slope of the vascular dilation and constriction 
responses to be calculated. The slope may be an important parameter to describe the 
endothelium-related changes in vessel diameter and the rate at which this change occurs, 
both of which parameters have shown to be altered in disease states individually (Lanzl et 
al., 2011).  
 
For the purpose of this thesis, the term of Dilation Slope which defined as the diameter 
changes of maximum dilation diameter minus the average baseline against to the time 
used to reach MD; and Constriction Slope which defined as the diameter changes of 
maximum constriction diameter subtracts the maximum dilation diameter against to the 
time used between the two points, were employed. The arterial and venous slopes for 
both dilation and constriction were calculated according to the Equation 2.3. 
 
 
         
 
 
Equation 2.3: The calculation of dilation slope and constriction slope. MD: maximum 
dilation; MC: maximum constriction; RT: reaction time to reach maximum dilation; tMDMC: 
time from the points of MD to MC. 
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Figure 2.11: Typical average dynamic retinal vessel response profile, generated 
through Matlab, displaying parameters calculated and used in analysis. MD: 
maximum dilation; MC: maximum constriction; RT: reaction time to reach maximum 
dilation; BDF: baseline diameter fluctuation; DA: dilation amplitude is defined as the 
difference between the maximum dilatation and subsequent constriction after flicker 
stimulation; MD(%): percentage change in diameter from baseline to MD; MC(%): 
percentage change in diameter from MC to baseline diameter; tMC: taken time to MC 
after the cessation of the flicker; tMDMC: time from the points of MD to MC. Baseline 
corrected flicker response (BFR) is calculated as DA-BDF. 
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2.5 Other ocular assessments 
2.5.1 Intraocular pressure (IOP) measurement 
As the design of the study did not allow the participants to be seated at a slit-lamp, IOP 
was measured using “The Pulsair EasyEye” (Keeler Ltd., Clewer Hill Road, Windsor, 
Berkshire, SL4 4AA) before and after instillation of tropicamide 1.0%, a topical 
anaesthetic. The Pulsair EasyEye is an easy to use, non-contract, portable handheld 
instrument that provides a speed and accuracy measurement of IOP with the accuracy 
comparable to the Goldmann tonometry. The Pulsair EasyEye automatically fires a gentle 
puff of air at the cornea when the hand unit is correctly aligned with the tested eye, and an 
average of IOP was recorded by taking four independent readings. 
 
2.5.2 Macular pigment optical density (MPOD) measurement 
MPOD was determined using the MPS 9000 (also known as the M:Pod and the 
QuantifEYE, Topcon,Topcon House, Kennet Side, Bone Lane, Newbury, Berkshire, RG14 
5PX, UK) (Figure 2.12). This device adopts a novel approach to measurement of MPOD 
by heterochromatic flicker photometry, in which subjects respond to the appearance of 
flicker as the alternation rate is decreased at 6 Hz per sec from a starting level of 60 Hz 
(van der Veen et al., 2009). As this is above the critical flicker fusion frequency for the test 
conditions, subjects do not perceive any flicker initially. A sequence of blue-green ratios is 
used and these are inverse-yoked to ensure that overall luminance remains constant. The 
device determines each observer‟s sensitivity to flicker prior to the main part of the test.    
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Figure 2.12: The device (MPS 9000) for the measurement of macular pigment optical 
density.  
 
The eye not being tested was occluded and participants wore their habitual refractive 
correction (a trial frame and lenses were used when necessary). The central target is a 1° 
circular stimulus composed of blue (465 nm) and green (530 nm) LEDs. For the foveal 
(central) test, the observer looked directly at the stimulus whilst the alternation rate 
between the blue and green was ramped down from 60 Hz. At the point when they first 
detected flicker, the observer pressed a response button and this plotted a point on a 
graph that was visible to the operator on a computer screen. Once the flicker had been 
perceived, the process started again. The first five responses were used to ascertain the 
flicker sensitivity of the subject. The observer is asked to respond to a series of green-blue 
ratios until a V-shaped curve is plotted on the computer screen. The minimum point on the 
curve corresponds to equiluminance of the blue and green lights (Figure 2.13). The 
process was then repeated for the peripheral test, where the subject‟s gaze was directed 
to a larger red target, 8° eccentric from the central spot. The difference between the 
central and peripheral minima is used by an internal algorithm to calculate the MPOD.   
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Figure 2.13: The measured curves on a computer screen. Showing the minimum 
points of peripheral and centre of the retina, which were used to calculate the 
macular pigment optical density. 
 
2.5.3 Fundus photography 
Colour fundus photograph were obtained from each participant, at a 30 degree angle and 
centred on the macular and optic nerve head (ONH), using the inbuilt Zeiss FF450 fundus 
camera (FF450 plus, Zeiss GmbH, Jena, Germany) of the DVA (IMEDOS Systems UG, 
Germany). The photograph was taken in a quiet, temperature-controlled room (22oC) after 
full dilation of one unselected eye (1% tropicamide, Chauvin Pharmaceuticals Ltd). Great 
care was taken to ensure good contrast and sufficient illumination of the images obtained. 
The obtained photographs were evaluated for grading of AMD patients using a 
modification of the Wisconsin AMD grading system (Cheung et al., 2007a;Cheung et al., 
2007b), which will be described in Section 4.4.1.2. 
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2.6 Blood assessments 
2.6.1 Blood collection and store 
For the purpose of the present thesis, venous blood were obtained from the antecubital 
fossa vein, and analysed in the house. The materials used for the blood collection is listed 
in Table 2.1. The obtained blood samples were processed immediately for storage 
according to each protocol described below. For glutathione, vWF and ET-1 assays, the 
obtained blood samples were stored in the -70 degrees Celsius freezer and stable at least 
for two months (Gherghel et al., 2005;Jones et al., 1998), and these assays were 
performed every month approximately depended on the number of obtained blood 
samples.   
 
 
Materials Supplier Purpose 
Safety Blood Collection 
Set with a butterfly needle 
attached  
Greiner Bio-One Ltd, 
catalogue number 
450091. 
Blood collection 
EDTA K3 pre- coated 
plastic tube 
Greiner Bio-One Ltd, 
catalogue number 
456036. 
Fasting glucose , TG, 
Choesterol, HDL, GSH, 
GSSG and ET-1 anaylsis 
3.2% buffered citrate pre-
coated plastic tube 
Greiner Bio-One Ltd, 
catalogue number 
454325. 
vWF analysis 
 
Table 2.1: Materials were used for blood collection and sampling. 
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2.6.2 Blood sampling and assessment for CVD risk- glucose, 
triglycerides and cholesterol 
Fasting glucose, triglycerides (TG), total cholesterol (CHOL) and high-density lipoprotein 
cholesterol (HDL-C) were measured using a Reflotron Desktop Analyser (Roche 
Diagnostics, UK), and various Reflotron test strips used were listed in the Table 2.2.  
 
 
Supplier Catalogue Number 
Glucose strip 
Inverness Medical UK Limited, 
Cheshire, SK7 5BW 
278006 
Triglycerides strip 
Inverness Medical UK Limited, 
Cheshire, SK7 5BW 
278009 
Total cholesterol strip 
Inverness Medical UK Limited, 
Cheshire, SK7 5BW 
278010 
High-density lipoprotein 
cholesterol strip 
Inverness Medical UK Limited, 
Cheshire, SK7 5BW 
278020 
 
Table 2.2: The test strips were used for glucose, triglycerides, total and high-
density lipoprotein cholesterol using a Reflotron Desktop Analyser (Roche 
Diagnostic, UK).  
 
In this step, 30 µl fresh EDTA (ethylenediamide tetra-acetic acid) blood were transferred 
to a glucose test strip and TG test strip, separately. The fasting glucose and TG levels 
were calculated automatically by the Reflotron Desktop Analyser. The remaining fresh 
EDTA blood were centrifuged at 35000 rpm for fifteen minutes, and 30 µl EDTA plasma 
were transferred to a total cholesterol strip and a HDL-C strip separately, and  then the 
CHOL and HDL-C were calculated automatically. The low-density lipoprotein cholesterol 
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(LDL-C) was calculated by the Friedewald Formula (Friedewald et al., 1972;Warnick et al., 
1990) (Equation 2.4):  
 
                              
Equation 2.4: The calculation of low-density lipoprotein cholesterol according to 
the Friedewald Formula. 
 
2.6.3 Assessment of oxidative stress - glutathione 
Glutathione (GSH) is a tripeptide consisting of glycine, cysteine and glutamic acid. It is an 
antioxidant which protects cells to be damaged by free radicals and toxic compounds. It is 
an important intracellular antioxidant that can detoxify ROS. Since, oxidative stress can 
lead to excessive production of ROS, loss of antioxidant defenses or both; result in GSH 
depletion. GSH is oxidized to GSSG and recycled back by glutathione reductase. 
Therefore, the ratio of GSH to GSSG is often used to assess exposure of cells to oxidative 
stress (Schulz et al., 2000;Vaziri et al., 2000). 
 
2.6.3.1 Blood sampling for the total GSH and GSSG assays 
Seven millilitres of blood was collected in EDTA (ethylenediamide tetra-acetic acid) tubes 
(to prevent oxidation) (Anderson, 1996) by venipuncture to the antecubital vein. Thirty 
microliters of blood was then transferred into centrifuge tubes for the initial processing. 
The GSH was released from the blood cells by protein precipitation and cellular disruption 
achieved by addition of 33.3 l of 5-sulphosalicylic acid (SSA), 1 g/ml within 10 minutes 
from the blood collection (Anderson and Meister, 1980). Each sample was then diluted 
        LDL-C = CHOL - HDL - 1/5TG  
•  LDL-C: low-density lipoprotein cholesterol  
•  CHOL: total cholesterol 
•  HDL-C: high-density lipoprotein cholesterol  
•  TG: triglycerides 
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with 936.7 l stock buffer (sodium phosphate, pH 7.5) and the content of each tube was 
mixed rapidly in a centrifuge, at 13000 rpm for five minutes. 150 l of supernatant were 
then collected into clean centrifuge tubes and immediately cooled at –70 degrees Celsius. 
Samples stored at this temperature are stable for at least two months and can be 
transported on dry ice without deterioration (Jones et al., 1998). In my hands, GSH loss is 
less than 5% over this time period. The total GSH and GSSG were then analysed 
according to a protocol described in next. 
 
2.6.3.2 Total GSH assay 
The total GSH levels (t-GSH) were assessed by a glutathione reductase-DTNB (5.5 
dithiobis-2-nitrobenzoic acid) recycling procedure (Anderson, 1996;Gherghel et al., 2005). 
The reagents used for this assay are listed in Table 2.3. 
 
The GSH standards were prepared 0 to 80 µM in 20 µM increments using 10 mM GSH 
solution, and contained the 33.3 µl of SSA and 966 µl stock buffer. The standards 
contained the same final concentrations of SSA as for the samples. To each well of a 96-
well plate, 150 µl of daily buffer, 50 µl of DTNB solution and 25 µl standards or blood 
samples were added in triplicate, and the plate was incubated at 37oC for three minutes. 
Finally, 25 µl glutathione reductase (GSR) solution was added to each previous mixture, 
and read the plate immediately was read at 410 nm using a 96-well plate reader (BioTek 
Ltd; model: EL800), and then read again at 1, 2, 5, 10 minutes. Changes in optical density 
(OD) at different time points, expressed against concentration of GSH standard,  and a 
most linear standard curve of total GSH was then generated using a linear regression 
program (Microsoft Excel® - Figure 2.14). 
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Reagents Contents 
Stock buffer 
125mM sodium phosphate (Sigma catalogue number S0876-500 
g), 6.3mM disodium EDTA (Sigma catalogue number ED-2SS 
100g), PH7.5 
Daily buffer 
3mg NADPH (Sigma catalogue number N1630-50mg) into 10ml 
stock buffer 
DTNB solution 
9.6mg DTNB (Sigma catalogue number D8130-1g) into 4ml stock 
buffer 
SSA solution 
1g SSA (Sigma catalogue number 247006-500MG) into 1ml distil 
water 
GSH solution 
30.7mg GSH (Sigma catalogue number G4251-5G) into 1ml distil 
water 
Glutathione 
reductase (GSR) 
solution 
Make up to 20U/ml in stock buffer. GSR is from Sigma, catalogue 
number G3664-500UN 
GSSG solution 
30.7mg GSSG (Sigma catalogue number 150568-500MG ) into 
0.5ml distil water 
TEA 
Triethanolamine, reagent grade, 98% (Sigma catalogue number 
T58300) 
2-VP 2-vinyl pyridine (Sigma catalogue number 132292-100ML) 
Table 2.3: The reagents were used in the GSH and GSSH assay. EDTA: 
ethylenediamide tetra-acetic acid; NADPH: β-Nicotinamide adenine dinucleotide 2′-
phosphate reduced tetrasodium salt hydrate. DTNB: 5.5 dithiobis-2-nitrobenzoic acid; 
SSA: 5-sulphosalicylic acid; GSH: glutathione in its reduced form; GSSG: glutathione in its 
oxidized form; TEA: triethanolamine; 2-VP: 2-vinyl pyridine. 
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Figure 2.14: A standard curve for total GSH assay.  
 
2.6.3.3 GSSG assay 
The GSSG levels were assessed using a glutathione reductase-DTNB (5.5 dithiobis-2-
nitrobenzoic acid) recycling procedure (Anderson, 1996;Gherghel et al., 2005). The 
reagents used in this assay were those already described in Table 2.3 and, in addition, 
triethanolamine (TEA) and 2-vinyl pyridine (2-VP). TEA prevents a local high pH and 
oxidation while 2-VP is used for derivitization GSH. 
 
A GSSG standard curve from 0 to 10 µM, in 1 µM increments was prepared, and 
contained the 33.3 µl of SSA and 966 µl stock buffer. The standards contained the same 
final concentrations of SSA as for the samples. 100 µl of standards and samples were 
transferred into separate centrifuge tubes and 2 µl 2-VP was added to each tube. TEA 
was then used to adjust the pH of the standards/samples to pH7.5. The assay was carried 
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out as for GSH assay described above. Finally, a most linear standard curve of GSSG 
was then generated using a linear regression program (Microsoft Excel® - Figure 2.15). 
 
     
 
Figure 2.15: A standard curve for GSSG assay. 
 
 
The GSH (Equation 2.5) and the redox index (Equation 2.6) were calculated in 
accordance with the equations (Rossi et al., 2002).  
 
                        
 
Equation 2.5: The calculation of the levels of reduced form glutathione. 
 
 
GSH= t-GSH – (2 x GSSG) 
•  GSH: glutathione in its reduced form 
•  t-GSH: the point of maximum dilation 
•  GSSH: glutathione in its oxidized form  
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Equation 2.6: The calculation of the redox index. 
 
2.6.4 Assessment of von Willebrand factor (vWF)  
vWF  is  an  important  glycoprotein  (released and  stored  in  the  endothelial  cells but 
also platelets)  involved  in cardiovascular physiology as it is associated with platelet 
aggregation and adhesion. The primary function of vWF is to bind other proteins (factor 
VIII in its inactive form) to be activated by thrombin so that it can bind to collagen or 
platelets when exposed to vessel damage and shear stress. (Constans and Conri, 
2006;Vlot et al., 1998). Therefore, vWF is considered a gold standard in the measurement 
of endothelial impairments and endothelial dysfunction and has prognostic value in those 
with heart disease, peripheral vascular disease and inflammatory vascular disease 
(Vischer, 2006).  
 
2.6.4.1 Blood sampling for the vWF assay 
Three millilitres of blood was collected in citrate vacuettes tubes by venipuncture to the 
antecubital vein, and was mixed rapidly in a centrifuge at 35000 rpm for fifteen minutes. 
The supernatant were then collected into clean cryogenic vials and immediately cooled at 
–70 degrees Celsius for further batch analysis by an enzyme-linked immunosorbent assay 
(ELISA) according to a protocol described in next. 
 
Redox index = GSH/ GSSG  
•  GSH: glutathione in its reduced form 
• GSSH: glutathione in its oxidized form  
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2.6.4.2 vWF assay 
A method ELISA was used for assessing the level of plasma vWF using commercial 
antisera from Danish company Dako. The method used in this thesis was developed and 
described by Dr. Blann (Blann, 1992). A similar method was performed in house by the 
author. The reagents used and the procedure of method for vWF assay were described in 
Table 2.4 and Figure 2.16. A standard curve was generated using a liner regression 
program (Microsoft Excel®- Figure 2.17).  
 
2.6.5 Assessment of endothelin-1 (ET-1)  
ET-1 is mainly generated by vascular endothelial cells, which has vasoactive properties 
that affect both systemic and peripheral circulation (Angerio and Kot, 1997). It has been 
demonstrated that ET-1 plasma levels are significantly increased in patients suffering from 
systemic vascular disease (Lerman et al., 1991;Videm et al., 2007), such CHD and 
symptomatic atherosclerosis. Moreover, as ET-1 has been shown to be involved in the 
systemic vascular diseases mechanisms and might alter the macro- and/or micro-vascular 
system, as well as ocular circulation as a part of micro-vascular circulation that might be 
influenced. Wollensak et al. has suggested that raised level of ET-1 is particular 
importance in a variety of ocular diseases including diabetes mellitus, hypertension and 
optic neuritis (Wollensak et al., 1998). According those studies, increased ET-1 may 
indicate the pathophysiology of the endothelial dysfunction, and therefore, ET-1 may act a 
potential indicator for endothelial function.  
 
 
 
 
 
Chapter 2 
_______________________________________________________________________ 
 
109 
 
1. Reagents used for the vWF assay 
The reagents used in the assay were listed in the Table 2.4.  
 
Table 2.4: The reagents used in vWF assay. 
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2. The procedure of vWF assay 
The procedure of vWF assay is described briefly in a flow chart (Figure 2.16).  
 
 
 
 
Figure 2.16: The procedure of vWF assay in brief. 
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Figure 2.17: A standard curve for von Willebrand factor assay.  
 
2.6.5.1 Blood sampling for the ET-1 assay 
Six millilitres of blood was collected in EDTA vacuettes tubes by venipuncture to the 
antecubital vein, and was mixed rapidly in a centrifuge at 35000 rpm for fifteen minutes. 
The supernatant were then collected into clean cryogenic vials and immediately cooled at 
–70 degrees Celsius for further batch analysis by ELISA according to a protocol described 
in below. 
 
2.6.5.2 ET-1 assay 
The plasma levels of ET-1 were determined by ELISA. This assay was performed by 
using the human ET-1 commercial kits (R&D Systems Europe Ltd, 19 Barton Lane, 
Abingdon Science Park, Abingdon, OX14 3NB, catalogue number QET00B) according to 
the manufacturer‟s protocol. Standards and plasma samples were added to each 
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monoclonal ET-1 antibody pre-coated well and incubated for 1.5 hours on a horizontal 
orbital microplate shaker at room temperature, and any ET-1 present was bound by the 
immobilized antibody. After washing away any unbound substances, an enzyme-linked 
monoclonal antibody specific for ET-1 is added to the wells. Following a wash to remove 
any unbound antibody-enzyme reagent, an enhanced luminol (a chemiluminescence) 
substrate solution was added to the wells and light is produced in proportion to the 
amount of ET-1 bound in each well. A microplate luminometer (Berthold Technologies 
(UK) Ltd; model: Orion II Microplate Luminometer) is used to measure the intensity of the 
light produced. Read the values of the intensity of the light expressed against the 
concentration of ET-1 standards, and a standard curve of plasma ET-1 was then 
generated using a linear regression program (Microsoft Excel®- Figure 2.18).        
 
 
 
 
 
Figure 2.18: A standard curve for Endothelin-1 assay. 
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Chapter 3 
 
Macular pigment optical density is related to blood 
glutathione levels in healthy individuals 
 
 
The publication of this work is presented in Appendix 2.1 
 
 
 
 
3 3 
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3.1 Abstract 
Purpose: To assess the relationship between MPOD and blood markers for antioxidant 
defence in otherwise healthy volunteers. 
 
Methods: 47 healthy volunteers were subjected to blood analysis to detect the levels of 
circulating GSH and GSSG. The level of MPOD was measured using heterochromatic 
flicker photometry. Systemic BP parameters, HR and BMI as well as plasma levels of 
CHOL, HDL-C and LDL-C cholesterol and TG were also determined.  
 
Results: A simple correlation model revealed that the level of MPOD correlated 
significantly and positively with both GSH (p<0.001) and t-GSH (p<0.001) levels but not 
with those of GSSG (p>0.05). Age, gender, systemic BP parameters, HR, BMI and 
plasma levels of cholesterol and TG did not have any influence on either MPOD or 
glutathione levels (all p>0.05). Furthermore, a forward stepwise multiple regression 
analysis showed MPOD to have a significantly and independent correlation with GSH 
levels (=0.63, p<0.001). 
 
Conclusions: There is a positive correlation between local and systemic antioxidant 
defence mechanisms in otherwise healthy, elderly individuals. 
 
3.2 Introduction 
Oxidative stress represents a harmful state defined by the presence of pathological levels 
of ROS relative to the antioxidant defence,  have been reported to play a role in the 
etiology of AMD (Beatty et al., 2000;Cai et al., 2000;Khandhadia and Lotery, 2010). In 
healthy subjects, local retinal protection against free radicals is aided by the presence of 
the MP, which is comprised of the carotenoid lutein and its isomers, zeaxanthin (Bone et 
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al., 1985) and meso-zeaxanthin (Khachik et al., 2002). It has been suggested that these 
xanthophylls play a similar role in humans as in plants, that is, as antioxidants and 
screeners of high-energy blue light (Krinsky, 2002). In this way, MP may prevent light-
initiated oxidative damage to the retina and therefore protect against subsequent AMD 
(Hammond B.R et al., 1998). Indeed, the absorbance spectrum of MP peaks at 460 nm 
and it is thought to act as a broadband filter, reducing the sensitivity of the macular region 
to short wavelength light which is most damaging in the 440 to 460 nm range (Pease et 
al., 1987;Reading and Weale, 1974). In addition, the fact that lutein and zeaxanthin have 
been found in higher concentration in the rod outer segments of the perifoveal retina than 
the peripheral retina, lends support to their proposed protective role against AMD (Rapp et 
al., 2000). These carotenoids are able to quench singlet oxygen (a potent oxidant) 
(Krinsky and NI, 1979), scavenge ROS (Di Mascio et al., 1989), limit peroxidation of 
membrane phospholipids (Lim et al., 1992), and reduce lipofuscin formation (Sundelin and 
Nilsson, 2001).  
 
In addition to local retinal damage,  high levels of oxidative stress also induces vascular 
changes that confer a background for circulatory disturbances in the systemic macro- and 
microcirculation that are also present in AMD patients (Lip et al., 2001;Zaliuniene et al., 
2008). Indeed, it has been demonstrated that in addition to ocular vascular complications, 
patients suffering from AMD are at higher risk for developing CHD and stroke (Wong et 
al., 2006;Wong et al., 2007); moreover, they also are more likely to have a decreased 
survival rate comparing to the general age-matched population (Hyman et al., 2000). It 
has been shown that AMD patients demonstrate lower circulating glutathione, a major 
low-molecular weight antioxidant peptide (Samiec et al., 1998); in addition to a direct 
vascular effect this deficiency could also result in low bioavailability of the vasodilatory 
molecule, NO (Evereklioglu et al., 2003) and endothelial dysfunction, a condition known to 
precede both metabolic and cardiovascular diseases but also ocular circulatory 
disturbances.   
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3.3 Hypothesis 
In fact, dietary intake of lutein and zeaxanthin can increase the level of MP with possible 
positive effect on AMD prevention and prognosis (Bhosale et al., 2007;Wenzel et al., 
2007). Additionally, in taking carotenoid rich food has a positive influence on systemic 
antioxidant status in healthy individuals (Upritchard et al., 2003). Therefore, I hypothesize 
that the local antioxidant defence is associated with the status of systemic antioxidant 
defence in healthy elderly volunteers. 
 
3.4 Aims  
The aim of the present study was to examine the relationship between local and systemic 
antioxidant defence markers in elderly population without ocular and/or systemic 
diseases. 
 
3.5 Subjects and Methods 
3.5.1 Recruitment of participants  
Healthy subjects were recruited by advertising at Aston University, Birmingham, UK. The 
participants had to be free from any form of vascular and heart disease. 
 
3.5.2 Exclusion criteria 
The details of exclusion criterion were described in Section 2.1.1. 
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3.5.3 Ethical approval 
Ethical approval was sought from the local ethics committee, and written informed consent 
was received from all participants prior to enrolling into the study. The study was designed 
and conducted according to the principles of the Declaration of Helsinki.  
 
3.5.4 Investigations  
3.5.4.1 Subjects preparation 
Subjects were instructed to fast after 9pm on the evenings before being tested. On the 
morning of the test, subjects were requested to have only a light breakfast such as simple 
toast. They were also asked to avoid any cooked breakfast, meat, cereal, fresh fruits or 
fruit juice (Jones et al., 1992). In addition, subjects were asked to abstain from caffeinated 
beverages and chocolate and from alcohol for at least two hours before the visit.  
 
All participants were required to complete a questionnaire on their general health, physical 
activity, alcohol consumption, daily intake of fruit and vegetables, as well as of other 
nutrients. Height and weight of the participants were measured and the BMI 
(weight/height²) was then calculated. 
 
3.5.4.2 BP measurement 
BP parameters were measured in each subject in the morning between 8 and 9 am with a 
BP monitor (UA-779, A7D Instruments Ltd., Oxford, UK). The details of measurement 
were described in the Section 2.3.1. 
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3.5.4.3 Blood sampling and analyses 
All blood samples were obtained between 9am and 10am in the same day of the visit. 
Fasting TG, CHOL and HDL-C were measured automatically using a Reflotron Desktop 
Analyser (Roche Diagnostics, UK) and described detailed in the Section 2.6.2.  
 
Total GSH assay: The total blood GSH sample was prepared using the EDTA blood with 
SSA (1g/ml) to minimizes artefactual sample oxidation and removes interfering protein 
thiols, and details of sample preparation have been offered in the Section 2.6.3.1. The 
total GSH assay were performed using a glutathione reductase-DTNB (5.5 dithiobis-2-
nitrobenzoic acid) recycling assay, which has been already described in the Section 
2.6.3.2.  
 
GSSG assay: The preparation of blood GSSG sample was same as total blood GSH 
sample, and details of sample preparation have been offered in the Section 2.6.3.1. The 
GSSG assay was also assessed using the glutathione reductase-DTNB recycling assay. 
In addition, TEA and 2-VP were added in this assay to prevent a local high PH and 
oxidation. More details of this assay have been offered in the Section 2.6.3.3.  
 
The GSH levels [t-GSH - (2 x GSSG)] and the redox index (defined as the GSH/ GSSG 
ratio) were then calculated. 
 
3.5.4.4  MPOD measurement 
MPOD was determined using the MPS 9000 (also known as the M:Pod and the 
QuantifEYE, Topcon, Topcon House, Kennet Side, Bone Lane, Newbury, Berkshire, 
RG14 5PX, UK) in each participant. Detailed description of this device and its 
measurement has been offered in the Section 2.5.2.  
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3.5.5 Statistical analysis 
The statistical analysis was performed using Statistica® (version 6.0, StatSoft Inc., Tulsa, 
OK, USA) for Windows. Data are expressed as mean with standard deviation (SD). A 
Pearson‟s correlation test and a forward stepwise multiple regression analysis were 
performed to test the relationship between the measured variables. P-values of less than 
0.05 were considered statistically significant. 
 
3.6 Results 
3.6.1 Sample 
Sixty-one healthy subjects with similar dietary habits were selected for the inclusion in the 
present study. However, after the evaluation of the fundus photographs and eliminating 
those with potential macular changes, only 47 healthy subjects (29 women and 18 men) 
were included in the final analysis. The characteristics of the study participants are given 
in the Table 3.1.  
 
 
 
 
Table 3.1: The characteristics of the study participants. F: female; M: male; SBP: 
systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; CHOL: 
total cholesterol; HDL-C: high-density lipoprotein; LDL-C: low-density lipoprotein; TG: 
triglycerides.  
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3.6.2 Measured blood lipids, oxidative stress and MPOD 
parameters 
Table 3.2 shows the measured anthropometric and vascular parameters determined by 
gender. Men exhibited higher SBP (p=0.018), DBP (p=0.01), MBP (p=0.09) and lower 
HDL-C levels (p=0.002) than women. However, MPOD and systemic oxidative markers 
were similar between the two genders (all p>0.05). 
 
 
Female Male P-value 
Age (years) 49 (9) 50 (8) >0.05 
MPOD 0.46 (0.18) 0.47 (0.12) >0.05 
SBP (mmHg) 115 (12) 124 (12) 0.018 
DBP (mmHg) 70 (9) 77 (8) 0.010 
MBP (mmHg) 88 (9) 92 (9) 0.009 
HR (bpm) 72 (7) 69 (8) >0.05 
BMI (kg/m2) 24.48 (4.06) 26.37 (4.13) >0.05 
TG (mmol/L) 1.16 (0.65) 1.35 (0.58) >0.05 
CHOL (mmol/L) 4.52 (0.69) 4.37 (1.00) >0.05 
HDL-C (mmol/L) 1.40 (0.29) 1.11 (0.30) 0.002 
LDL-C (mmol/L) 2.58 (0.75) 2.65 (0.89) >0.05 
    
t-GSH (mol/L) 1177 (564) 1089 (416) >0.05 
GSSG (mol/L) 88 (44) 78 (51) >0.05 
GSH (mol/L) 1002 (526) 932 (383) >0.05 
Redox index 
(GSH:GSSG) 
11 (7) 12 (6) >0.05 
 
Table 3.2: The measured parameters for men and women. MPOD: macular pigment 
optical density; SBP: systolic blood pressure; DBP: diastolic blood pressure; MBP: mean 
blood pressure; HR: heart rate; BMI: body mass index; TG: triglycerides; CHOL: total 
cholesterol; HDL-C: high-density lipoprotein; LDL-C: low-density lipoprotein; GSSG: 
oxidized glutathione; GSH: reduced glutathione; t-GSH: total GSH. 
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3.6.3 Correlation  
A simple correlation model revealed that the level of MPOD correlated significantly and 
positively with both blood GSH (r=0.64; p<0.001) and t-GSH (r=0.63, p<0.001) levels but 
not with those of GSSG (p>0.05). Age, systemic BP parameters, BMI and plasma levels of 
cholesterol and TG did not have any influence on either MPOD or blood glutathione levels 
(all p>0.05). A stepwise multiple regression analysis revealed MPOD levels to be 
independently, significantly and positively correlated with the blood GSH levels (=0.64, 
r2=0.413, p<0.001, Figure 3.1). 
 
 
 
Figure 3.1: The correlation between the levels of MPOD and GSH in the study 
population (p<0.001). MPOD: macular pigment optical density; GSH: reduced 
glutathione. 
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3.7 Discussions 
3.7.1 Main finding 
The present study assessed the MPOD, circulating GSH and GSSG levels in the elderly 
healthy population. The results demonstrated that MPOD correlated with the circulating 
GSH level in older, health individuals.  
 
3.7.2 Relationship between MPOD and systemic oxidative stress 
At the retinal level, oxidative stress results in degeneration and death of the RPE and 
photoreceptors (Liang and Godley, 2003). As these retinal structures are not able to 
regenerate after such insult, protective mechanisms have developed to ensure a minimal 
local effect of free radicals (Davies and Morland, 2004). Indeed, MP is present in the rod 
outer segments and RPE and its specific spectral absorption and the presence of lutein 
and zeaxanthin have enabled it with strong, protective antioxidant properties. There are 
several methods for measuring the level of MP, including various subjective 
psychophysical and objective optical techniques (Davies and Morland, 2004). One of 
these subjective methods is represented by the heterochromatic flicker photometry that 
involves the calculation of MPOD based on the luminance ratio of short wavelength blue 
light presented in the central retina (where is assumed to be partially absorbed by the MP) 
compared to that presented at a more peripheral retinal point, where MP levels are 
assumed to be minimal (Bartlett et al., 2010). This method offers a good measure of the 
MPOD levels and is widely available in the practice. By using such method, it has shown 
for the first time an independent, significant and positive relationship between MPOD and 
blood GSH levels. At this stage more research is necessary to provide better knowledge 
of the exact mechanisms responsible; nevertheless, few hypotheses can be still proposed.  
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It has been reported that dietary intake of carotenoids had an influence not only on the 
level of MP (Bhosale et al., 2007;Wenzel et al., 2007) but also on the systemic circulating 
antioxidant markers (Upritchard et al., 2003). In addition, exogenous supply of GSH 
protects the RPE against oxidative damage (Sternberg et al., 1993). Although the 
individuals included in the present study did not receive either a special diet rich in 
carotenoids nor GSH or other antioxidant supplementation, the above mentioned results 
simply show that a relationship between local and systemic protective mechanisms, such 
as that found by this study could exist. Consequently, although novel, the results should 
not represent a surprise. Other mechanisms can also be speculated. Melatonin, a 
neurohormone that is secreted by retinal and the pineal gland, has an influence on the 
RPE and controls the amount of light reaching the photoreceptors; in addition, it also acts 
as potent antioxidant at both ocular and systemic level and, in such capacity, it has been 
advocated to reduce the risk for pathologies associated with high oxidative damage such 
as AMD (Yi et al., 2005) and cardiovascular disease (Reiter et al., 2010). In addition, 
melatonin also activates other antioxidant defences including glutathione peroxidase 
(GPx), an enzyme that uses GSH as a substrate to eliminate ROS (Bendich, 
1990;Pompella et al., 2003). The melatonin production could be affected by ageing as the 
pupil diameter and the light absorption through the crystalline lens changes with age 
progression (Charman, 2003;Skene and Arendt, 2006;Turner and Mainster, 2008). 
Consequently, ageing contributes to an abnormal melatonin production and in addition 
decreases antioxidant defence, which in turn will result in accelerated ageing processes 
with various effects throughout the human body, including the eye.  
 
Although measuring melatonin levels was not an aim in the present research, it could be 
still hypothesized that a link between ocular and systemic antioxidant mechanisms could 
also be established indirectly via melatonin. This hypothesis should, however, be tested in 
various age groups. In addition, other mechanisms are most certainly involved and should 
be further researched using more complex analyses. The role of antioxidants proved to 
Chapter 3 
_______________________________________________________________________ 
 
124 
 
have a link to both macular pigment and circulating GSH levels should also be 
researched. Nevertheless, as previously emphasized the positive correlation between the 
levels of MPOD and GSH level demonstrated in this study‟s selected sample probably 
only shows that in healthy individuals, the antioxidant defence mechanisms present at 
various levels act in the same direction to protect the body against harmful effects of ROS. 
However and maybe most importantly, this research points towards the necessity of 
studying various normal relationships between ocular and systemic protective 
mechanisms against diseases with multiple etiologies and complications, such as AMD. In 
this way we could understand better results reported after various pathological changes 
have already occurred. Reducing the risk for AMD is important and strengthening bodily 
natural mechanisms that are at their best in healthy individuals seems to be one of the 
possible approaches.  
 
Although some studies report gender differences in plasma GSH levels (Flagg et al., 
1993), others did not confirm it in either plasma or blood GSH (Michelet et al., 1995). In 
agreement with the later studies I also could not find any difference between men and 
women with respect to blood glutathione levels. It is possible that various methods used 
for glutathione assay are responsible for this lack in results consistency. There is no 
general agreement to what method is best for analyzing circulating glutathione.  In the 
present study I used a validated method for measuring blood levels of GSH and GSSG 
(Anderson, 1996;Gherghel et al., 2005;Griffith, 1980) and known to minimize variability 
from more complicated sample preparation steps associated with methods measuring 
plasma GSH (Michelet et al., 1995). In addition, in order to avoid variations and GSH loss 
I have paid particular attention to blood collection, initial processing and storage. Blood 
samples were collected at the same time (between 9am and 10am) and processed in the 
same way and time interval from collection in all individuals. Moreover, incorporation of 
GSR in our assay confers it specificity to glutathione.     
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3.7.3 Conclusion 
In conclusion, this study has demonstrated for the first time that in older, healthy, non-
smoking individuals MPOD correlates with the whole blood levels of GSH. As assays for 
measuring systemic levels of antioxidant molecules are complex and need specialized 
laboratories, it is tempting to propose that a simple MPOD assessment could be used as 
surrogate indicator of the individual‟s systemic capacity of dealing with the damaging 
effect of free radicals and, consequently, of their risk for developing chronic ocular and/or 
systemic pathologies. Nevertheless, this assumption should be verified in larger studies 
and clinical significance of association such as the one reported by this present research 
should be carefully analyzed.  
 
3.7.4   Study limitations 
As previously emphasized, this present research included only patients over the age of 40 
that were carefully selected to exclude macular changes or other ocular pathologies as 
well as systemic chronic disease and various therapeutic interventions. I have also 
excluded smokers and individuals taking any antioxidant supplements. This careful 
selection has limited the number of individuals included in the final analysis. It is possible 
that the relationship between MPOD and circulating glutathione level is different not only 
in various age groups but also in individuals with additional risk factors for AMD and/or 
vascular disease. Moreover, individuals having a diet either lacking or very rich in 
carotenoids or receiving various supplements as well as patients suffering from AMD with 
or without vascular complications may display very different results.  More studies to 
include larger and more various populations to cover the many possible confounds that 
have been either missed or intentionally avoided in the present study are warranted. 
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4.1 Abstract 
Purpose: To investigate signs of systemic and retinal vascular dysfunction and their 
relationship to circulatory markers of oxidative stress in patients diagnosed with early 
AMD. 
 
Methods: All the participants were underwent BP, C-IMT and AIx measurements. Retinal 
vascular reactivity was assessed by means of DVA using a modified protocol. Blood 
analyses were conducted to detect the level of blood GSH and GSSG, as well as for 
plasma levels of CHOL, HDL-C, LDL-C and TG. 
 
Results: The AMD patients showed significantly higher LDL-C (p=0.033), C-IMT 
(p=0.029) and AIx (p=0.042) than the age-matched controls. In addition, they 
demonstrated greater venous reaction time (RT) (p=0.026) as well as a shallower slope of 
arterial dilation (SlopeAD) (p=0.005). Blood analyses also revealed that AMD patients 
exhibited higher levels of blood GSSG (p=0.024) and lower redox index (p=0.043) than 
the healthy controls. Venous RT parameter correlated positively with blood GSSG levels 
(r=0.58, p=0.038) in AMD subjects, but not in the controls (p>0.05).  
 
Conclusions: Even in the absence of overt systemic vascular disease, in patients 
diagnosed with early AMD there are potential signs of retinal vascular function impairment 
that correlates with high levels of systemic oxidative stress.  
 
4.2 Introduction 
Systemic risk factors suggested for AMD, a blinding disease affecting millions of people 
worldwide, include smoking (Chakravarthy et al., 2010), increased BMI (Adams et al., 
2011), and poor nutrition (Cho et al., 2001). In addition, high levels of oxidative stress (Cai 
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et al., 2000;Khandhadia and Lotery, 2010), chronic inflammation (Nagineni et al., 2012), 
and endothelial dysfunction (Lip et al., 2001) also involved in the pathogenesis of this 
disease. These later risk factors confer a background for functional and structural 
circulatory disturbances in both the macro- and micro-circulation in subjects at risk and 
are shared by other serious vascular pathologies, such as CVD. Indeed, data from the 
Rotterdam Eye (Vingerling et al., 1995), Beaver Dam Eye (Klein et al., 1993) and 
Cardiovascular Health Studies (Klein et al., 2003) showed that AMD is associated with 
subclinical signs of CVD. In addition, the Atherosclerosis Risk in Communities (ARIC) 
Study found that patients suffering from AMD are at higher risk than age-matched healthy 
controls for developing overt pathologies, such as CHD and stroke (Wong et al., 
2006;Wong et al., 2007), all leading to a decreased survival rate (Tan et al., 2008). By 
screening more than 1.5 million subjects over 65 years of age, Liao et al. (2008) also 
found that independent of demographic factors and comorbidity, the risk of incident stroke 
was 20-30% higher in AMD patients (representing 10.6% of the total) compared to 
controls (Liao et al., 2008).  
 
In an attempt to comprehensively characterise the risk for CVD in AMD patients, 
measures such as BP, peripheral arterial stiffness (McCarty et al., 2008;Sato et al., 
2006a), and C-IMT (Klein et al., 2007;Sato et al., 2006a;Zaliuniene et al., 2008) have all 
been employed in isolation or in combination with various blood analyses. Nevertheless, 
the results reported by the above studies are not consistent, possibly due to various 
confounding factors, such as smoking, existing chronic diseases and systemic 
medications which effect vascular health. In addition, these studies used techniques that 
cannot be easily performed in primary care settings and, therefore, are not useful as 
screening methods. As a positive AMD diagnosis may, independently of other risk factors, 
predict future occurrence of stroke or CHD (Tan et al., 2007;Tan et al., 2008), early 
screening of AMD patients for such pathologies could, however, represent an important 
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step to allow disease prevention and disease modifying interventions at both ocular and 
systemic levels.  
 
Vascular endothelial dysfunction is known to precede both metabolic and cardiovascular 
diseases (De Vriese et al., 2000;Yoshinaga et al., 2011). By using the flow mediated 
dilation (FMD) technique, a standard method of measuring systemic endothelial function 
(Donald et al., 2006), Zaliuniene et al. (2008) did not find any difference in brachial artery 
function between patients with AMD and those with cataract (Zaliuniene et al., 2008). 
Endothelial dysfunction however, is known to occur much earlier at the microvascular than 
the macrovascular level (Gates et al., 2009) and, consequently several tests including 
retinal vascular function have been developed to demonstrate the presence of such 
microcirculatory abnormalities in patients with various diseases including AMD. Indeed, by 
using DVA, Lanzl et al. demonstrated abnormal retinal arterial and venous reaction to 
flickering light in patients suffering from exudative AMD and systemic hypertension (Lanzl 
et al., 2011). As the measured changes could have been induced by the already present 
ocular and systemic vascular pathologies, the question remains, however, if similar 
changes are also evident and measurable in AMD patients at a much earlier stage. It has 
been already validated that the usefulness of retinal microvascular function as a measure 
of early vascular changes that signal the risk for future CVD in asymptomatic individuals 
(Heitmar et al., 2010;Patel et al., 2011), therefore, finding an answer to this question 
seems achievable.  
 
4.3 Aim 
This longitudinal prospective study investigates the retinal vascular function using a novel 
analysis and its relationship to systemic indicators for risk of general vascular dysfunction 
in otherwise healthy individuals diagnosed with early AMD. 
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4.4 Subjects and methods 
4.4.1 Recruitment of untreated AMD patients and healthy controls 
AMD patients and age-matched healthy subjects, recruited by advertisement at the 
Optometry Clinic, Aston University, Birmingham, UK, were considered for inclusion in this 
prospective study.  
 
4.4.1.1 Inclusion criteria 
Subjects with signs of early AMD were recruited for the AMD group. Age- matched healthy 
subjects were enrolled into control group. 
  
4.4.1.2 Early AMD assessment 
Retinal photographs were taken using a digital camera (FF450 plus, Zeiss GmbH, Jena, 
Germany). Signs of AMD were evaluated prior to inclusion in the study using the 
Wisconsin AMD grading system (Cheung et al., 2007a;Cheung et al., 2007b). Soft drusen 
was defined as those having a diameter larger than 63 m. Retinal pigmentary changes 
associated with AMD were defined as present or absent. Early AMD was defined as the 
presence of either soft drusen alone, retinal pigmentary changes alone, or a combination 
of soft drusen with increased retinal pigment, retinal depigmentation in the absence of late 
AMD, or both (Cheung et al., 2007a;Cheung et al., 2007b). Patients with late AMD, 
defined as the presence of exudative AMD or pure geographic atrophy (Cheung et al., 
2007a;Cheung et al., 2007b) were excluded from being included in the study. Only one 
eye per subject was included in the analysis. If both eyes had changes consistent with 
AMD, the eye with the more advanced changes was used to categorise the patients. 
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4.4.1.3 Exclusion criteria  
Subjects were excluded if they were smokers, and if they had a history of intraocular 
surgery or any form of retinal or neuro-ophthalmic disease affecting the ocular vascular 
system. The more details of exclusion criterion were described in Section 2.1.1. 
 
4.4.2 Ethical approval 
Ethical approval was sought from the local ethics committee, and written informed consent 
was received from all participants prior to enrolling into the study. The study was designed 
and conducted according to the principles of the Declaration of Helsinki.  
 
4.4.3 Investigations 
4.4.3.1 Subjects preparation 
Subjects were instructed to fast after 9pm on the evenings before being tested. On the 
morning of the test, subjects were requested to have only a light breakfast such as simple 
toast. They were also asked to avoid any cooked breakfast, meat, cereal, fresh fruits or 
fruit juice (Jones et al., 1992). In addition, subjects were asked to abstain from caffeinated 
beverages and chocolate and from alcohol for at least two hours before the visit. All 
participants were required to complete a questionnaire on their general health, daily diet, 
physical activity and alcohol consumption. 
 
4.4.3.2 General assessment for the presence of cardiovascular risk factors 
1. General Investigations 
All the participants underwent standardized anthropometric measurements for height and 
weight (used then to calculate BMI= weight/height²). SBP and DBP were measured in each 
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subject in the morning between 8 and 9 am with a BP monitor (UA-779, A7D Instruments 
Ltd., Oxford, UK). The details of measurement were offered in the Section 2.3.1. 
 
Blood samples were obtained in the morning between 9 am and 10 am, as well as fasting 
plasma glucose, TG, CHOL and HDL-C were measured using standard routine laboratory 
techniques using the Reflotron Desktop Analyser (Roche Diagnostics, UK), and described 
detailed in the Section 2.6.2. The Framingham risk score of CHD (10- year risk) was also 
calculated from the above values according to Framingham Heart Study (Wilson et al., 
1998).  
 
2. Carotid Intima-media thickness (C-IMT) measurement 
C-IMT, a thickness between tunica intima and tunica media of a carotid artery, was 
measured for all participants through analysis of ultrasound images taken from the left 
common carotid artery (Siemens; Acuson Sequoia, UK). A normal C-IMT was considered 
to be less than 1mm (Simon et al., 2002). The details of assessment were offered in 
Section 2.3.3. 
 
3. Assessment of arterial stiffness  
An assessment of arterial stiffness was obtained using the SphygmoCor device (AtCor 
Medical /PWV Medical Pty Ltd, Australia) and pulse wave analysis. AIx, a parameter 
indicating the amount by which the aortic pressure is increased by the peripheral reflection 
of the blood flow and it is given as a percentage value corrected for a heart rate of 75 
beats per minute (Skinner et al., 2011), was used as a measure of arterial stiffness. The 
SphygmoCor software generates quality control indices and therefore, to ensure reliability 
of measurements, only those readings obtained with an operator index of greater than 
80% were accepted. The details of assessment were described in Section 2.3.4. 
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4.4.3.3 Retinal vascular function measurements 
Retinal vessel reactivity was measured with the DVA (IMEDOS GmbH, Jena, Germany) 
using an already established protocol. Briefly, this protocol allows continuous 
measurement of retinal vessel diameter over a 350 seconds time period, which consists of 
50 seconds of baseline measurements under still illumination (25Hz), followed by 3 cycles 
of 20 seconds flicker stimulation (optoelectronically generated at 12.5 Hz) each 
interrupted by 80 seconds of still illumination (recovery). All measurements were 
performed in a quiet, temperature-controlled room (22oC) following full dilation of one 
unselected eye (1% tropicamide, Chauvin Pharmaceuticals Ltd). The details of 
assessment were described in Section 2.4.1. In order to fully explore the nature of the 
entire dynamic response profile of the retinal microvasculature to flicker light stimulation, a 
novel analysis was employed in this study, and have already described in details in 
Section 2.4.2. 
 
4.4.3.4 Assessments for circulating t-GSH and GSSG 
Glutathione reductase-DTNB (5.5 dithiobis-2-nitrobenzoic acid) recycling assay was used 
to determine the t-GSH and GSSG concentration, and further calculate to the GSH levels 
[t-GSH – (2 x GSSG)] and the redox index (defined as the GSH/ GSSG ratio). The details 
of the assay were offered in Section 2.6.3. 
 
4.4.4 Statistics 
All statistical analyses were performed using the software package Statistica version 6.0 
(Statsoft, UK). Distributions of continuous variables were determined by the Shapiro-Wilks 
test because of small sample sizes. Differences between the groups were assessed using 
either the t-test for normally distributed as mean with SD, or the Mann-Whitney-U test for 
non-normally distributed as median with inter-quartile range (IQR). Data were correlated 
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using Pearson‟s method (if normally distributed) or Spearman‟s method (if non-normally 
distributed). A p-value of <0.05 was considered as statistically significant.  
 
4.5 Results 
4.5.1 Sample  
Eighteen AMD patients were selected for the inclusion in the present study. However, 
after the evaluation of the fundus photographs and eliminating those with potential 
advanced macular changes, only 14 AMD patients (2 men and 12 women) were included 
in the final analysis. In addition, 14 age-matched healthy subjects (4 men and 10 women) 
were also included in the present research.  
 
The baseline characteristics of both study groups are presented in the Table 4.1. The 
AMD patients showed significant higher LDL-C (p=0.033), C-IMT (p=0.029) and AIx 
(p=0.042) in comparison to the healthy controls. 
 
4.5.2 Dynamic retinal vessel analysis (DVA) 
For ease of interpretation, the dynamic retinal vessel profile curve is considered in two 
parts, the first part being the dilation response (baseline to maximum dilation) and the 
second part being the constriction response (maximum dilation to maximum constriction). 
All results are given based on the average of the 3 flicker cycles and have been calculated 
from the fitted degree 20 polynomial curves generated by a program written in Matlab. No 
significant differences were found between groups for arterial and venous BDF, MD, MC, 
DA,  BFR and arterial RT (all p>0.05, Table 4.2); however, AMD patients demonstrated a 
significantly longer venous RT than the age-matched healthy controls (26.33 vs. 20.67 
seconds, p=0.026, Figure 4.1).  
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 AMD [n=14] Controls [n=14] p-value 
Age [years] 59 (8) 57 (5) >0.05 
SBP [mmHg] 122 (16) 119 (14) >0.05 
DBP [mmHg] 74 (11) 76 (10) >0.05 
HR [bpm] 69 (8) 65 (8) >0.05 
BMI [kg/m2] 25.50 (3.49) 24.90 (2.96) >0.05 
TG [mmol/L] 1.18 (0.60) 1.07 (0.54) >0.05 
CHOL [mmol/L] 4.56 (0.83) 4.02 (0.69) >0.05 
HDL-C [mmol/L] 1.32 (0.37) 1.32 (0.39) >0.05 
LDL-C [mmol/L] 2.62 (0.77) 2.03 (0.63) 0.033 
Framingham risk score [%] 6 (3 - 7) 4 (3 - 7) >0.05 
C-IMT [mm] 0.78 (0.01) 0.66 (0.01) 0.029 
AIx [%] 33 (26 - 37) 26 (20 - 28) 0.042 
 
Table 4.1: Anthropometric profile of the study population. p<0.05 is considered a 
significant difference. SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: 
heart rate; BMI: body mass index; TG: Triglycerides; CHOL: total cholesterol; HDL-C: 
high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; 
Framingham risk score: a risk score to predict 10 year absolute risk of CHD event; C-IMT: 
Intima-media thickness of the carotid artery; AIx: augmentation index, was defined as the 
∆P (was the maximum systolic pressure minus pressure at the inflection point) divided by 
pulse pressure and expressed as a percentage. 
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  AMD [n=14] Controls [n=14] p-value 
Arteries 
   BDF 5.78 (4.09 - 8.71) 7.48 (5.94 - 9.22) >0.05 
MD [%] 4.93 (3.27 - 6.18) 5.15 (4.13 - 6.85) >0.05 
RT [seconds] 23.00 (20.33 - 32.33) 18.17 (17.17 - 26.83) >0.05 
MC [%] -2.17 (-3.44 - -1.34) -2.43 (-3.74 - -1.58) >0.05 
DA 6.68 (5.33 - 8.01) 7.58 (7.32 - 9.01) >0.05 
BFR 0.59 (-0.45 - 2.27) 1.19 (-2.38 - 2.93) >0.05 
    Veins 
   BDF 5.27 (4.18 - 7.45) 6.05 (4.68 - 8.82) >0.05 
MD [%] 5.01 (4.11 - 7.34) 5.27 (4.16 - 7.71) >0.05 
RT [seconds] 26.33 (23.33 - 30.67) 20.67 (17.33 - 25) 0.026 
MC [%] -0.82 (-1.36 - -0.19) -1.13 (-1.93 - -0.72) >0.05 
DA 6.15 (5.24 - 9.85) 8.64 (6.88 - 10.48) >0.05 
BFR 1.96 (-0.30 - 3.51) 2.20 (-1.61 - 3.87) >0.05 
 
Table 4.2: Vascular function parameters on ocular level determined using the 
dynamic vessel analysis (DVA). p<0.05 is considered significant. BDF: baseline 
diameter fluctuation; MD (%): percentage change in diameter from baseline to maximum 
dilation; RT: reaction time to reach maximum dilation; MC (%): percentage change in 
diameter from maximum constriction to baseline diameter; DA: dilation amplitude is 
defined as the difference between the maximum dilatation and subsequent constriction 
after flicker stimulation; BFR: the baseline-corrected flicker response, is calculated as DA-
BDF. 
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Figure 4.1: Averaged venous response profile for the AMD patients and healthy 
controls generated through Matlab. Demonstrates the veins took longer time to 
reach the maximum dilation to response flicker in AMD patients compared to the 
healthy controls.  
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The „Slope‟ parameters of both the arterial and venous dilation and constriction were 
calculated based on the extreme values of the fitted polynomials. In the AMD group, the 
SlopeAD was significant shallower than the age-matched healthy controls (0.22 vs. 0.45, 
p=0.005, Figure 4.2); however, no significant differences were found between the study 
groups for slope of arterial constriction (SlopeAC), slope of venous dilation (SlopeVD) and 
slope of venous constriction (SlopeVC) (all p>0.05, Table 4.3).  
 
 
  AMD [n=14] Health [n=14] p-value 
Arteries    
SlopeAD 0.22 (0.14 - 0.27) 0.45 (0.25 - 0.60) 0.005 
SlopeAC -0.29 (-0.44 - -0.23) -0.33 (-0.35 - -0.28) >0.05 
    
Veins    
SlopeVD 0.26 (0.16 - 0.36) 0.30 (0.20 - 0.65) >0.05 
SlopeVC -0.23 (-0.29 - -0.21) -0.31(-0.36 - -0.19) >0.05 
 
Table 4.3: Slope parameters of dynamic retinal vessel analysis. p<0.05 is 
considered significant. SlopeAD: slope of arterial dilation, which defined as the diameter 
changes of maximum dilation diameter minus the diameter measured at the flicker start 
against to the time used between the two points; SlopeAC: slope of arterial constriction, 
which defined as the diameter changes of maximum constriction diameter minus the 
maximum dilation diameter against to the time used between the two points; SlopeVD: 
slope of venous dilation; SlopeAC: slope of venous constriction. 
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Figure 4.2: Averaged arterial response profile for the AMD patients and healthy 
controls generated through Matlab. Demonstrates the significant shallower slope of 
arterial dilation found in AMD patients compared to the healthy controls.  
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4.5.3 Oxidative stress markers and relationship to vascular 
function parameters 
The results of the blood analyses are displayed in Table 4.4. The AMD patients exhibited 
statistically significant higher levels of blood GSSG (p=0.024) and lower redox index 
(p=0.043) than the healthy individuals; however, the GSH levels were comparable 
(p>0.05).  
 
  AMD [n=14] Controls [n=14] p-value 
t-GSH [µmol/L] 875 (663 - 1559) 1086 (809 - 1497) >0.05 
GSSG [µmol/L] 113 (64 - 118) 55 (43 - 82) 0.024 
GSH [µmol/L] 715 (452 - 1349) 981 (723 - 1397) >0.05 
Redox index [GSH:GSSG] 9 (4 - 14) 17 (10 - 23 ) 0.043 
 
Table 4.4: Circulatory markers of oxidative stress. p<0.05 is considered significant.  
GSH: reduced glutathione; t-GSH: total GSH; GSSG: oxidized glutathione. 
 
Blood GSH and GSSG were within the ranges observed in previous studies in subjects of 
the same age as our patients and normal groups (Rossi et al., 2002;Samiec et al., 1998). 
There was no relationship between circulating glutathione levels and systemic measures 
for early vascular disease in either AMD patients or healthy controls (all p>0.05). 
However, correlations between retinal vascular reactivity parameters and blood markers 
of oxidative stress showed a significant positive relationship between venous RT and 
blood GSSG levels (r=0.58, p=0.038, Figure 4.3) in AMD patients. No such relationship 
was found in the age-matched control group (p>0.05).  
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Figure 4.3: The correlation between the oxidized glutathione and the venous 
reaction time to reach maximum dilation to response flicker in the AMD group 
(r=0.58, p=0.038). GSSH: oxidized glutathione; Venous RT:  the reaction time to reach 
maximum dilation during stimulation with flickering light on veins.  
 
4.6 Discussions and conclusion 
4.6.1 Discussions 
The present results demonstrated that patients suffering from early AMD and without overt 
CVD exhibit signs of vascular abnormalities at different levels and measurable by different 
validated techniques. In addition, the results showed for the first time a relationship 
between retinal vascular reaction to flickering light and blood markers of oxidative stress 
in these patients.  
 
Predicting individuals at risk for CVD is important, particularly in AMD patients known to 
have higher chance of developing such pathologies. Indeed, similarly to previous research 
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(Sato et al., 2006a) the present study has shown that AMD patients demonstrate signs of 
possible atherosclerotic changes at both central (carotid) and peripheral arterial levels. In 
addition and also supporting previous results (Ikeda et al., 2001;Nowak et al., 2005), I 
have found that the group of AMD patients demonstrated abnormal lipids metabolism 
markers compared to age-matched healthy controls. It has been shown previously that 
high levels of LDL-C, a vasoconstrictor, pro-inflammatory and thrombogenic molecule, 
inhibits synthesis and release of eNOS, hence resulting in endothelial dysfunction 
(Rosendorff, 2002) and atherosclerosis. Consequently, the results emphasise once again 
the importance of screening for systemic vascular pathologies in patients suffering from 
AMD and more importantly, that early therapeutic interventions to address modifiable risk 
factors such as high cholesterol should be considered in AMD patients.  
 
The state of the macro- and micro-circulation are known to be closely related (Mitchell et 
al., 2005;O'Rourke and Safar, 2005;Wong et al., 2001) and in addition to systemic 
vascular changes, ocular microcirculatory abnormalities have also been reported in 
patients suffering from AMD (Lanzl et al., 2011;Sato et al., 2006b). By using a new 
computational model, the author has also demonstrated a significant shallower SlopeAD in 
the AMD patients compared to the age-matched controls, possibly indicating some form of 
reduced vascular compliance as previously reported in these types of patients (Lanzl et 
al., 2011;Sato et al., 2006b). In addition, it was also obvious that arterial dilation profile did 
appear to follow a different path in the AMD patients compared to controls (Figure 4.2), 
the latter group demonstrating the „two humped‟ arterial dilation response that is 
consistent with that reported by previous studies in younger individuals but not in older 
ones (Lanzl et al., 2011). This particular aspect of the retinal arteries response to the 
flicker in younger normals was related by Lanzl et al. (2010) to the possible existence of 
two separate systems contributing to dilation, the first being a fast onset, short duration 
system, mediated by eNOS and free NO and the second being a slow onset, long duration 
system which represents the summation of dilation and constriction factors. Our controls 
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were slightly younger than those included in the above research and the analysis showed 
that the „two humped‟ aspect was still preserved. In addition, the present study has also 
excluded smokers due to the possible effect on the retinal vascular function (Heitmar et 
al., 2010) and it is not clear if smoking was an exclusion criterion in the paper by Lanzl et 
al. (2010). Nevertheless, similar to previous reported in more advanced disease, the „two 
humped‟ shape of the vascular response to flicker was missing in our patients with early 
AMD. In our AMD patients this pattern was altered, with the first fast onset phase 
exclusively NO-dependent looking blunted, while the second dilatory phase was 
unaltered. At this point it is difficult to determine precisely what factors have contributed to 
this particular aspect especially as no significant differences were found in the arterial MD 
[%] and RT parameters between the two study groups. Local factors, such as reduced 
microvascular compliance as well as systemic contributors could all have played a role.  
 
Similarly to Lanzl et al. also showing impaired venous dilation response to flicker in 
advanced AMD patients (Lanzl et al., 2011), the present research demonstrated a longer 
venous RT to flickering light at a much earlier stage of the disease. Retinal veins are 
generally thought to play a more secondary role in retinal autoregulation, perhaps 
providing a fine tuning of the regulation response following the active reaction of the 
retinal arteries (Kotliar et al., 2004). It has been proposed that this regulatory contribution 
of the retinal veins may occur passively in response to increased blood flow; nevertheless, 
passive diameter changes in response to increased blood flow still require an intact 
endothelium and a certain degree of vessel elasticity. In addition, the possibility that above 
reported venous reactivity could occur actively in response to flicker cannot be entirely 
ruled out (Kotliar et al., 2004). More research is, however, required in order to understand 
the relevance of impaired venous dilation response to flicker in AMD patients. This 
clarification is important since epidemiological studies have linked increased retinal 
venous calibre with the presence of endothelial dysfunction, as well as other systemic risk 
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factors for vascular disease (Sun et al., 2009). In addition, other factors that might be 
involved in the genesis of the above reported alteration should also be researched. 
High levels of oxidative stress represent a harmful state defined by the presence of 
pathological levels of ROS relative to the antioxidant defence. Glutathione (GSH, L--
glutamyl-L-cysteinylglycine), a tripeptide consisting of glycine, cysteine and glutamic acid, 
prevents the effects of ROS either directly as an antioxidant or indirectly, by maintaining 
other cellular antioxidants in a functional state (Bendich, 1990;Pompella et al., 2003). With 
either ageing or pathology, glutathione oxidation effects vital cell functions such as 
proliferation rate (Abate et al., 1990;Huh et al., 2006) and apoptosis (Malorni et al., 
1993;Sykes et al., 2007) leading to accelerated ageing (Rebrin and Sohal, 2008) and 
increased risk for various pathologies, including CVD and AMD (Ballatori et al., 2009). 
Previous research demonstrated the importance of oxidative stress markers as predictors 
of systemic vascular dysfunction in asymptomatic individuals (Ashfaq et al., 2006;Ashfaq 
et al., 2008) and similar to other studies (Javadzadeh et al., 2010), this present work also 
reported abnormal circulatory levels of oxidation markers in the patients suffering from 
AMD. In my samples, I have determined high levels of GSSG possibly resulting from GSH 
overuse; however, the two groups demonstrated similar GSH levels. One explanation 
could be that the GSSG resulting from the reaction between GSH and ROS was rapidly 
reduced back to GSH, thus completing the redox cycle and rebuilding GSH levels (Wang 
and Ballatori, 1998); nevertheless, this mechanism was somehow faulty, higher level of 
GSSG still remaining in the circulation and possibly contributing to some of the observed 
vascular dysfunctions (Vallance et al., 1989;Vallance and Chan, 2001). In addition, it is 
also possible that the otherwise healthy AMD patients could have retained the ability for 
rapid de novo glutathione synthesis, therefore keeping the GSH levels normal; however, 
all the GSH produced this way could have been used in oxidant generation and its 
regeneration from the disulfide form was impaired resulting in the observed major shift in 
GSH/GSSG ratio (Rebrin and Sohal, 2008). Further investigation would be needed, 
however, to validate all the above assumptions. 
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Although a deficit in local or systemic NO due to high levels of oxidative stress could result 
in altered vascular function, to date no study has linked circulating thiols to retinal vascular 
reactivity and this study is the first to do so in patients with AMD, a disease in which both 
local (Bhutto et al., 2010) and plasma (Totan et al., 2001) NO levels have been found to 
be altered. In my recent study (Qin et al., 2011a) demonstrated that in older, healthy 
subjects, the level of macular pigment, which is known to have local strong, protective 
antioxidant properties, correlated with blood levels of glutathione, possibly indicating that 
in healthy individuals, the antioxidant defence mechanisms present at various levels act in 
the same direction to protect the body against harmful effects of free radicals. Oxidative 
stress seems, therefore, a common link between ocular and systemic changes that occur 
simultaneously in patients at risk or suffering from AMD. As both oxidative stress and 
endothelial dysfunction are modifiable variables, the effect of specific therapeutic 
interventions to improve or reduce either or both should be better researched in this type 
of patients (Zhang and Osborne, 2006). 
 
4.6.2 Conclusion 
In conclusion, this present study demonstrates for the first time that patients suffering from 
AMD with no subclinical signs of systemic vascular disease, show signs of abnormal 
retinal vascular function that could be due, amongst other things, to the harmful effect of 
free radicals and oxidation and that should be addressed by preventive measures with 
positive effect at both ocular and systemic level.   
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Relationship between retinal vascular reactivity 
and circulatory markers of endothelial function and 
cardiovascular risk in ageing healthy individuals 
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5.1 Abstract  
Purpose: To assess the relationship between retinal microvascular function and 
circulatory markers of endothelial dysfunction and cardiovascular risk in otherwise healthy 
individuals.  
 
Methods: Fifty-one healthy subjects were subjected to blood analyses to detect the level 
of circulatory GSH, GSSG, ET-1, and vWF. Fasting glucose as well as cholesterols and 
TG levels were also determined. Retinal vascular function was assessed by means of 
DVA using a novel computational analysis.  
 
Results: Men exhibited higher DBP (p=0.021) as well as Framingham risk score 
(p=0.013), and lower HDL-C levels (p=0.002) and AIx (p=0.006) than women. A simple 
correlation model revealed that SlopeAC positively correlated with CHOL (r=0.29, 
p=0.049), LDL-C (r=0.35, p=0.014), ET-1 (r=0.31, p=0.033) and Framingham risk score 
(r=0.35, p=0.015); additionlly, SlopeAD positively correlated with SBP and redox index 
(r=0.32, p=0.026 and r=0.32, p=0.027, respectively); but the similar relationships were not 
found in the retinal venous parameters (all p>0.05). Age had a positive effect on the level 
of ET-1, vWF and SlopeAC (r=0.61, p<0.001; r=0.37, p=0.010; and r=0.35, p=0.017, 
respectively), but not on other measured parameters (all p>0.05). Furthermore, a forward 
stepwise multiple regression analysis revealed that the SlopeAC significantly and positively 
correlated with the level of ET-1 and LDL-C (β=0.30, p=0.029; and β=0.35, p=0.014, 
respectively); and SlopeAD positively correlated with redox index (β=0.32, p=0.027). 
 
Conclusion: In otherwise healthy individuals, the microvascular function as assessed at 
the retinal level is in direct relationship with established circulation markers for endothelial 
dysfunction/CVD risk.  
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5.2 Introduction 
Although systemic factors such as hypertension, hyperlipidemia, diabetes, smoking and 
ageing are still considered as the main risk factors for the development of CVD (Gerszten 
and Wang, 2008;Greenland et al., 2003;Khot et al., 2003), oxidative stress and endothelial 
dysfunction are also thought to contribute to the onset and progression of this type of 
pathology, possibly due to dysregulation of vascular tone and thrombogenicity and 
inflammation induced by these changes (Lerman and Zeiher, 2005;Lusis, 2000;Staels, 
2002;Thomas, 2011). vWF is a large glycoprotein produced by endothelial cells, and 
represents a powerful biomarker for endothelial dysfunction, via mediating platelet 
adhesion to injured endothelium which is the first step in thrombus formation (Frankel et 
al., 2008;Smith et al., 2010). Additionally, ET-1 is released by endothelial cells, causing 
massive vasoconstriction and increased blood pressure. In addition, ET-1 also stimulates 
ROS excessive production (oxidative stress) leading to endothelial dysfunction (Kamata et 
al., 2004;Matsumoto et al., 2008;Piechota et al., 2010). Recent studies suggested that 
high ET-1 levels have been involved in the pathogenesis of atherosclerotic vascular 
disease (Dashwood and Tsui, 2002;Miyauchi and Masaki, 1999;Stauffer et al., 2008). 
Indeed, Freixa et al. demonstrated that high levels of ET-1 were associated with signs of 
microvascular dysregulation and obstruction (Freixa et al., 2011). Furthermore, abnormal 
cholesterol levels are also associated with atherosclerosis and CVD risk (Holewijn et al., 
2010;Kawamoto et al., 2005), and contribute to endothelial dysfunction and onset of 
vascular disorders in both the macro- and micro-circulation. In fact, endothelial 
dysfunction occurs early in the disease process, and it is easily modifiable through proper 
interventions (Celermajer, 1997); therefore, representing an ideal indicator for assessing 
risk of future vascular disease (Bacon et al., 2011). Consequently, scanning individuals at 
risk of CVD for early signs of endothelial dysfunction could contribute towards prevention 
of disease and associated disabilities for early intervention and prevention for future 
vascular diseases occurrence including CVD.  
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Ageing acts as a major risk factor is also considered to be involved in various vascular 
diseases (Ehrlich et al., 2009;Lee and Oh, 2010;Parmacek and Epstein, 2009). One of the 
consequences of ageing is a decline in the ability of tissues and organs to respond to 
different stresses including ischemia, which is a major risk of developing CVD. Indeed, 
circulating endothelial progenitor cells can home to ischemic tissues and contribute to the 
angiogenesis (Asahara et al., 1997). Previous researches found that the number and/or 
the function activities of endothelial progenitor cells have been impaired by ageing 
(Groleau et al., 2011;Hill et al., 2003;Werner et al., 2005). In addition, a loss of the 
adaptive response to oxidative stress is one of the major characteristic of ageing, leading 
to varying degrees of intimal and medial changes of vessels including degeneration of 
endothelial function, a risk for development of vascular disease (Finkel and Holbrook, 
2000;Harman, 2003;Yu and Chung, 2006). This results in systolic hypertension and loss 
of arterial elasticity (Sawabe, 2010). Moreover, several studies have also been 
demonstrated that ageing could cause an increase in concentration of ET-1 and vWF 
even in healthy individuals (Davies et al., 2007;Gill et al., 1987;Maeda et al., 2003). This 
age-dependent degeneration of macrocirculation has been widely studied; however the 
microcirculation and its relationship with macrocirculation in elderly healthy individuals are 
few investigated.   
 
Vascular endothelial dysfunction has been implicated in the development of both 
metabolic and cardiovascular diseases (De Vriese et al., 2000;Yoshinaga et al., 2011). 
Endothelial dysfunction is known to occur much earlier at microvascular level than at the 
macrovascular level (Gariano and Gardner, 2005;Gates et al., 2009), and consequently 
various tests including retinal vascular function assessment, have been developed and 
are used to detect such microcirculatory abnormalities at the earliest stage of the disease. 
Indeed, by using DVA, some studies found a reduced retinal vessel diameter response to 
a flicker stimulation in patients suffering from diabetes (Garhofer et al., 2004b;Mandecka 
et al., 2007) and in those diagnosed with glaucoma (Garhofer et al., 2004a). In addition, 
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Heitmar et al. demonstrated that patients suffering from coronary artery disease (CAD) 
showed reduced retinal vessel responses to flickering light (Heitmar et al., 2011). The 
question remains, however, if the similar retinal microcirculatory changes are also obvious 
and measurable at an early stage of such impaired endothelial function in otherwise 
healthy individuals but at risk. In the present thesis, it has been already demonstrated that 
abnormal retinal microcircular function correlated with high levels of systemic oxidative 
stress in patients diagnosed with AMD and free systemic vascular disease (see Chapter 
4); therefore, finding an answer to this question seems achievable.   
 
5.3 Hypothesis  
I hypothesised that microvascular function at the retinal level, could be an indicator for 
systemic vascular/endothelial dysfunction and CVD risk in otherwise healthy individuals 
without the overt vascular diseases but at risk because of the possible effect of ageing on 
vascular health.  
 
5.4 Aim 
The aim of this study was to examine the relationship between the retinal microvascular 
function and various circulatory makers of CVD risk in ageing healthy subjects. 
 
5.5 Subjects and Methods 
5.5.1 Study Sample 
Healthy subjects recruited by advertising at Aston University, Birmingham, UK were 
considered for inclusion in this prospective study. Ethical approval was sought from the 
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local ethics committee, and written informed consent was received from all participants 
prior to enrolling into the study. The study was designed and conducted according to the 
principles of the Declaration of Helsinki.  
 
5.5.1.1 Exclusion criteria 
Exclusion criteria for the healthy participants were described in the Section 2.1.1. 
Additionally, Individuals younger than 40 years old were excluded from the present study. 
 
5.5.2 Investigations 
5.5.2.1 Subjects preparation 
Subjects were instructed to fast after 9pm on the evenings before being tested. On the 
morning of the test, subjects were requested to have only a light breakfast such as simple 
toast. They were also asked to avoid any cooked breakfast, meat, cereal, fresh fruits or 
fruit juice (Jones et al., 1992). In addition, subjects were asked to abstain from caffeinated 
beverages and chocolate and from alcohol for at least two hours before the visit. All 
participants were required to complete a questionnaire on their general health, daily diet, 
physical activity and alcohol consumption. 
 
5.5.2.2 General assessment for the presence of cardiovascular risk factors 
All subjects were investigated in the morning after an over-night fast. All the participants 
underwent standardized anthropometric measurements for height and weight (used then to 
calculate BMI= weight/height²). Systemic BP was measured in each subject in the morning 
between 8 and 9 AM with a BP monitor (UA-779, A7D Instruments Ltd., Oxford, UK). The 
measurement details have been offered in Section 2.3.1. 
 
Chapter 5 
_______________________________________________________________________ 
 
152 
 
Blood samples were obtained in the morning between 9 and 10 AM, and fasting plasma 
glucose, TG, CHOL and HDL-C were measured using standard routine laboratory 
techniques using the Reflotron Desktop Analyser (Roche Diagnostics, UK) (more details 
have been described in Section2.6.2). The Framingham risk score was also determined 
from the above values according to an already published method (Wilson et al., 1998). 
 
C-IMT and PWA/AIx were also measured for each participant, and more details have 
been offered in Section 2.3.3 and Section 2.3.4. 
 
5.5.2.3 Retinal vascular function measurements  
Retinal vessel reactivity was measured with the DVA (IMEDOS GmbH, Jena, Germany) 
using an already established and recommended protocol (Garhofer et al., 2010;Nagel et 
al., 2004). Using a newly developed computational model, the entire dynamic vascular 
response profile to flicker light was imaged and used for analysis. The details of 
measurement and analysis have been described in Section 2.4.1 and Section 2.4.2. 
 
5.5.2.4 Blood assay for markers of oxidative stress and endothelial 
dysfunction 
1. t-GSH and GSSG assay 
Glutathione reductase-DTNB (5.5 dithiobis-2-nitrobenzoic acid) recycling assay was used 
to determine the t-GSH and GSSG concentration, and further calculate to the GSH levels 
[t-GSH – (2 x GSSG)] and the redox index (defined as the GSH/ GSSG ratio). The details 
of the assay were offered in Section 2.6.3. 
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2. vWF assay 
A method ELISA was used for assessing the level of plasma vWF using commercial 
antisera from Danish company Dako. The procedure of vWF assay was described in 
Section 2.6.4. 
 
3. ET-1 assay 
This assay was performed by using the human ET-1 commercial kits (R&D Systems 
Europe Ltd, 19 Barton Lane, Abingdon Science Park, Abingdon, OX14 3NB, catalogue 
number QET00B) using an ELISA method according to the manufacturer‟s protocol. The 
more details of the procedure were described in Section 2.6.5. 
 
5.5.3 Statistical analysis 
All analyses were performed using Statistica® software (StatSoft Inc.; Version 6, USA). 
Distributions of continuous variables were determined by the Shapiro-Wilks test. Data are 
expressed for normally distributed as mean with SD or non-normally distributed as median 
with IQR. A Pearson‟s method (if normally distributed) or Spearman‟s method (if non-
normally distributed), and forward stepwise regression analysis were performed to test the 
correlation between the measured variables. A p-value of <0.05 was considered as 
statistically significant. 
 
5.6 Results 
5.6.1 Subjects 
Fifty-nine healthy subjects with similar dietary habits were selected for the inclusion in the 
present study. However, after the evaluation of the fundus photographs and eliminating 
those with macular changes, only fifty-one non-smoking healthy subjects (age from 40 to 
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69 years old) were included in the final analysis. Table 5.1 shows the anthropometric and 
vascular parameters determined by gender. Men exhibited higher DBP (p=0.021) and 
Framingham risk score (p=0.013), and lower HDL-C (p=0.002) and AIx (p=0.006) than 
women.  
 
 
 
Female [n=30] Male [n=21] p-value 
Age [years] 50 (10) 50 (9) >0.05 
SBP [mmHg] 115 (15) 122 (10) >0.05 
DBP [mmHg] 73 (9) 79 (8) 0.021 
HR [bpm] 64 (7) 65 (10) >0.05 
BMI [kg/m2] 25.50 (3.49) 24.95 (3.01) >0.05 
TG [mmol/L] 1.15 (0.64) 1.36 (0.56) >0.05 
CHOL [mmol/L] 4.50 (0.69) 4.40 (1.01) >0.05 
HDL-C [mmol/L] 1.41 (0.29) 1.13 (0.29) 0.002 
LDL-C [mmol/L] 2.56 (0.74) 2.65 (0.90) >0.05 
Framingham risk score [%] 4 (3) 6 (3) 0.013 
C-IMT [mm] 0.60 (0.15) 0.65 (0.14) >0.05 
AIx [%] 22 (11) 13 (10) 0.006 
 
Table 5.1: The characteristics of the study participants. SBP: systolic blood pressure; 
DBP: diastolic blood pressure; HR: heart rate; BMI: body mass index; TG: triglycerides; 
CHOL: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density 
lipoprotein cholesterol; Framingham risk score: a risk score to predict 10 year absolute 
risk of CHD event; C-IMT: carotid intima-media thickness; AIx: augmentation index. 
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5.6.2 Age effect on measured vascular functional parameters at 
both systemic and retinal level 
In the study group, age had a positive effect on the levels of ET-1 and vWF as well as 
SlopeAC (r=0.61, p<0.001, Figure 5.1; r=0.37, p=0.010, Figure 5.2; and r=0.35, p=0.017, 
Figure 5.3, respectively), but not on other measured parameters (all p>0.05). 
 
 
 
 
Figure 5.1: Age effect on the plasma level of endthelin-1 (ET-1). 
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Figure 5.2: Age effect on the plasma level of von Willebrand factor (vWF). 
 
 
 
Figure 5.3 Age effect on the slope of retinal arterial constriction. SlopeAC: slope of 
arterial constriction. 
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5.6.3 Measured CVD risk biomarkers and retinal function 
parameters 
In this healthy population, there are no significant differences between female and male 
participants in theses measured parameters (Table 5.2, all p>0.05). 
  Female [n=30] Male [n=21] p-value 
Biomarkers for CVD risk  
   
t-GSH [µmol/L] 1206 (576) 991 (462) >0.05 
GSSG [µmol/L] 86 (45) 75 (50) >0.05 
GSH [µmol/L] 1034 (545) 841 (426) >0.05 
Redox index [GSH:GSSG] 12 (10) 11 (7) >0.05 
ET-1 [pg/mL] 1.35 (0.23) 1.42 (0.30) >0.05 
vWF [IU/dL] 84 (47) 92 (37) >0.05 
    
Parameters of retinal vascular function 
   
Arteries: 
   
MD [%] 5.15 (2.26) 5.58 (2.68) >0.05 
MC [%] _3.38 (2.36) _3.96 (2.75) >0.05 
RT [seconds] 21 (9) 18 (6) >0.05 
SlopeAD 0.49 (0.29) 0.51 (0.21) >0.05 
SlopeAC 
_0.37 (0.19) _0.33 (0.15) >0.05 
    
Veins: 
   
MD [%] 5.80 (2.58) 5.45 (2.52) >0.05 
MC [%] _1.90 (1.32) _2.89 (2.93) >0.05 
RT [seconds] 22 (5) 20 (4) >0.05 
SlopeVD 0.28 (0.14) 0.29 (0.14) >0.05 
SlopeVC 
_0.28 (0.12) _0.27 (0.13) >0.05 
 
Table 5.2: Vascular function parameters on circulatory level, and ocular level 
determined using the dynamic vessel analysis. GSH: reduced glutathione; t-GSH: total 
GSH; GSSG: oxidized glutathione; ET-1: endothelin-1; vWF: von Willebrand factor; MD: 
maximum dilation; MC: maximum constriction; RT: reaction time to reach maximum 
dilation; SlopeAD: slope of arterial dilation; SlopeAC: slope of arterial constriction; SlopeVD: 
slope of venous dilation; SlopeVC: slope of venous constriction. p<0.05 is considered 
significant. 
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5.6.4 Correlation analysis 
A simple correlation model revealed that SlopeAC positively correlated with the level of 
CHOL (r=0.29, p=0.049), LDL-C (r=0.35, p=0.014) and ET-1 (r=0.31, p=0.033) as well as 
Framingham risk score (r=0.35, p=0.015); moreover, SlopeAD positively correlated with 
SBP and redox index (r=0.32, p=0.026; 0.32, p=0.027, respectively); however, the similar 
relationships were not found in the retinal venous parameters (all p>0.05). A forward 
stepwise multiple regression analysis (Table 5.3) revealed the SlopeAC to be 
independently, significantly and positively correlated with the level of ET-1 and LDL-C 
(β=0.30, p=0.029, Figure 5.4 and β=0.35, p=0.014, Figure 5.5 and, respectively); and 
SlopeAD positively correlated with redox index (β=0.32, p=0.027, Figure 5.6). 
 
 
Y variable 
X variable 
selected R R2 R2 change F p 
Slope AC LDL-C 0.354 0.126 0.126 6.482 0.014 
 
ET-1 0.465 0.216 0.090 5.069 0.029 
       Slope AD Redox index 0.322 0.104 0.104 5.22 0.027 
 
Table 5.3: A forward stepwise multiple regression analysis results. It demonstrates 
LDL-C (R2 change=0.126) had most important influence on Slope AC, and ET-1 slight 
related to Slope AC (R
2 change=0.090). Slope AD is strongly predicted by redox index (R
2 
change=0.104). SlopeAC: slope of arterial constriction; SlopeAD: slope of arterial dilation; 
LDL-C: low-density lipoprotein cholesterol; ET-1: endothelin-1; redox index: GSH/GSSG. 
p<0.05 is considered significant. 
Chapter 5 
_______________________________________________________________________ 
 
159 
 
 
Figure 5.4: The relationship between the slope of retinal arterial constriction and 
the level of ET-1.  
 
 
 
Figure 5.5: The relationship between the slope of retinal arterial constriction and 
the level of LDL-C.  
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Figure 5.6: The relationship between the slope of retinal arterial dilation and the 
level of redox index (GSH/GSSG ratio).  
 
5.7 Discussion 
5.7.1 Main finding 
Using a novel computational model, it was demonstrated that in otherwise healthy, ageing 
individuals impaired retinal microcirculation function was associated with circulating 
markers for the risk of CVD. 
 
5.7.2 Age effect on endothelial function 
In this study, it showed a positive correlation between age and both ET-1 and vWF. 
Several studies have been demonstrated that ageing could contribute an increase in 
concentration of ET-1 and vWF even in healthy individuals (Davies et al., 2007;Gill et al., 
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1987;Maeda et al., 2003) and the present results confirm that ageing plays an important 
role in the occurrence of endothelial dysfunction. In addition, this present results 
demonstrated that a reduced rate of arterial constriction correlated with increased age. 
Boehm et al reported a decreased blood flow in the retinal microcirculation with ageing 
(Boehm et al., 2005). Other researches also shown that reduced blood flow velocities was 
correlated with advanced age (Greenfield et al., 1995;Groh et al., 1996;Rizzo et al., 1991). 
Therefore, it is possible that the observed decrease rate of arterial constriction in my 
subjects, part of a general vascular ageing process that might be attributed to arterial 
stiffening as well as to increased concentration of vasoconstrictor molecules (such as ET-
1), and which results in reduction of perfusion with blood in all tissues and organs 
including the eye.  
 
5.7.3 Gender influence for CVD risk  
It has been previously shown that BP demonstrated gender differences, with men 
demonstrating higher BP then women (Reckelhoff, 2001). Holland et al. demonstrated that 
woman had a higher AIx (arterial stiffness indictor) than age-matched men (Holland et al., 
2009). In this study, these findings were confirmed in our cohort of healthy individuals. In 
addition, this present results have also shown that men had higher Framingham risk score 
and lower AIx compared to age-matched healthy women. The above cited papers do not 
offer a clear explanation for all these gender-based discrepancies, however, an 
association between body size and myocardial tissue velocities have been reported and 
may partly explain it (Peverill et al., 2004).  
 
5.7.4 Retinal microcirculation and CVD risk factors 
Among other risk factors, high levels of oxidative stress, abnormal cholesterol as well as 
abnormal level of plasma markers for endothelial dysfunction such as ET-1 are known to 
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contribute to dysregulation of vascular tone at multiple levels including the microcirculation 
(Freixa et al., 2011). In a recent study, it has been also demonstrated that in elderly 
healthy subjects, the local retinal antioxidant defense mechanisms were related to the 
systemic antioxidant capacity possibly acting in the same direction to protect the body 
against the harmful effects of free radicals (Qin et al., 2011a). By using DVA, it 
demonstrated that in otherwise healthy ageing subjects, signs of microvascular 
dysregulations measured at the retinal vessels level correlated with established markers 
of endothelial dysfunction and CVD risk. At this stage more research is necessary to 
provide better knowledge of the exact mechanisms responsible; nevertheless, few 
hypotheses still can be proposed.  
 
GSH acts as an antioxidant to prevent the effects of ROS (Bendich, 1990;Pompella et al., 
2003). With ageing or pathology, GSH oxidation results in decreased proliferation rate and 
cellular apoptosis includes endothelial cells (Huh et al., 2006;Sykes et al., 2007), leading 
to accelerate ageing processes as well as to increased risks for various pathologies 
(Ballatori et al., 2009). The ratio of GSH to GSSG, so-called „redox index‟ represents an 
indicator for the circulatory oxidative stress status (James et al., 2009;Jones, 
2006a;Jones, 2006b). The present results have shown that signs of retinal 
microcirculation function correlated positively with the redox index. It is possible that high 
levels of ROS due to ageing, diffuse to the microcirculation and results in a local 
overproduction of GSSG and consequently breaks the balance of redox status, leading to 
abnormal vascular reactivity (Feletou et al., 2010;Jin and Loscalzo, 2010;Michiels, 
2003;Ogita and Liao, 2004;Schulz et al., 2011).  
 
Another explanation for the observed signs of vascular dysfunction could be that under 
high oxidative stress condition, LDL-C particles trapped in the local vessel wall become 
oxidized (oxLDL-C). This oxLDL-C causes a series of reactions leading to endothelial 
dysfunction (Chen et al., 2007;Cominacini et al., 2001;Sawamura et al., 1997). It has been 
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reported that oxLDL-C could reduce the expression of eNOS, leading to decrease in the 
production of NO, increase in expression of ET-1 and adhesion molecules (Itabe et al., 
2011;Ou et al., 2010). In turn, the impaired endothelial function could result in reduction in 
NO production and release and, thereby down-regulate the local retinal vascular tone and 
function. In addition, oxLDL-C could bind LOX-1, a receptor of oxLDL-C expressed in 
endothelial cells and smooth muscle cells (Sawamura et al., 1997), to activate NADPH 
oxidise on cells membrane, leading to rapid increases in intracellular ROS including O2
- 
and H2O2 (Chen et al., 2007). The increased levels of O2
- could react with intracellular NO 
and, consequent resulting in the decrease of local retinal NO release and leading to 
dysregulation of local retinal vascular tone (Cominacini et al., 2001). Therefore, a slow 
recovery rate under flicker stimulation may result from this down-regulated local retinal 
microcirculatory function that was associated with the increased LDL-C level. In this 
present study, the levels of oxLDL-C were not measured; however, this observation opens 
new research venues to be explored in the future. 
 
In the subjects of the present work, SlopeAC correlated with the circulation levels of ET-1, 
a potent vasoconstrictor produced primarily in the endothelial cells (Yanagisawa et al., 
1988). It is possible that an increased ET-1 production results in platelet adhesion to 
injured endothelium, arterial thrombogenicity, leading to dysregulation of local retinal 
vascular tone (Itabe et al., 2011). Additionally, some studies reported that ET-1 can inhibit 
eNOS activity through up-regulating caveolin-1 pathway which is a negative regulatory 
protein for eNOS activity, leading to decrease NO production (Kamoun et al., 2006;Karaa 
et al., 2005;Minshall et al., 2003) and consequently resulting in the local endothelial 
dysfunction and disrupted vascular tone. Moreover, there is another hypothesis that ET-1 
leads to up-regulation of ROS production. Amiri et al. study found that endothelial 
overproduction of ET-1 could impair NO-dependent vasodilation and increase in vascular 
ROS production that leading to local retinal microcirculatory disorders (Amiri et al., 2004). 
If one or all of these mechanisms are responsible for the observed vascular reactivity 
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abnormalities is unclear at this moment and more research is necessary to fill in this gap 
in knowledge. 
5.7.5 Conclusion 
In conclusion, this study has demonstrated for the first time that in healthy, non-smoking, 
ageing individuals that retinal microcirculatory function correlated with the circulatory 
marker of endothelial dysfunction and CVD risk. As assays for measuring such as 
circulatory markers are complex and need specialized laboratories, it is tempting to 
propose that a simple retinal vascular function assessment could be used as surrogate 
indicator for the individual‟s systemic capacity of dealing with the damaging effect of 
excess LDL-C, ET-1 as well as free radicals and, consequently, for their risk of endothelial 
dysfunction and future CVD, even in healthy individuals without overt vascular disease.  
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6.1 Abstract  
Purpose:  To assess the relationship between ANS and vascular function in middle-aged 
and elderly healthy subjects. 
 
Methods: Sixty-four healthy subjects underwent ambulatory 24-hour ECG monitoring 
using Cardiotens-01(PMS Instruments Ltd., Maidenhead, UK). Blood analyses also 
employed to detect the level of circulatory markers of ET-1 and vWF for endothelial 
function, along with C-IMT and AIx assessment. Retinal vascular function was assessed 
by means of DVA using a novel approach, which represent the entire dynamic vascular 
reactivities response to flicker stimulation.  
 
Results:  The healthy elderly group demonstrated significantly different circadian changes 
in HF (p=0.011) than the middle-aged controls. ET-1 (p<0.001), vWF (p=0.025), C-IMT 
(p=0.004), and AIx (p=0.004) were also significantly higher in the elderly group compared 
to middle-aged controls; moreover, the elderly individuals exhibited a shallow SlopeAC 
(p=0.047) than middle-aged subjects. In addition, the SlopeAC had a positively correlation 
with the circadian HF (p=0.012) in the elderly group, but no similar relationship found in 
the middle-aged controls.  
 
Conclusion: Even in the absence of overt vascular pathologies, the elderly healthy 
individuals showed impaired ANS and vascular function at both macro- and micro-
vascular level compared to the middle-aged subjects. In addition, the impaired retinal 
vascular function correlated with abnormal circadian PSNS activity only in the elderly 
individuals and these parallel changes could represent the first sign of an increment in the 
general risk for CVD with ageing.  
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6.2  Introduction  
Ageing is characterized by a progressive dysfunction of cells, tissues and organs that 
sometimes and in the presence of other risk factors lead to development of vascular 
diseases, such as CVD and stroke (Karavidas et al., 2010;Lee and Oh, 2010;Shirwany 
and Zou, 2010). Nevertheless, although there is a general consensus that ageing plays a 
role in such pathologies, its exact influence on the balance between various factors 
influencing the vascular homeostasis, such as ANS and endothelial function is still unclear 
(Harris and Matthews, 2004). It is possible that ageing acts as a disruptor of this carefully 
maintained equilibrium. Indeed, it has been already demonstrated that senescence has a 
negative influence on the HRV (Bigger et al., 1996;Corino et al., 2007;Yu et al., 2010). 
Moreover, ageing is accompanied by a reduction in parasympathetic tone leading to 
deregulation of ANS controlled function including cardiovascular function, resulting in a 
higher risk for hypertension (Charkoudian and Rabbitts, 2009;Harris and Matthews, 2004). 
In addition, it has been shown that ageing associates with a redox imbalance shown as 
high levels of oxidative stress, inflammation and endothelial dysfunction and, therefore, 
confers a background for functional and structural disturbances in both macro- and 
microcirculation in subjects at risk (Lip et al., 2001;Zaliuniene et al., 2008). Indeed, 
dilation, stiffening, and thickening of the arteries as well as a reduction in cardiac functions 
are widely reported in ageing-associated changes of the vasculature. Moreover, the 
endothelium power to counteract the sympathetic-induced vasoconstriction is also 
diminished in elderly and biochemical markers for endothelial dysfunction also show an 
increase with ageing (Davies et al., 2007;Davies et al., 2007;Gill et al., 1987;Maeda et al., 
2003), all contributing to the increased cardiovascular risk and mortality in these 
individuals (Harris and Matthews, 2004;Morange et al., 2004;Whincup et al., 2002). All the 
above evidences show that ageing has indeed a potential disruptive effect on the ANS 
and endothelial function and, consequently, on the vascular health. Nevertheless, this 
Chapter 6 
_______________________________________________________________________ 
 
168 
 
effect on retinal vascular function via ANS and endothelial function has never been 
researched.  
 
6.3 Hypothesis 
I hypothesise that the impaired ANS and endothelial function in individuals belonging to 
different age groups, could act as a fresh insight on the ageing involvement in the 
development of the first signs of vascular disease.  
 
6.4 Aim 
The aim of this study was to assess the both endothelial and ANS function, and their 
relationship to retinal vascular function in healthy elderly individuals compared to middle-
aged healthy subjects. 
 
6.5 Subjects and Methods 
6.5.1 Study Sample 
Healthy subjects recruited by advertising at Aston University, Birmingham, UK were 
considered for inclusion in this prospective study. Ethical approval was sought from the 
local ethics committee, and written informed consent was received from all participants 
prior to enrolling into the study. The study was designed and conducted according to the 
principles of the Declaration of Helsinki.  
 
6.5.1.1 Exclusion criteria 
Exclusion criteria for the healthy subjects were described in the Section 2.1.1. 
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6.5.2 Investigations 
6.5.2.1 Subjects preparation 
Subjects were instructed to fast after 9pm on the evenings before being tested. On the 
morning of the test, subjects were requested to have only a light breakfast such as simple 
toast. They were also asked to avoid any cooked breakfast, meat, cereal, fresh fruits or 
fruit juice (Jones et al., 1992). In addition, subjects were asked to abstain from caffeinated 
beverages and chocolate and from alcohol for at least two hours before the visit. All 
participants were required to complete a questionnaire on their general health, daily diet, 
physical activity and alcohol consumption. 
 
6.5.2.2 General assessment for the presence of cardiovascular risk factors 
All subjects were investigated in the morning after an over-night fast. All the participants 
underwent standardized anthropometric measurements for height and weight then were 
used to calculate BMI (weight/height²).  
 
Systemic BP was measured in each subject in the morning between 8 and 9 AM with a 
BP monitor (UA-779, A7D Instruments Ltd., Oxford, UK). The measurement details have 
been offered in Section 2.3.1. C-IMT and PWA/AIx have also been investigated, and more 
details have been offered in Section 2.3.3 and Section 2.3.4. 
 
6.5.2.3 HRV assessment 
HRV analysis is a measure of ANS function as described in Section 2.3.2.1 and Section 
2.3.2.2. All HRV values were calculated using the Cardiovision 1.7.2 software (PMS 
Instruments Ltd., Maidenhead, UK). For HRV evaluation, the frequency domain analysis 
was employed as described earlier in Section 2.3.2.3. Values for LF, HF and ratio of 
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LF/HF were automatically calculated and obtained for 24 hours, day time (active-period) 
and night time (passive-period), and then used to calculate circadian changes using the 
Equation 6.1 according to a previous study (Heitmar et al., 2011). 
 
 
Equation 6.1: Calculating the circadian changes of heart rate variability. 
 
6.5.2.4 Blood assay for markers of endothelial dysfunction 
1. vWF assay 
A method ELISA was used for assessing the level of plasma vWF using commercial 
antisera from Danish company Dako. The procedure of vWF assay was described in 
Section 2.6.4. 
 
2. ET-1 assay 
This assay was performed by using the human ET-1 commercial kits (R&D Systems 
Europe Ltd, 19 Barton Lane, Abingdon Science Park, Abingdon, OX14 3NB, catalogue 
number QET00B) using an ELISA method according to the manufacturer‟s protocol. The 
more details of the procedure were described in Section 2.6.5. 
 
6.5.2.5 Retinal vascular function measurements 
Retinal vessel reactivity was measured with the DVA (IMEDOS GmbH, Jena, Germany) 
using an already established and recommended protocol (Garhofer et al., 2010;Nagel et 
al., 2004). Using a newly developed computational model, the entire dynamic vascular 
response profile to flicker light was imaged and used for analysis. The details of 
measurement and analysis have been described in Section 2.4.1 and Section 2.4.2. 
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6.5.3 Statistics 
All statistical analyses were performed using the software package Statistica version 6.0 
(Statsoft, UK). Distributions of continuous variables were determined by the Shapiro-Wilks 
test. Data distributed normally are presented as mean with SD and the differences 
between the groups were assessed using t-test. If non-normally distributed, they 
represented as median with IQR and groups compared by Mann-Whitney-U test. Data 
were correlated using Pearson‟s method (if normally distributed) or Spearman‟s method (if 
non-normally distributed). A p-value of <0.05 was considered as statistically significant.  
 
6.6 Results 
6.6.1 Sample 
64 healthy participants were included the study. There were grouped into middle-aged 
group (31-54 years old) and elderly group (55-71 years old). The baseline characteristics 
of both study groups are presented in the Table 6.1. The only difference between the two 
groups was represented by higher SBP values (122 vs. 112, p=0.008) in the elderly group 
compared to the middle-aged group. 
 
6.6.2 Parameters of ANS function 
Table 6.2 outlines the measured parameters of the autonomic nervous system function. 
The elderly individuals had significantly different circadian variations in HF (3.5 NU vs. -
8.5 NU, p=0.011) compared to middle-aged controls. However, no significant differences 
were found for other measured parameters of ANS function (all p>0.05).  
 
 
Chapter 6 
_______________________________________________________________________ 
 
172 
 
 
 
 Elderly [n=31] Middle-aged [n=33] p-value 
Age [years] 59 (4) 39 (5) <0.001 
SBP [mmHg] 122 (17) 112 (13) 0.008 
DBP [mmHg] 77 (10) 73 (11) >0.05 
HR [bpm] 66 (8) 68 (6) >0.05 
BMI [kg/m2] 25.88 (4.61) 25.16 (3.84) >0.05 
 
Table 6.1: Anthropometric profile of the study population. p<0.05 is considered 
significant. SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; 
BMI: body mass index. 
 
 
 
 
  Elderly [n=31] Middle-aged [n=33] p-value 
LF-24hr [NU] 68 (8) 66 (12) >0.05 
HF-24hr [NU] 29 (7) 32 (11) >0.05 
LF/HF-24hr  2.5 (0.9) 2.5 (1.4) >0.05 
 
 
  
Circadian LF [NU] 4 (-6.5 - 19) 11 (3 - 17) >0.05 
Circadian HF [NU] 3.5 (-7.5 - 13.5) -8.5 (-16 - -2 ) 0.011 
Circadian LF/HF 0.35 (-0.8 - 1.5) 1.1 (0.3 - 2.1) >0.05 
 
Table 6.2: Heart rate variability parameters measured using a 24 hours ECG 
monitor. LF: low frequency; HF: high frequency; NU: normalised units. Circadian LF= day 
period LF - night period LF; circadian HF= day period HF - night period HF; circadian 
LF/HF = day period LF/HF - night period LF/HF. 
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6.6.3 Parameters for systemic vascular function 
Table 6.3 showed the elderly group had a significant increment in circulating level of ET-1 
(p<0.001) and vWF (p=0.025), as well as C-IMT (p=0.004) and AIx (p=0.004) compared to 
the middle-aged healthy controls. 
 
  Elderly [n=31] Middle-aged [n=33] p-value 
Blood markers    
ET-1 [pg/mL] 1.45 (0.26) 1.15 (0.32) <0.001 
vWF [IU/dL] 99 (39) 76 (40) 0.025 
    
Vascular tone    
C-IMT [mm] 0.69 (0.17) 0.55 (0.13) 0.004 
AIx [%] 26 (8) 15 (12) 0.004 
 
Table 6.3: Measured parameters for systemic vascular function. ET-1: endothelin-1; 
vWF: von Willebrand factor, a marker for endothelial dysfunction; C-IMT: Intima-media 
thickness of the carotid artery; AIx: augmentation index, was defined as the P (was the 
maximum systolic pressure minus pressure at the inflection point) divided by pulse 
pressure and expressed as a percentage. 
 
6.6.4 Retinal vascular function measured by DVA 
The „Slope‟ parameters of both the arterial and venous dilation and constriction were 
calculated based on the extreme values of the fitted polynomials using DVA (Table 6.4). 
The elderly individuals demonstrated a shallow SlopeAC after flicker (-0.29 vs. -0.38, 
p=0.047, Figure 6.1) comparing with middle-aged group, but not in other retinal functional 
parameters (all p>0.05).  
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  Elderly [n=31] Middle-aged [n=33] p-value 
Arteries    
SlopeAD 0.53 (0.47) 0.46 (0.22) >0.05 
SlopeAC -0.29 (0.10) -0.38 (0.21) 0.047 
    
Veins    
SlopeVD 0.33 (0.20) 0.28 (0.14) >0.05 
SlopeVC -0.27 (0.15) -0.24(0.12) >0.05 
 
Table 6.4: Vascular function parameters on ocular levels determined by the 
dynamic vessel analysis. SlopeAD: slope of arterial dilation; SlopeAC: slope of arterial 
constriction; SlopeVD: slope of venous dilation; SlopeAC: slope of venous constriction. 
 
 
 
 
Figure 6.1: Averaged arterial response profile for the elderly and middle-aged 
subjects generated through Matlab. Demonstrates the significant shallower slope of 
arterial constriction found in the elderly individuals compared to the middle-aged 
group. 
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6.6.5 Correlation 
Multiple regression analysis (Table 6.5) revealed that in the elderly group, SlopeAC 
significantly correlated with circadian changes in HF (β=0.725, p=0.012, Figure 6.2). 
However, in the middle-aged subjects, the indices failed to correlate significantly (p>0.05). 
 
Y variable 
X variable 
selected R R2 R2 change F p 
Slope AC vWF 0.387 0.150 0.150 2.469 0.138 
 
Circadian HF 0.697 0.485 0.336 8.477 0.012 
 
Table 6.5: A forward stepwise multiple regression analysis results. It demonstrates 
circadian changes of HF (R2 change=0.336, p=0.012) had most important influence on 
Slope AC. SlopeAC: slope of arterial constriction; circadian HF= day period HF - night period 
HF; HF: high frequency; vWF: von Willebrand factor. p<0.05 is considered significant.  
 
 
 
Figure 6.2: The relationship between the slope of retinal arterial constriction and 
circadian HF in the elderly group. SlopeAC: slope of arterial constriction; circadian HF: 
circadian changes of high frequency. 
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6.7 Discussion 
6.7.1 Main finding 
Parameters reflecting ANS tone in the healthy elderly were significantly different 
compared to the healthy middle-aged group. In addition, the elderly group exhibited higher 
levels of systemic markers for endothelial/vascular dysfunction, and impaired retinal 
vascular function compared to the middle-aged group. Moreover, the impaired retinal 
vascular function correlated with ANS disturbance in the healthy elderly individuals. 
 
6.7.2 Autonomic function  
The HRV analysis is a reliable non-invasive method for indirect evaluation of ANS function 
(Bootsma et al., 1994;Pagani et al., 1986). The ratio of the LF to HF components 
represents a measure of sympathovagal balance (Choi et al., 2006;Pagani and Malliani, 
2000). Several studies have demonstrated that elderly individuals exhibited a disturbance 
in ANS activities compared to young subjects (Choi et al., 2006;Dawson et al., 1999;Yu et 
al., 2010). In addition, abnormal circadian variations in HRV could indirect reflect an 
abnormal adaptation to changes in mental and physical activity that occur during the day-
to-day life, and this function could be modified by ageing.  
 
Several researches reported that in normal conditions, the PSNS tone is higher during the 
night (Davy et al., 1998;De Meersman, 1993;Gregoire et al., 1996). Similar these studies, 
the present study also found a negative value (expected) of circadian HF in the middle-
aged subjects from day to night; whereas the elderly group did not show the similar 
circadian changes in HF that possibly suggested a reduced circadian variation in the 
parasympathetic activity with ageing. Indeed, previous researches have already shown 
that the a decline in parasympathetic activity occurs in elderly individuals (Amano et al., 
Chapter 6 
_______________________________________________________________________ 
 
177 
 
2001;Antelmi et al., 2004;Bigger et al., 1996;Choi et al., 2006;Corino et al., 
2007;Hrushesky et al., 1984;Oida et al., 1999;Yu et al., 2010) and could be responsible 
for BP alterations (Monahan, 2007). The present results also demonstrated that elderly 
individuals had higher SBP values than middle-aged controls. It was not able to 
demonstrate any changes in the SNS with age between the groups. It is possible that the 
small number of participants included in the present study has acted as a major limitation.   
 
6.7.3 Plasma markers for endothelial function 
It has been already demonstrated that vWF acts as an indicator for endothelial 
dysfunction (Blann and Lip, 1998;Lip et al., 2001). Additionally, ET-1 is described as the 
most potent vasoconstrictor and plays an important role in endothelial dysfunction (Amiri 
et al., 2004;Yanagisawa et al., 1988). High levels of vWF and ET-1 have been 
demonstrated in vascular diseases (Freixa et al., 2011;Heitmar et al., 2011;Kappers et al., 
2010), moreover, increased ET-1 has also been found with advanced age (Maeda et al., 
2003). Similar to previous research (Maeda et al., 2003), the present results also 
demonstrated higher circulating levels of ET-1 in the elderly group; moreover, the elderly 
subjects exhibited higher vWF levels compared to the middle-aged group. Increased ET-1 
levels could result in an inhibition of the NO production possibly through down-regulation 
of the eNOS activity (Minshall et al., 2003), therefore, leading to endothelial dysfunction. 
An overproduction of ET-1 also results in chronic vasoconstriction, hypoxia and high 
levels of ROS (Duerrschmidt et al., 2000;Loomis et al., 2005). ROS further react with BH4 
(tetrahydrobiopterin), a cofactor for production of NO (Landmesser et al., 2003;Zheng et 
al., 2003) leading to further impairment of the eNOS function (eNOS uncoupling). Taken 
together, increased ET-1 results to ROS over-production, decrease of BH4 bioavailability 
and hence eNOS uncoupling, and this cascade of events may play a key role in the age-
related endothelial dysfunction that are measurable at various levels including plasma and 
retinal vessels.  
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6.7.4 Ocular vascular function  
Lanzal et al. recently investigated ocular vascular indices in different age groups, and 
showed that elderly group exhibited a smaller arterial constriction below baseline after 
cessation of flickering light compared to young individuals (Lanzl et al., 2011). By using a 
new computational model, it has been also demonstrated that a decrease rate of arterial 
constriction following cessation of flicker in the elderly otherwise healthy subjects 
compared to middle-aged group. This shallow slope of arterial constriction might be 
related to the impaired basal vascular tone in retina arteries (Lanzl et al., 2011), possible 
due to higher circulatory levels of ET-1 that negatively influence the retinal endothelial 
function. In addition, in line with previous research (Lanzl et al., 2011;Mroczkowska et al., 
2011;Qin et al., 2011b), the arterial reaction profile measured in both groups did appear to 
have the expected „two humped‟ arterial dilation response profile (Figure 6.1)(Lanzl et al., 
2011)(Lanzl et al., 2011). This particular aspect of the retinal arteries response to 
flickering light was explained by the possible existence of two separate systems 
responsible for retinal arterial dilation, the first being a fast onset, short duration system 
which mediated by eNOS and NO and the second being a slow onset, long duration 
system that represents the summation of dilation and constriction factors (Lanzl et al., 
2011).  
 
6.7.5 ANS and vascular function 
The effect of ANS to endothelial function has been widely studied. The ANS and the 
endothelium works together to control the vascular tone through a balance between the 
releases of vasoconstrictor from sympathetic nerve terminals and vasodilator from 
endothelial cells (Harris and Matthews, 2004). Harris and Matthews research suggested 
that a decreased PSNS activity can impair the ability of the ANS to regulate the vascular 
tone (Harris and Matthews, 2004). This abnormal ANS activity and impaired endothelial 
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function could contribute to a dysregulation of vascular tone, possible influence on both 
macro- and micro-vascular levels including retinal vascular function. In addition, previous 
report suggested that the ANS was more responsible for integrating systemic factors, 
whereas the endothelium was more responsive to local factors (Burnstock, 1993;Harris 
and Matthews, 2004). The present results demonstrated that observed the impaired 
retinal vascular function significantly correlated with the abnormal circadian variation in the 
PSNS activity in elderly individuals. It is possible that these parallel changes represent the 
first sign of an increased risk for CVD with ageing.  
 
6.7.6 Conclusion 
The healthy elderly subjects showed impaired ANS and vascular function at both macro- 
and micro-vascular levels compared to the middle-aged group. Additionally, the impaired 
retinal vascular function was associated with abnormal circadian PSNS activity in elderly 
individuals and these parallel alterations could represent the first sign of an increment in 
the general risk for CVD with ageing. At this point, more non-invasive assessment of ANS 
and ocular function should be needed to complement the diagnosis, risk assessment and 
monitoring even in healthy elderly individuals as ageing is a vital risk factor for various 
vascular diseases. 
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7.1 Summary and Conclusions 
The importance of vascular risk factors that increase with the ageing process, such as 
oxidative stress and endothelial dysfunction, has been researched previously in various 
age-related diseases including AMD, and the relevant scientific literature has been 
reviewed in Chapter 1 of this thesis. However, it is still unclear when and how 
haemodynamic disturbances occurring in various ocular and systemic vascular beds act 
either separately or in association to induce disease. An answer to these questions could 
open new screening, diagnosis and therapeutic avenues for those at risk. This thesis has 
been concerned with investigating the presence and impact of ocular and systemic 
vascular functional and biochemical vascular risk factors in healthy elderly individuals and 
in AMD patients. Moreover, the possible role played by disruption in the equilibrium 
between various systems that act to maintain the vascular homeostasis has also been 
investigated. A separate chapter was dedicated to the relationship between ocular and 
systemic antioxidative mechanisms in maintaining a healthy status. 
 
In summary, the main findings of this work were: 
 
7.1.1 The relationship between ocular and systemic antioxidant in 
defense mechanisms in healthy individuals 
Oxidative stress is defined by the presence of pathological levels of ROS relative to the 
antioxidant defence, and it has been reported to play a key role in the aetiology of AMD 
(Beatty et al., 2000;Khandhadia and Lotery, 2010). In addition, high levels of oxidative 
stress direct causes low bioavailability of the vasodilatory molecule, NO (Evereklioglu et 
al., 2003) and endothelial dysfunction (Cai and Harrison, 2000;Nedeljkovic et al., 2003) 
which is a condition known to precede both metabolic and CVD, as well as ocular 
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circulatory disturbances (Lip et al., 2001;Zaliuniene et al., 2008). GSH represent one of 
the most potent factors to prevent oxidative damage to human body. A low level of 
circulating GSH could cause imbalance of redox status (GSH: GSSG ratio), and have 
potential harmful effect on various tissues and organs including eyes. At the local level the 
antioxidant defence is represented by the MP; it consists of lutein, zeaxanthin and meso-
zeaxanthin, all potent antioxidants molecules that act against the oxidative damage of 
high-energy blue light to the retina (Bone et al., 1985;Khachik et al., 2002;Krinsky, 2002) 
and therefore, protect against subsequent AMD (Hammond B.R et al., 1998).  
 
Although dietary intake of lutein and zeaxabthin could increase the level of MP with 
positive effects on AMD prevention and prognosis (Bartlett et al., 2010;Davies and 
Morland, 2004), and carotenoid rich food intake enhance the systemic antioxidant level in 
healthy individuals (Sternberg et al., 1993), to date no study has investigated whether the 
local and systemic antioxidant systems are somehow related. Therefore, the aim of this 
study was to determine if there was a relationship between local and systemic antioxidant 
defence markers in subjects without either ocular or systemic diseases. In Chapter 3, the 
results demonstrated that independent of age and gender, there was a positive correlation 
between MPOD and circulating GSH level in the healthy individuals. As it is complex to 
measure systemic levels of antioxidant molecules and need specialized laboratories, a 
simple MPOD assessment could be used as surrogate indicator of the individual‟s 
systemic ability of dealing with the harmful effect of free radicals, and consequently to 
monitor those at risk of developing chronic ocular and/or systemic pathologies.  
 
This study only included the participants over the age of 40 years who are free of macular 
changes or other ocular pathologies as well as systemic chronic diseases and various 
therapeutic interventions. Additionally, smokers and individuals taking any antioxidant 
supplements were also excluded. This careful selection has limited the number of subjects 
in the final analysis. It is possible that the relationship between MPOD and blood GSH 
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level is different not only in various age groups but also in individuals with other risk 
factors for vascular diseases. Further studies may need to be investigated in large and 
more populations to cover the many possible confounders that have been either missed or 
intentionally avoided in the present study. 
 
7.1.2 Macro- and micro-vascular abnormalities in patients with 
early age-related macular degeneration: correlation with 
blood markers of oxidative stress 
Some studies shown that AMD is related with subclinical signs of CVD (Klein et al., 
1993;Vingerling et al., 1995). More reports found that patients suffering from AMD are at 
higher risk than age-matched healthy individuals for developing CHD and stroke (Liao et 
al., 2008;Wong et al., 2006;Wong et al., 2007). Therefore, early screening of AMD 
patients for such pathologies could represent an important step of prevention and 
disease-modifying interventions. It is well known that oxidative stress and endothelial 
dysfunction have been suggested as early events involved in the pathogenesis of CVD 
(Lee et al., 2011;Madamanchi et al., 2005;Shechter et al., 2007;Weil et al., 2011), and 
endothelial dysfunction occur much earlier at the microvascular than the macrovascular 
level. Consequently, measurements of retinal vascular function have been developed to 
demonstrate the presence of such microcirculatory abnormalities in patients with already 
present various diseases including exudative AMD (Gugleta et al., 2011;Lanzl et al., 
2011). However, it was never proved if there is an obvious abnormal retinal vascular 
function that could be measured in early AMD patients. It has been already validated that 
measures of retinal microvascular function are useful in demonstrating early vascular 
changes that signal risk for CVD in individuals without overt disease (Heitmar et al., 
2010;Patel et al., 2011). The work outlined in this study aimed to assess the retinal 
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vascular function and its relationship to established systemic factor for CVD risk in early 
AMD patients without overt systemic pathologies.  
 
The recruitment was limited by the fact that patients diagnosed with early AMD often take 
antioxidant supplements, and this was an exclusion criterion for my study. Finding healthy 
elderly individuals was also limiting variable, although this was general problem for the 
entire study. In addition, I also excluded smokers. However, this very careful selection 
helped us to remove all the possible biases and to demonstrate that indeed there was an 
altered vascular response pattern both at retinal and systemic levels in patients suffering 
from early AMD without overt CVD. Moreover, the present results shown for the first time 
that a abnormal retinal vascular response to flickering light was related to circulating 
markers of oxidative stress in these patients. Oxidative stress is a risk factor for 
developing CVD (Lee et al., 2011;Madamanchi et al., 2005), and contributes to abnormal 
vascular function. The fact that this extended to the microvessels and we were able to 
measure it in apparently healthy individuals, is a novelty. This finding could be the first 
signal for risk of future systemic vascular diseases, and more aggressive interventions to 
prevent disease should be deployed in these patients. 
 
7.1.3 Relationship between retinal vascular function and 
circulatory markers of endothelial dysfunction and 
cardiovascular risk   
Among other risk factors, oxidative stress and endothelial dysfunction are also thought to 
be involved in development of CVD, via dysregulation of vascular tone, growth, 
thrombogenicity and inflammation (Lerman and Zeiher, 2005;Lusis, 2000;Staels, 
2002;Thomas, 2011). Endothelial dysfunction however is known to occur much earlier at 
microascular level than macrovascular level (Gariano and Gardner, 2005;Gates et al., 
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2009), and therefore, many approaches including assessing retinal vascular function, 
have been developed to investigate such abnormal microcirculation at the earliest stage of 
vascular disease. Some previous studies have already reported that reduced retinal 
vascular responses to a flicker stimulation in patients diagnosed with diabetes, glaucoma 
and CAD (Garhofer et al., 2004a;Garhofer et al., 2004b;Heitmar et al., 2011;Mandecka et 
al., 2007). This retinal vascular function was demonstrated in patients suffering from overt 
systemic diseases with already impaired systemic endothelial function, however, if the 
similar dysregulation of retinal microcirculation exist and measurable at an early process 
of such endothelial dysfunction in otherwise healthy subjects. By using DVA and novel 
computational analysis, the present results have shown that retinal vascular function was 
closely correlated with the oxidative stress, LDL-C and ET-1, established blood markers of 
CVD risk. These circulating molecules of CVD risk, could have a such early influence on 
the retinal vascular tone. Early detection of such abnormal retinal vascular function 
however, could prevent those subjects at risk for future vascular disease.    
 
Only at this stage, more studies need to carry out to provide better knowledge of the exact 
mechanisms responsible; however, few hypotheses could be proposed. Indeed, with 
ageing, local high levels of oxidative stress results in apoptosis of endothelial cells, 
leading down-regulation of local endothelial function and vascular tone (Ballatori et al., 
2009;Huh et al., 2006;Jones, 2006a;Sykes et al., 2007). Additionally, under the high 
oxidative stress, LDL-C is oxidized and form oxLDL-C, cause a decrease in the production 
of NO, enhance in expression of ET-1, leading to local retinal endothelial dysfunction and 
deyregulation of vascular tone (Chen et al., 2007;Cominacini et al., 2001;Itabe et al., 
2011;Ou et al., 2010;Sawamura et al., 1997). At the moment, it is unclear if one or all of 
these mechanisms contribute to the observed abnormal vascular reactivity, however, 
more research is needed to explore it.    
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7.1.4 Age-associated changes in ANS and vascular function  
Ageing is a process that degeneration of cells including endothelial cells over time that 
could increase the risk for development of vascular diseases such as CVD and stroke 
(Harman, 2001;Harman, 2006;Karavidas et al., 2010;Kruk et al., 1995;Lee and Oh, 
2010;Shirwany and Zou, 2010). It has been already demonstrated that senescence 
negatively affects the HRV and endothelial function (Charkoudian and Rabbitts, 
2009;Corino et al., 2007;Maeda et al., 2003;Morange et al., 2004). This present study 
demonstrated that the healthy elderly individuals had abnormal circadian changes of 
PSNS activity, and higher levels of vWF and ET-1 compared to middle-aged subjects. 
These evidences confirmed again that ageing has a potential disruptive effect on both 
ANS and endothelial function. Indeed, ANS and the endothelium work together to regulate 
a proper vascular tone (Harris and Matthews, 2004). Additionally, by using DVA, it firstly 
demonstrated that the abnormal carcidan changes of PSNS correlated with impaired 
retinal vascular function in the elderly subjects. These parallel alterations could represent 
the first sign of increased risk for CVD with ageing.   
 
7.2 Conclusions 
The aims of this work were: 
 
7.2.1 To assess the relationship between ocular and systemic 
anti-oxidative defence in healthy individuals  
The main findings of this work were: 
 Age, gender and BP parameters had no effect on either MPOD or blood 
glutathione parameters. 
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 It has been shown that MPOD independently, significantly and positively correlated 
with circulatory GSH levels. 
 
7.2.2 To investigate macro- and microcirculation and oxidative 
stress in early AMD patients without overt systemic disease 
The main findings of this work were: 
 Patients diagnosed with early AMD exhibit signs of subclinical vascular disese. 
 Blood GSSG level was significantly higher in early AMD patients than age-
matched controls. 
 Patients suffering from early AMD showed abnormal vascular function at retinal 
level compared to age-matched healthy controls and only in AMD patients this 
abnormality correlated with blood GSSG levels. 
 
7.2.3 To assess the relationship between ocular vascular function 
and circulatory markers of endothelial dysfunction and CVD 
risk  
The main findings of this work were: 
 Age had a positive effect on ET-1, vWF and slope of retinal arterial constriciton in 
otherwise healthy individuals. 
 Even in otherwise healthy individuals, it has been shown that SlopeAC 
independently, significantly and positively correlated with the level of ET-1 ad LDL-
C; additionally, SlopeAD independently, significantly and positively correlated with 
redox index.  
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7.2.4 To assess age-related changes in ANS and vascular 
function, and their relationship to retinal vascular function 
parameters  
The main findings of this work were: 
 Elderly individuals demonstrated abnormal circadian changes of PSNS activity 
compared to middle-aged healthy subjects. 
 Circulatory levels of ET-1 and vWF, as well as C-IMT and AIx were significant 
higher in elderly group than middle-aged group. 
 Elderly subjects showed the impaired retinal vascular function compared to 
middle-aged group. 
  In the elderly individuals, impaired retinal vascular function independently, 
significantly and positively correlated with the dysregulation of PSNS activity. 
 
7.3 Clinical implications arising from these results 
Retinal vascular function has exhibited a close relationship with circulatory makers of 
oxidative stress, endothelial dysfunction and CVD risk in otherwise healthy individuals but 
with various degrees of risk. Assessing retinal vascular function could be a tempting non-
invasive approach to monitor potential risk for endothelial dysfunction and CVD risk at a 
much earlier stage of the disease process when disease-modifying interventions are still 
possible. In addition, MPOD acts as a non-invasive measurement of retinal oxidative 
status that positively correlated with circulatory GSH levels; therefore, simple MPOD 
assessment could be used as surrogate indicator of the systemic capacity of dealing with 
the damaging effect of free radicals and, consequently, of their risk for developing chronic 
ocular and/or systemic pathologies. The results of this thesis show that the retinal 
vascular tone/function could be used as surrogate markers in a number other applications, 
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such as; mass population screening for vascular diseases, vascular function in other at 
risk individuals (i.e. advanced age), therapeutic prevention of vascular diseases (i.e. 
improve life style, exercise, nutritional, medicine), assessment of vascular function in other 
ocular/vascular disorders (i.e. AMD). This assessment of retinal vasulcar reactivity is a 
quick and non-invasive technique acts as a screening and preventive measure could be 
used in everyday clinical setting.  
 
7.4 Future areas of research arising from the present 
work 
Of the number of new questions that this thesis uncovered, three particular avenues of 
future research are worth highlighting.  
 
7.4.1 The effect on ocular endothelial function in the wet-AMD 
patients treated with anti-VEGF drugs 
Vascular endothelial growth factor (VEGF) represents a major mediator of angiogenesis 
and a strong vascular permeability factor (Ferrara, 2004), therefore playing a vital role in 
the pathogenesis of retinal neovascularization and vessel leakage in wet AMD (Ford et al., 
2011). Patients suffering from AMD are at higher risk for developing CHD, myocardial 
infarction and stroke (Liao et al., 2008;Wong et al., 2006;Wong et al., 2007); moreover, 
they also are more likely to have a increased  mortality compared to the age-matched 
healthy population (Tan et al., 2008). Additionally, some of anti-VEGF treatments could 
increase the risk for stroke; and this possibility could have important therapeutic 
implications. Therefore, early identification of those AMD patients at high risk of 
developing serious cardio and/or cerebro-vascular pathology after receiving anti-VEGF 
treatments is a priority. The present results of this thesis have already showed that retinal 
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vascular function measurements could be used to detect early cardiovascular risk. It is 
possible that by using similar approach to investigate the effect of anti-VEGF drugs used 
fir AMD treatment on patients‟ vascular function. In addition, the effect of the anti-VEGF 
treatment on the vascular healthy could also be monitored, allowing prompt intervention 
when first signs of risk occur. 
 
7.4.2 Macular pigment as a marker of cardiovascular risk  
Among various risk factors such as environmental, nutritional and genetic involved in the 
aetiology of AMD, high levels of oxidative stress have also been thought to play a role. As 
already mentioned, in healthy subjects, local retinal protection against free radicals is 
aided by the presence of MP. In addition to local retinal damage, high levels of oxidative 
stress also induces vascular changes that confer a background for circulatory 
disturbances in the systemic macro- and microcirculation that are also present in patients 
suffering from AMD. Systemically, the body is protected against such effects by a number 
or circulating substances. In the Chapter 3 of the present thesis, it has been found that the 
level of MPOD correlates with the circulatory level of antioxidant molecules. However, 
MPOD is only one way of measuring MP levels.  It would be interesting  to validate 
different types of measurements of MP as surrogate indicators of the individual‟s systemic 
capacity of dealing with the damaging effect of free radicals and, consequently, of their 
risk for developing chronic ocular and/or systemic pathologies. In this way, optometrists 
and ophthalmologists will be equipped with the possibility of screening individuals for 
vascular health through a simple measurement of the MP and the need of more 
sophisticated analyses and waiting lists will be thus avoided. 
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7.4.3 Antioxidant supplementation effect on ocular and systemic 
vascular parameters in AMD 
During the recruitment of early AMD patients for this present thesis, I have found that 
most of them were taking various antioxidant supplements that included lutein. Indeed, 
lutein and its isomers, zeaxanthin and meso-zeaxanthin act as antioxidants and a filter of 
high power blue light (Krinsky, 2002); in addition, they seem to help with improving the 
visual function in patients suffering from AMD (Richer et al., 2004;Sasamoto et al., 2011). 
Nevertheless, the results reported after lutein supplementation are inconsistent (Bartlett 
and Eperjesi, 2008) and more work is necessary to demonstrate the beneficial effect of 
such supplements at both ocular and systemic level. As antioxidants also claim to improve 
vascular health, and AMD patients have high oxidative stress and are at higher risk of 
developing CVD, a prospective, controlled study to assess the effect of antioxidants on 
the ocular disease prognosis and risk for future vascular pathologies in AMD patients is 
warranted.  
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Appendix 1. A sample of HRV report 
 
 
 
 
 
 
LF: low frequency component; HF: high frequency component. Active period refers to Day 
chart, and passive period refers to Night chart. 
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